E3	B-protein
,	O
a	O
hematopoietic-specific	B-protein
transcript	I-protein
directly	O
regulated	O
by	O
the	O
retinoic	B-protein
acid	I-protein
receptor	I-protein
alpha	I-protein
.	O

Retinoic	O
acid	O
(	O
RA	O
)	O
-induced	O
maturation	O
mediated	O
by	O
the	O
retinoic	B-protein
acid	I-protein
receptor	I-protein
alpha	I-protein
(	O
RAR	B-protein
alpha	I-protein
)	O
has	O
been	O
implicated	O
in	O
myeloid	O
development	O
.	O

We	O
have	O
used	O
differential	O
hybridization	O
analysis	O
of	O
a	O
cDNA	B-DNA
library	I-DNA
constructed	O
from	O
the	O
murine	O
RA-inducible	B-cell_line
MPRO	I-cell_line
promyelocyte	I-cell_line
cell	I-cell_line
line	I-cell_line
to	O
identify	O
immediate-early	B-DNA
genes	I-DNA
induced	O
by	O
RA	O
during	O
granulocytic	O
differentiation	O
.	O

E3	B-protein
,	O
one	O
of	O
nine	O
sequences	O
identified	O
,	O
was	O
upregulated	O
in	O
an	O
immediate-early	O
manner	O
,	O
with	O
transcript	O
levels	O
peaking	O
after	O
60	O
minutes	O
exposure	O
to	O
RA	O
.	O

E3	B-protein
transcripts	I-protein
were	O
RA-inducible	O
in	O
HL60	B-cell_line
cells	I-cell_line
,	O
but	O
not	O
in	O
an	O
RA-resistant	B-cell_line
subclone	I-cell_line
,	O
HL60R	B-cell_line
,	O
that	O
harbors	O
a	O
mutated	O
RAR	B-DNA
alpha	I-DNA
gene	I-DNA
.	O

However	O
,	O
when	O
HL60R	B-cell_line
cells	I-cell_line
were	O
transduced	O
with	O
a	O
functional	O
copy	O
of	O
the	O
RAR	B-DNA
alpha	I-DNA
gene	I-DNA
,	O
RA	O
induced	O
a	O
10-fold	O
increase	O
in	O
E3	B-protein
mRNA	O
levels	O
.	O

E3	B-protein
transcripts	I-protein
are	O
present	O
in	O
the	O
myeloid	B-cell_type
,	I-cell_type
B-lymphoid	I-cell_type
,	I-cell_type
and	I-cell_type
erythroid	I-cell_type
lineages	I-cell_type
,	O
absent	O
in	O
nonhematopoietic	B-cell_type
cells	I-cell_type
,	O
and	O
encode	O
a	O
highly	O
hydrophobic	O
,	O
potentially	O
phosphorylated	O
polypeptide	O
of	O
unknown	O
function	O
with	O
significant	O
homology	O
to	O
a	O
putative	O
protein	O
expressed	O
in	O
myeloid	B-cell_type
cells	I-cell_type
.	O

The	O
murine	O
E3	B-DNA
promoter	I-DNA
harbors	O
a	O
single	O
bipartite	B-DNA
retinoic	I-DNA
acid	I-DNA
response	I-DNA
element	I-DNA
which	O
in	O
transient	O
transfection	O
assays	O
conferred	O
RA	O
sensitivity	O
.	O

These	O
results	O
indicate	O
that	O
E3	B-protein
is	O
a	O
hematopoietic-specific	B-DNA
gene	I-DNA
that	O
is	O
an	O
immediate	O
target	O
for	O
the	O
activated	O
RAR	B-protein
alpha	I-protein
during	O
myelopoiesis	O
.	O

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

E3	NULL
,	NULL
a	NULL
Hematopoietic-Specific	NULL
Transcript	NULL
Directly	NULL
Regulated	NULL
by	NULL
the	NULL
Retinoic	NULL
Acid	NULL
Receptor	NULL
a	NULL
By	NULL
Linda	NULL
M.	NULL
Scott	NULL
,	NULL
LeMoyne	NULL
Mueller	NULL
,	NULL
and	NULL
Steven	NULL
J.	NULL
Collins	NULL
Retinoic	NULL
acid	NULL
(	NULL
RA	NULL
)	NULL
-induced	NULL
maturation	NULL
mediated	NULL
by	NULL
the	NULL
retinoic	NULL
acid	NULL
receptor	NULL
a	NULL
(	NULL
RARa	NULL
)	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
myeloid	NULL
development	NULL
.	NULL

We	NULL
have	NULL
used	NULL
differential	NULL
hybridization	NULL
analysis	NULL
of	NULL
a	NULL
cDNA	NULL
library	NULL
constructed	NULL
from	NULL
the	NULL
murine	NULL
RA-inducible	NULL
MPRO	NULL
promyelocyte	NULL
cell	NULL
lins	NULL
to	NULL
identify	NULL
immediate-early	NULL
genes	NULL
induced	NULL
by	NULL
RA	NULL
during	NULL
granulocytic	NULL
differentiation	NULL
.	NULL

E3	NULL
,	NULL
one	NULL
of	NULL
nine	NULL
sequences	NULL
identified	NULL
,	NULL
was	NULL
upregulated	NULL
in	NULL
an	NULL
immediate-early	NULL
manner	NULL
,	NULL
with	NULL
transcript	NULL
levels	NULL
peaking	NULL
after	NULL
60	NULL
minutes	NULL
exposure	NULL
to	NULL
RA	NULL
.	NULL

E3	NULL
transcripts	NULL
were	NULL
RA-inducible	NULL
in	NULL
HL60	NULL
cells	NULL
,	NULL
but	NULL
not	NULL
in	NULL
an	NULL
RA-resistant	NULL
subclone	NULL
,	NULL
HLGOR	NULL
,	NULL
that	NULL
harbors	NULL
a	NULL
mutated	NULL
AMARe	NULL
gene	NULL
.	NULL

However	NULL
,	NULL
when	NULL
HLG6OR	NULL
cells	NULL
were	NULL
transduced	NULL
with	NULL
a	NULL
functional	NULL
copy	NULL
of	NULL
the	NULL
ETINOIC	NULL
ACID	NULL
(	NULL
RA	NULL
)	NULL
,	NULL
the	NULL
active	NULL
metabolite	NULL
of	NULL
vitamin	NULL
A	NULL
,	NULL
appears	NULL
to	NULL
contribute	NULL
to	NULL
a	NULL
wide	NULL
range	NULL
of	NULL
biologic	NULL
processes	NULL
involved	NULL
with	NULL
epithelial	NULL
differentiation	NULL
,	NULL
cellular	NULL
homeostasis	NULL
,	NULL
embryogenesis	NULL
,	NULL
and	NULL
tumor	NULL
suppression	NULL
.	NULL

The	NULL
diverse	NULL
range	NULL
of	NULL
responses	NULL
to	NULL
RA	NULL
appears	NULL
to	NULL
be	NULL
mediated	NULL
primarily	NULL
by	NULL
two	NULL
classes	NULL
of	NULL
ligand-dependent	NULL
transcription	NULL
factors	NULL
that	NULL
belong	NULL
to	NULL
the	NULL
steroid/thyroid	NULL
superfamily	NULL
of	NULL
hormone	NULL
receptors	NULL
.	NULL

These	NULL
are	NULL
the	NULL
RA	NULL
receptor	NULL
(	NULL
RAR	NULL
)	NULL
and	NULL
retinoid-X	NULL
receptor	NULL
(	NULL
RXR	NULL
)	NULL
families	NULL
,	NULL
``	NULL
of	NULL
which	NULL
there	NULL
are	NULL
at	NULL
least	NULL
three	NULL
different	NULL
members	NULL
,	NULL
a	NULL
,	NULL
3	NULL
,	NULL
and	NULL
y	NULL
,	NULL
usually	NULL
present	NULL
in	NULL
several	NULL
isoforms	NULL
.	NULL

Although	NULL
the	NULL
RAR	NULL
and	NULL
RXR	NULL
molecules	NULL
specifically	NULL
respond	NULL
to	NULL
RA	NULL
,	NULL
they	NULL
differ	NULL
from	NULL
one	NULL
another	NULL
in	NULL
primary	NULL
structure	NULL
and	NULL
ligand	NULL
specificity	NULL
.	NULL

RXRs	NULL
bind	NULL
the	NULL
9-cis	NULL
RA	NULL
isomer	NULL
with	NULL
high	NULL
affinity	NULL
,	NULL
whereas	NULL
RARs	NULL
bind	NULL
both	NULL
the	NULL
9-cis	NULL
and	NULL
the	NULL
all-trans	NULL
isoforms	NULL
.	NULL
``	NULL

This	NULL
complex	NULL
array	NULL
of	NULL
receptor	NULL
molecules	NULL
forms	NULL
dimers	NULL
capable	NULL
of	NULL
altering	NULL
transcription	NULL
of	NULL
target	NULL
genes	NULL
in	NULL
a	NULL
positive	NULL
or	NULL
a	NULL
negative	NULL
manner	NULL
,	NULL
dependent	NULL
on	NULL
the	NULL
cellular	NULL
context	NULL
.	NULL

RARs	NULL
activate	NULL
transcription	NULL
of	NULL
target	NULL
genes	NULL
by	NULL
direct	NULL
interaction	NULL
with	NULL
specific	NULL
DNA	NULL
sequences	NULL
known	NULL
as	NULL
RA	NULL
response	NULL
elements	NULL
.	NULL

Several	NULL
target	NULL
genes	NULL
regulated	NULL
directly	NULL
via	NULL
these	NULL
response	NULL
elements	NULL
have	NULL
been	NULL
identified	NULL
and	NULL
include	NULL
genes	NULL
involved	NULL
in	NULL
RA-mediated	NULL
signaling	NULL
,	NULL
such	NULL
as	NULL
RARa	NULL
and	NULL
RAR,3	NULL
,	NULL
*~	NULL
cellular	NULL
retinol	NULL
binding	NULL
protein	NULL
I	NULL
and	NULL
cellular	NULL
retinoic	NULL
acid	NULL
binding	NULL
protein	NULL
II	NULL
,	NULL
**	NULL
homeobox	NULL
genes	NULL
Hoxal	NULL
and	NULL
Hoxb1	NULL
,	NULL
*	NULL
``	NULL
and	NULL
the	NULL
immediate-early	NULL
gene	NULL
,	NULL
zif268	NULL
.	NULL
``	NULL

Promoter	NULL
analysis	NULL
of	NULL
multiple	NULL
target	NULL
genes	NULL
has	NULL
shown	NULL
RA	NULL
response	NULL
elements	NULL
to	NULL
be	NULL
direct	NULL
repeats	NULL
of	NULL
a	NULL
hexameric	NULL
consensus	NULL
motif	NULL
,	NULL
AGGTCA	NULL
,	NULL
although	NULL
the	NULL
sequence	NULL
,	NULL
spacing	NULL
,	NULL
and	NULL
number	NULL
of	NULL
these	NULL
half-sites	NULL
is	NULL
variable	NULL
and	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
binding	NULL
affinity	NULL
and	NULL
dimer	NULL
specificity	NULL
of	NULL
the	NULL
enhancer	NULL
elements	NULL
.	NULL

'*	NULL
``	NULL
Several	NULL
lines	NULL
of	NULL
evidence	NULL
suggest	NULL
RA	NULL
and	NULL
its	NULL
receptor	NULL
,	NULL
RARa	NULL
,	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
hematopoietic	NULL
regulation	NULL
.	NULL

RA	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
induce	NULL
terminal	NULL
granulocytic	NULL
differentiation	NULL
of	NULL
the	NULL
human	NULL
myeloid	NULL
HL6O0	NULL
cell-line	NULL
.	NULL
'	NULL

''	NULL
Evidence	NULL
that	NULL
RARa	NULL
mediates	NULL
this	NULL
response	NULL
was	NULL
obtained	NULL
when	NULL
an	NULL
RA-resistant	NULL
subclone	NULL
,	NULL
HL6OR	NULL
,	NULL
was	NULL
observed	NULL
to	NULL
harbor	NULL
RA	NULL
receptors	NULL
with	NULL
significantly	NULL
reduced	NULL
affinity	NULL
for	NULL
RA	NULL
.	NULL
``	NULL

These	NULL
receptors	NULL
are	NULL
produced	NULL
as	NULL
the	NULL
result	NULL
of	NULL
a	NULL
point	NULL
mutation	NULL
within	NULL
one	NULL
copy	NULL
of	NULL
the	NULL
RARa	NULL
gene	NULL
,	NULL
leading	NULL
to	NULL
the	NULL
synthesis	NULL
of	NULL
truncated	NULL
RARa	NULL
molecules	NULL
with	NULL
aberrant	NULL
ligand-binding	NULL
domains	NULL
.	NULL
``	NULL

Retroviral-mediated	NULL
transfer	NULL
of	NULL
a	NULL
functional	NULL
RARa	NULL
gene	NULL
into	NULL
these	NULL
HLGOR	NULL
cells	NULL
restored	NULL
their	NULL
sensitivity	NULL
to	NULL
RA	NULL
,	NULL
facilitat-	NULL
Blood	NULL
,	NULL
Vol	NULL
88	NULL
,	NULL
No	NULL
7	NULL
(	NULL
October	NULL
1	NULL
)	NULL
,	NULL
1996	NULL
:	NULL
pp	NULL
2517-2530	NULL
gene	NULL
,	NULL
RA	NULL
induced	NULL
a	NULL
10-fold	NULL
increase	NULL
in	NULL
E3	NULL
mRNA	NULL
levels	NULL
.	NULL

E3	NULL
transcripts	NULL
are	NULL
present	NULL
in	NULL
the	NULL
myeloid	NULL
,	NULL
B-lymphoid	NULL
,	NULL
and	NULL
erythroid	NULL
lineages	NULL
,	NULL
absent	NULL
in	NULL
nonhematopoietic	NULL
cells	NULL
,	NULL
and	NULL
encode	NULL
a	NULL
highly	NULL
hydrophobic	NULL
,	NULL
potentially	NULL
phosphorylated	NULL
polypeptide	NULL
of	NULL
unknown	NULL
function	NULL
with	NULL
significant	NULL
homology	NULL
to	NULL
a	NULL
putative	NULL
protein	NULL
expressed	NULL
in	NULL
myeloid	NULL
cells	NULL
.	NULL

The	NULL
murine	NULL
E3	NULL
promoter	NULL
harbors	NULL
a	NULL
single	NULL
bipartite	NULL
retinoic	NULL
acid	NULL
response	NULL
element	NULL
which	NULL
in	NULL
transient	NULL
transfection	NULL
assays	NULL
conferred	NULL
RA	NULL
sensitivity	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
E3	NULL
is	NULL
a	NULL
hematopoietic-specific	NULL
gene	NULL
that	NULL
is	NULL
an	NULL
immediate	NULL
target	NULL
for	NULL
the	NULL
activated	NULL
RARa	NULL
during	NULL
myslopoiesis	NULL
.	NULL

©	NULL
1996	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

ing	NULL
granulocytic	NULL
differentiation	NULL
.	NULL

Introduction	NULL
into	NULL
multipotent	NULL
FDCP	NULL
mixA4	NULL
cells	NULL
of	NULL
a	NULL
similarly	NULL
mutated	NULL
RARe	NULL
,	NULL
RARa403	NULL
,	NULL
significantly	NULL
alters	NULL
their	NULL
differentiation	NULL
character-istics	NULL
,	NULL
implying	NULL
that	NULL
the	NULL
role	NULL
of	NULL
RARa	NULL
during	NULL
hematopoiesis	NULL
may	NULL
be	NULL
to	NULL
promote	NULL
granulocytic	NULL
differentiation	NULL
.	NULL
``	NULL

Similarly	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
RARa403	NULL
in	NULL
mouse	NULL
bone	NULL
marrow	NULL
(	NULL
BM	NULL
)	NULL
cells	NULL
has	NULL
led	NULL
to	NULL
the	NULL
establishment	NULL
of	NULL
a	NULL
granulocyte/macro-phage	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
GM-CSF	NULL
)	NULL
-dependent	NULL
promyelocytic	NULL
cell-line	NULL
,	NULL
MPRO	NULL
,	NULL
*°	NULL
the	NULL
cells	NULL
of	NULL
which	NULL
closely	NULL
resemble	NULL
the	NULL
leukemic	NULL
myeloblasts	NULL
present	NULL
in	NULL
human	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
.	NULL

Acute	NULL
promyelocytic	NULL
leukemia	NULL
(	NULL
APL	NULL
)	NULL
is	NULL
a	NULL
subtype	NULL
of	NULL
myeloid	NULL
leukemia	NULL
that	NULL
is	NULL
distinguished	NULL
in	NULL
part	NULL
by	NULL
the	NULL
accumulation	NULL
of	NULL
proliferating	NULL
promyelocytes	NULL
.	NULL

As	NULL
RA	NULL
exerts	NULL
a	NULL
strong	NULL
effect	NULL
on	NULL
APL	NULL
BM	NULL
cultures	NULL
by	NULL
inducing	NULL
progressive	NULL
differentiation	NULL
of	NULL
blasts	NULL
into	NULL
mature	NULL
granulocytes	NULL
,	NULL
``	NULL
and	NULL
as	NULL
patients	NULL
rapidly	NULL
achieve	NULL
remission	NULL
by	NULL
the	NULL
oral	NULL
administration	NULL
of	NULL
su-praphysiological	NULL
concentrations	NULL
of	NULL
RA	NULL
,	NULL
``	NULL
it	NULL
has	NULL
been	NULL
suggested	NULL
that	NULL
perturbations	NULL
in	NULL
RA-mediated	NULL
granulocytic	NULL
differentiation	NULL
may	NULL
play	NULL
a	NULL
pivotal	NULL
role	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
this	NULL
disorder	NULL
.	NULL

An	NULL
additional	NULL
association	NULL
between	NULL
APL	NULL
and	NULL
RA	NULL
is	NULL
apparent	NULL
at	NULL
the	NULL
molecular	NULL
level	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
chromosomal	NULL
breakpoints	NULL
present	NULL
in	NULL
the	NULL
translocations	NULL
,	NULL
t	NULL
(	NULL
15	NULL
;	NULL
17	NULL
)	NULL
(	NULL
q22	NULL
;	NULL
q12-21	NULL
)	NULL
,	NULL
which	NULL
is	NULL
detectable	NULL
in	NULL
the	NULL
vast	NULL
majority	NULL
of	NULL
APL	NULL
cases	NULL
,	NULL
and	NULL
t	NULL
(	NULL
11	NULL
;	NULL
17	NULL
)	NULL
(	NULL
q23	NULL
;	NULL
q21	NULL
)	NULL
,	NULL
an	NULL
infrequent	NULL
APL	NULL
translocation	NULL
,	NULL
localized	NULL
the	NULL
breakpoint	NULL
on	NULL
chromosome	NULL
17	NULL
to	NULL
within	NULL
the	NULL
RARa	NULL
gene	NULL
.	NULL

``	NULL
*	NULL
``	NULL
Both	NULL
translocations	NULL
result	NULL
in	NULL
expression	NULL
of	NULL
RARa	NULL
chimeric	NULL
proteins	NULL
,	NULL
either	NULL
PML/RARa	NULL
or	NULL
PLZF/RARa	NULL
,	NULL
respectively	NULL
,	NULL
which	NULL
retain	NULL
the	NULL
majority	NULL
of	NULL
From	NULL
the	NULL
Division	NULL
of	NULL
Molecular	NULL
Medicine	NULL
,	NULL
Fred	NULL
Hutchinson	NULL
Cancer	NULL
Research	NULL
Center	NULL
,	NULL
Seattle	NULL
WA	NULL
.	NULL

Submitted	NULL
November	NULL
22	NULL
,	NULL
1995	NULL
;	NULL
accepted	NULL
May	NULL
21	NULL
,	NULL
1996	NULL
.	NULL

Supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grant	NULL
No	NULL
.	NULL

CAS8292	NULL
to	NULL
SJ.C	NULL
.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
Steven	NULL
J.	NULL
Collins	NULL
,	NULL
MD	NULL
,	NULL
Division	NULL
of	NULL
Molecular	NULL
Medicine	NULL
,	NULL
Fred	NULL
Hutchinson	NULL
Cancer	NULL
Research	NULL
Center	NULL
,	NULL
1124	NULL
Columbia	NULL
St	NULL
,	NULL
€2-023	NULL
,	NULL
Seattle	NULL
,	NULL
WA	NULL
98104	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

©	NULL
1996	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-4971/96/8807-0036	NULL
$	NULL
3.00/0	NULL
2517	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2518	NULL
the	NULL
functional	NULL
domains	NULL
present	NULL
within	NULL
the	NULL
parental	NULL
proteins	NULL
,	NULL
including	NULL
the	NULL
RARa	NULL
ligand-binding	NULL
and	NULL
DNA-binding	NULL
do-mains	NULL
.	NULL
``	NULL

''	NULL
``	NULL
'	NULL
Although	NULL
the	NULL
PLZF	NULL
and	NULL
PML	NULL
sequences	NULL
are	NULL
not	NULL
related	NULL
to	NULL
one	NULL
another	NULL
,	NULL
they	NULL
each	NULL
contain	NULL
zinc	NULL
fingers	NULL
and	NULL
proline-rich	NULL
sequences	NULL
that	NULL
have	NULL
been	NULL
implicated	NULL
in	NULL
transcriptional	NULL
regulation	NULL
``	NULL
and	NULL
that	NULL
are	NULL
retained	NULL
in	NULL
the	NULL
chimeric	NULL
RARa	NULL
proteins	NULL
.	NULL

The	NULL
observation	NULL
that	NULL
RARa	NULL
is	NULL
the	NULL
common	NULL
target	NULL
in	NULL
translocations	NULL
associated	NULL
with	NULL
APL	NULL
strongly	NULL
implicates	NULL
expression	NULL
of	NULL
an	NULL
abnormal	NULL
RARa	NULL
fusion	NULL
product	NULL
in	NULL
the	NULL
etiology	NULL
of	NULL
this	NULL
disease	NULL
.	NULL

However	NULL
,	NULL
the	NULL
cellular	NULL
implications	NULL
of	NULL
the	NULL
presence	NULL
of	NULL
mutated	NULL
RARa	NULL
proteins	NULL
on	NULL
promyelocytic	NULL
differentiation	NULL
have	NULL
yet	NULL
to	NULL
be	NULL
explored	NULL
.	NULL

One	NULL
of	NULL
the	NULL
barriers	NULL
to	NULL
identifying	NULL
the	NULL
role	NULL
of	NULL
RA	NULL
and	NULL
its	NULL
receptors	NULL
in	NULL
the	NULL
development	NULL
of	NULL
neutrophils	NULL
has	NULL
been	NULL
the	NULL
identification	NULL
of	NULL
sequences	NULL
whose	NULL
transcription	NULL
during	NULL
normal	NULL
myelopoiesis	NULL
is	NULL
directly	NULL
modulated	NULL
by	NULL
RARa	NULL
.	NULL

To	NULL
approach	NULL
this	NULL
problem	NULL
we	NULL
have	NULL
used	NULL
the	NULL
murine	NULL
promyelocytic	NULL
MPRO	NULL
cell-line	NULL
,	NULL
the	NULL
cells	NULL
of	NULL
which	NULL
can	NULL
be	NULL
rapidly	NULL
induced	NULL
to	NULL
terminally	NULL
differentiate	NULL
into	NULL
mature	NULL
granulocytes	NULL
by	NULL
high	NULL
concentrations	NULL
of	NULL
RA	NULL
.	NULL
``	NULL

Differential	NULL
screening	NULL
techniques	NULL
were	NULL
used	NULL
to	NULL
identify	NULL
sequences	NULL
whose	NULL
transcription	NULL
can	NULL
be	NULL
induced	NULL
in	NULL
an	NULL
immediate-early	NULL
manner	NULL
by	NULL
exposure	NULL
to	NULL
RA	NULL
.	NULL

Here	NULL
we	NULL
report	NULL
the	NULL
isolation	NULL
and	NULL
characterization	NULL
of	NULL
nine	NULL
potential	NULL
immediate-early	NULL
sequences	NULL
,	NULL
one	NULL
of	NULL
which	NULL
,	NULL
E3	NULL
,	NULL
is	NULL
expressed	NULL
selectively	NULL
in	NULL
myeloid	NULL
,	NULL
B-lymphoid	NULL
,	NULL
and	NULL
erythroid	NULL
cells	NULL
.	NULL

Sequence	NULL
analysis	NULL
of	NULL
the	NULL
murine	NULL
E3	NULL
promoter	NULL
region	NULL
revealed	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
single	NULL
RA	NULL
response	NULL
element	NULL
that	NULL
appeared	NULL
to	NULL
confer	NULL
RA-sensitivity	NULL
on	NULL
various	NULL
promoter	NULL
constructs	NULL
in	NULL
transient	NULL
transfection	NULL
experiments	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
E3	NULL
is	NULL
a	NULL
likely	NULL
target	NULL
of	NULL
the	NULL
activated	NULL
RARa	NULL
during	NULL
myelopoiesis	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Tissue	NULL
culture	NULL
.	NULL

HL60	NULL
,	NULL
HL6OR	NULL
,	NULL
HLGOR/RARa	NULL
,	NULL
Jurkat	NULL
,	NULL
K562	NULL
,	NULL
Colo320-DM	NULL
,	NULL
MEL	NULL
F3	NULL
,	NULL
and	NULL
MEL	NULL
FLDS-19	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
supplemented	NULL
with	NULL
5	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
FCS	NULL
)	NULL
.	NULL

MPRO	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
(	NULL
DMEM	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FCS	NULL
and	NULL
1	NULL
%	NULL
CHO.HMS-conditioned	NULL
media	NULL
,	NULL
used	NULL
as	NULL
a	NULL
source	NULL
of	NULL
GM-CSF	NULL
.	NULL

MPRO	NULL
and	NULL
HL6O-derived	NULL
cells	NULL
were	NULL
induced	NULL
to	NULL
differentiate	NULL
by	NULL
application	NULL
of	NULL
10	NULL
pmol/L	NULL
RA	NULL
.	NULL

For	NULL
the	NULL
induction	NULL
of	NULL
erythroid	NULL
differentiation	NULL
,	NULL
MEL	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
4	NULL
mmol/L	NULL
hexamethylene	NULL
bis-acetamide	NULL
(	NULL
HMBA	NULL
)	NULL
.	NULL

EML	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
Iscove	NULL
's	NULL
modified	NULL
Dulbecco	NULL
's	NULL
medium	NULL
(	NULL
IMDM	NULL
)	NULL
and	NULL
20	NULL
%	NULL
horse	NULL
serum	NULL
,	NULL
supplemented	NULL
with	NULL
200	NULL
ng/mL	NULL
rat	NULL
stem	NULL
cell	NULL
factor	NULL
(	NULL
Amgen	NULL
,	NULL
Thousand	NULL
Oaks	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

For	NULL
induction	NULL
of	NULL
erythroid	NULL
differentiation	NULL
in	NULL
EML	NULL
cells	NULL
,	NULL
8	NULL
U/mL	NULL
erythropoietin	NULL
was	NULL
added	NULL
to	NULL
these	NULL
culture	NULL
conditions	NULL
.	NULL

32D	NULL
c13	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
IMDM	NULL
containing	NULL
10	NULL
%	NULL
FCS	NULL
and	NULL
5	NULL
%	NULL
WEHI	NULL
3B-conditioned	NULL
media	NULL
as	NULL
a	NULL
source	NULL
of	NULL
interleukin-3	NULL
.	NULL

For	NULL
granulocytic	NULL
differentiation	NULL
,	NULL
32D	NULL
c13	NULL
cells	NULL
were	NULL
placed	NULL
in	NULL
IMDM	NULL
and	NULL
10	NULL
%	NULL
FCS	NULL
containing	NULL
500	NULL
U/	NULL
mL	NULL
G-CSF	NULL
(	NULL
Amgen	NULL
)	NULL
.	NULL

SP2	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
DMEM	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FCS	NULL
,	NULL
and	NULL
MPC-11	NULL
cells	NULL
in	NULL
80	NULL
%	NULL
DMEM	NULL
and	NULL
20	NULL
%	NULL
horse	NULL
serum	NULL
.	NULL

Mouse	NULL
L	NULL
and	NULL
NIH	NULL
3T3	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
DMEM	NULL
and	NULL
10	NULL
%	NULL
FCS	NULL
.	NULL

RNA	NULL
isolation	NULL
and	NULL
Northern	NULL
blot	NULL
analysis	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
was	NULL
isolated	NULL
using	NULL
the	NULL
guanidinium	NULL
isothiocyanate-cesium	NULL
chloride	NULL
precipitation	NULL
procedure	NULL
.	NULL
``	NULL

Polyadenylated	NULL
transcripts	NULL
were	NULL
purified	NULL
by	NULL
two	NULL
cycles	NULL
of	NULL
selection	NULL
using	NULL
oligo	NULL
(	NULL
dT	NULL
)	NULL
-cellulose	NULL
spin	NULL
columns	NULL
(	NULL
5'-3	NULL
'	NULL
Inc	NULL
,	NULL
Boulder	NULL
,	NULL
CO	NULL
)	NULL
.	NULL

For	NULL
Northern	NULL
blot	NULL
analysis	NULL
,	NULL
10-ug	NULL
samples	NULL
of	NULL
heat-denatured	NULL
total	NULL
RNA	NULL
were	NULL
separated	NULL
by	NULL
electrophoresis	NULL
through	NULL
1	NULL
%	NULL
agarose	NULL
,	NULL
0.6	NULL
%	NULL
formaldehyde	NULL
,	NULL
morpholinepropane-sul-	NULL
SCOTT	NULL
,	NULL
MUELLER	NULL
,	NULL
AND	NULL
COLLINS	NULL
fonic	NULL
acid	NULL
(	NULL
MOPS	NULL
)	NULL
denaturing	NULL
gels	NULL
,	NULL
and	NULL
transferred	NULL
to	NULL
nylon-sup-ported	NULL
nitrocellulose	NULL
(	NULL
Schleicher	NULL
&	NULL
Schuell	NULL
,	NULL
Keene	NULL
,	NULL
NH	NULL
)	NULL
.	NULL

Filters	NULL
were	NULL
baked	NULL
in	NULL
vacuo	NULL
at	NULL
80°C	NULL
,	NULL
then	NULL
prehybridized	NULL
for	NULL
an	NULL
hour	NULL
at	NULL
42°C	NULL
in	NULL
5	NULL
%	NULL
SSC	NULL
;	NULL
25	NULL
mmol/L	NULL
1:1	NULL
Na	NULL
,	NULL
HPO	NULL
,	NULL
;	NULL
:	NULL
NaH	NULL
,	NULL
PO	NULL
,	NULL
,	NULL
(	NULL
pH	NULL
6.5	NULL
)	NULL
;	NULL
0.02	NULL
%	NULL
bovine	NULL
serum	NULL
albumin	NULL
(	NULL
BSA	NULL
)	NULL
;	NULL
0.25	NULL
mg/mL	NULL
yeast	NULL
RNA	NULL
;	NULL
0.02	NULL
%	NULL
Fi-coll-400	NULL
;	NULL
0.02	NULL
%	NULL
PVP	NULL
and	NULL
50	NULL
%	NULL
formamide	NULL
,	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
dextran	NULL
sulfate	NULL
.	NULL

Radiolabeled	NULL
probes	NULL
(	NULL
10	NULL
'	NULL
dpm	NULL
)	NULL
generated	NULL
by	NULL
nick	NULL
translation	NULL
were	NULL
heat-denatured	NULL
,	NULL
then	NULL
added	NULL
directly	NULL
to	NULL
the	NULL
prehybridized	NULL
filter	NULL
and	NULL
hybridized	NULL
for	NULL
20	NULL
hours	NULL
.	NULL

Filters	NULL
were	NULL
washed	NULL
briefly	NULL
at	NULL
65°C	NULL
in	NULL
2	NULL
%	NULL
SSC	NULL
,	NULL
0.1	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
,	NULL
then	NULL
in	NULL
0.1	NULL
x	NULL
SSC	NULL
,	NULL
0.1	NULL
%	NULL
SDS	NULL
for	NULL
30	NULL
minutes	NULL
and	NULL
autoradiographed	NULL
at	NULL
-70°C	NULL
.	NULL

The	NULL
Northern	NULL
blots	NULL
in	NULL
Figs	NULL
3A	NULL
,	NULL
3B	NULL
,	NULL
and	NULL
4A	NULL
were	NULL
probed	NULL
with	NULL
the	NULL
2.466-kb	NULL
murine	NULL
E3	NULL
cDNA	NULL
presented	NULL
in	NULL
Fig	NULL
2	NULL
,	NULL
whereas	NULL
the	NULL
Northern	NULL
blot	NULL
presented	NULL
in	NULL
Fig	NULL
4B	NULL
was	NULL
probed	NULL
with	NULL
a	NULL
0.7-kb	NULL
EcoRI	NULL
fragment	NULL
of	NULL
the	NULL
human	NULL
E3	NULL
cDNA	NULL
(	NULL
L.M.S	NULL
.	NULL

,	NULL
S.J.C	NULL
.	NULL

,	NULL
unpublished	NULL
)	NULL
.	NULL

cDNA	NULL
library	NULL
preparation	NULL
.	NULL

_	NULL
A	NULL
directionally	NULL
cloned	NULL
cDNA	NULL
library	NULL
was	NULL
constructed	NULL
using	NULL
the	NULL
Uni-ZAP	NULL
cloning	NULL
kit	NULL
(	NULL
Stratagene	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*®	NULL
mRNA	NULL
isolated	NULL
from	NULL
MPRO-C	NULL
cells	NULL
(	NULL
see	NULL
next	NULL
paragraph	NULL
)	NULL
stimulated	NULL
by	NULL
exposure	NULL
for	NULL
2.5	NULL
hours	NULL
to	NULL
10	NULL
mol/L	NULL
RA	NULL
and	NULL
1	NULL
pg/mL	NULL
cycloheximide	NULL
(	NULL
RA	NULL
+	NULL
CHX	NULL
)	NULL
.	NULL

Five	NULL
micrograms	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
mRNA	NULL
was	NULL
used	NULL
as	NULL
the	NULL
template	NULL
for	NULL
synthesis	NULL
of	NULL
first-strand	NULL
cDNA	NULL
,	NULL
directed	NULL
by	NULL
an	NULL
Xho	NULL
T-oligo	NULL
(	NULL
dT	NULL
)	NULL
primer	NULL
.	NULL

The	NULL
resulting	NULL
double-stranded	NULL
hemi-methylated	NULL
cDNA	NULL
were	NULL
ligated	NULL
to	NULL
phosphorylated	NULL
EcoRI	NULL
adapters	NULL
,	NULL
then	NULL
digested	NULL
with	NULL
Xho	NULL
I.	NULL
Ligation	NULL
of	NULL
cDNA	NULL
species	NULL
greater	NULL
than	NULL
0.5	NULL
kb	NULL
in	NULL
length	NULL
into	NULL
Xho	NULL
I/EcoRI-digested	NULL
UniZap	NULL
phage	NULL
vector	NULL
and	NULL
packaging	NULL
with	NULL
GigaPackII	NULL
Gold	NULL
packaging	NULL
extract	NULL
(	NULL
Stratagene	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
resulted	NULL
in	NULL
a	NULL
primary	NULL
library	NULL
consisting	NULL
of	NULL
9	NULL
x	NULL
10°	NULL
recombinant	NULL
phage	NULL
.	NULL

Approximately	NULL
2	NULL
x	NULL
10°	NULL
recombinants	NULL
were	NULL
amplified	NULL
on	NULL
NZYM-agarose	NULL
plates	NULL
to	NULL
generate	NULL
a	NULL
stock	NULL
with	NULL
an	NULL
approximate	NULL
titer	NULL
of	NULL
10	NULL
'	NULL
recombinants/mL	NULL
.	NULL

To	NULL
isolate	NULL
full-length	NULL
cDNA	NULL
sequences	NULL
,	NULL
5	NULL
ug	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
mRNA	NULL
isolated	NULL
from	NULL
murine	NULL
32D	NULL
c13	NULL
cells	NULL
was	NULL
used	NULL
to	NULL
construct	NULL
a	NULL
directionally	NULL
cloned	NULL
cDNA	NULL
library	NULL
with	NULL
the	NULL
Uni-ZAP	NULL
cDNA	NULL
cloning	NULL
kit	NULL
.	NULL

Size-fractionated	NULL
cDNAs	NULL
in	NULL
the	NULL
range	NULL
of	NULL
0.5	NULL
kb	NULL
to	NULL
greater	NULL
than	NULL
8.0	NULL
kb	NULL
in	NULL
length	NULL
were	NULL
cloned	NULL
into	NULL
the	NULL
UniZap	NULL
phage	NULL
vector	NULL
,	NULL
resulting	NULL
in	NULL
a	NULL
cDNA	NULL
library	NULL
consisting	NULL
of	NULL
2	NULL
x	NULL
10°	NULL
independent	NULL
recombinants	NULL
.	NULL

Differential	NULL
screening	NULL
.	NULL

-	NULL
We	NULL
used	NULL
two	NULL
different	NULL
MPRO	NULL
subclones	NULL
to	NULL
synthesize	NULL
high	NULL
specific-activity	NULL
,	NULL
P-labeled	NULL
first-strand	NULL
cDNA	NULL
probes	NULL
to	NULL
minimize	NULL
the	NULL
effect	NULL
of	NULL
any	NULL
background	NULL
spontaneous	NULL
differentiation	NULL
that	NULL
could	NULL
generate	NULL
a	NULL
false-positive	NULL
hybridization	NULL
pattern	NULL
.	NULL

The	NULL
subclone	NULL
M-PRO	NULL
BK/RF	NULL
(	NULL
in	NULL
this	NULL
report	NULL
referred	NULL
to	NULL
as	NULL
MPRO-B	NULL
)	NULL
is	NULL
relatively	NULL
resistant	NULL
to	NULL
RA	NULL
,	NULL
with	NULL
no	NULL
spontaneous	NULL
differentiation	NULL
in	NULL
serum-cultured	NULL
cells	NULL
,	NULL
whereas	NULL
MPRO-C	NULL
cells	NULL
are	NULL
more	NULL
RA-re-sponsive	NULL
,	NULL
with	NULL
a	NULL
small	NULL
level	NULL
of	NULL
spontaneous	NULL
differentiation	NULL
apparent	NULL
in	NULL
serum-cultured	NULL
cells	NULL
(	NULL
S.	NULL
Tsai	NULL
,	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

Poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
mRNA	NULL
isolated	NULL
from	NULL
RA-	NULL
and	NULL
CHX-treated	NULL
MPRO-C	NULL
and	NULL
from	NULL
untreated	NULL
MPRO-B	NULL
cells	NULL
was	NULL
used	NULL
as	NULL
a	NULL
template	NULL
to	NULL
synthesize	NULL
the	NULL
appropriate	NULL
first-strand	NULL
cDNA	NULL
probes	NULL
.	NULL

In	NULL
a	NULL
typical	NULL
reaction	NULL
,	NULL
0.3	NULL
mCi	NULL
[	NULL
a-	NULL
``	NULL
P	NULL
]	NULL
dCTP	NULL
(	NULL
3,000	NULL
Ci/mmol	NULL
;	NULL
New	NULL
England	NULL
Nuclear	NULL
[	NULL
NEN	NULL
]	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
)	NULL
was	NULL
dried	NULL
down	NULL
,	NULL
and	NULL
2	NULL
ug	NULL
each	NULL
of	NULL
twice-purified	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
mRNA	NULL
and	NULL
oligo	NULL
(	NULL
dT	NULL
;	NULL
;	NULL
,	NULL
;	NULL
)	NULL
primer	NULL
(	NULL
Pharmacia	NULL
,	NULL
Piscataway	NULL
,	NULL
NJ	NULL
)	NULL
added	NULL
.	NULL

After	NULL
heating	NULL
the	NULL
mRNA	NULL
template	NULL
to	NULL
70°C	NULL
and	NULL
cooling	NULL
on	NULL
ice	NULL
,	NULL
cDNA	NULL
probes	NULL
were	NULL
synthesized	NULL
at	NULL
42°C	NULL
in	NULL
buffer	NULL
containing	NULL
50	NULL
mmol/L	NULL
Tris-HCl	NULL
,	NULL
(	NULL
pH	NULL
8.3	NULL
)	NULL
;	NULL
75	NULL
mmol/L	NULL
KCI	NULL
;	NULL
3	NULL
mmol/L	NULL
MgC1	NULL
;	NULL
;	NULL
10	NULL
mmol/	NULL
L	NULL
dithiothreitol	NULL
(	NULL
DTT	NULL
)	NULL
;	NULL
1	NULL
mmol/L	NULL
dATP	NULL
;	NULL
1	NULL
mmol/L	NULL
dGTP	NULL
;	NULL
1	NULL
mmol/	NULL
L	NULL
dTTP	NULL
;	NULL
40	NULL
U	NULL
RNasin	NULL
:	NULL
;	NULL
and	NULL
400	NULL
U	NULL
Moloney	NULL
murine	NULL
leukemia	NULL
virus	NULL
reverse	NULL
transcriptase	NULL
.	NULL

Unlabeled	NULL
dCTP	NULL
was	NULL
added	NULL
to	NULL
a	NULL
1	NULL
mmol/L	NULL
concentration	NULL
after	NULL
15	NULL
minutes	NULL
,	NULL
and	NULL
the	NULL
incubation	NULL
continued	NULL
for	NULL
another	NULL
hour	NULL
,	NULL
After	NULL
alkali	NULL
hydrolysis	NULL
of	NULL
its	NULL
template	NULL
,	NULL
labeled	NULL
cDNA	NULL
was	NULL
recovered	NULL
by	NULL
ethanol	NULL
precipitation	NULL
.	NULL

Approximately	NULL
4	NULL
x	NULL
10¢	NULL
recombinants	NULL
of	NULL
the	NULL
primary	NULL
MPRO-C	NULL
(	NULL
RA	NULL
+	NULL
CHX	NULL
)	NULL
cDNA	NULL
library	NULL
were	NULL
plated	NULL
at	NULL
medium	NULL
density	NULL
on	NULL
lawns	NULL
of	NULL
XL1-Blue	NULL
MRF	NULL
bacteria	NULL
in	NULL
150-cm	NULL
'	NULL
dishes	NULL
(	NULL
25	NULL
plaques/cm	NULL
'	NULL
)	NULL
,	NULL
and	NULL
duplicate	NULL
sets	NULL
of	NULL
plaque	NULL
lifts	NULL
taken	NULL
using	NULL
Hybond-N*	NULL
nylon	NULL
membrane	NULL
(	NULL
Amersham	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
.	NULL

These	NULL
lifts	NULL
were	NULL
hybridized	NULL
with	NULL
2	NULL
x	NULL
10°	NULL
cpm/ml	NULL
of	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

HEMATOPOIETIC-SPECIFIC	NULL
TARGET	NULL
OF	NULL
RARe	NULL
the	NULL
MPRO-B	NULL
cDNA	NULL
probe	NULL
or	NULL
the	NULL
MPRO-C	NULL
(	NULL
RA	NULL
+	NULL
CHX	NULL
)	NULL
cDNA	NULL
probe	NULL
in	NULL
0.5	NULL
mol/L	NULL
2:1	NULL
Na	NULL
;	NULL
,	NULL
HPO	NULL
,	NULL
:	NULL
NaH	NULL
,	NULL
PO	NULL
,	NULL
;	NULL
7	NULL
%	NULL
SDS	NULL
;	NULL
10	NULL
mmoV/L	NULL
EDTA	NULL
for	NULL
40	NULL
hours	NULL
at	NULL
62°C	NULL
;	NULL
washed	NULL
briefly	NULL
in	NULL
2x	NULL
SSC	NULL
,	NULL
0.1	NULL
%	NULL
SDS	NULL
;	NULL
then	NULL
washed	NULL
for	NULL
30	NULL
minutes	NULL
at	NULL
62°C	NULL
in	NULL
0.1	NULL
X	NULL
SSC	NULL
,	NULL
0.1	NULL
%	NULL
SDS	NULL
.	NULL

Autora-diographs	NULL
from	NULL
each	NULL
matched	NULL
pair	NULL
of	NULL
filters	NULL
were	NULL
obtained	NULL
by	NULL
exposure	NULL
for	NULL
20	NULL
hours	NULL
at	NULL
-70°C	NULL
,	NULL
then	NULL
compared	NULL
by	NULL
eye	NULL
.	NULL

Those	NULL
plaques	NULL
hybridizing	NULL
preferentially	NULL
to	NULL
the	NULL
probe	NULL
synthesized	NULL
from	NULL
(	NULL
RA	NULL
+	NULL
CHX	NULL
)	NULL
-treated	NULL
MPRO-C	NULL
mRNA	NULL
were	NULL
rescreened	NULL
twice	NULL
,	NULL
then	NULL
plaque	NULL
purified	NULL
.	NULL

The	NULL
cDNA	NULL
inserts	NULL
from	NULL
recombinant	NULL
phage	NULL
of	NULL
interest	NULL
were	NULL
excised	NULL
in	NULL
vivo	NULL
by	NULL
coinfection	NULL
with	NULL
ExAssist	NULL
helper	NULL
phage	NULL
(	NULL
Stra-tagene	NULL
)	NULL
to	NULL
produce	NULL
pBluescript	NULL
clones	NULL
,	NULL
which	NULL
were	NULL
used	NULL
for	NULL
the	NULL
initial	NULL
sequence	NULL
analysis	NULL
.	NULL

Sequence	NULL
analysis	NULL
.	NULL

Double-stranded	NULL
DNA	NULL
obtained	NULL
from	NULL
phagemid	NULL
clones	NULL
were	NULL
sequenced	NULL
directly	NULL
using	NULL
T3	NULL
,	NULL
T7	NULL
,	NULL
or	NULL
sequence-specific	NULL
oligonucleotide	NULL
primers	NULL
with	NULL
the	NULL
Taq-Dye-Primer-Cycle	NULL
sequencing	NULL
kit	NULL
(	NULL
Applied	NULL
Biosystems	NULL
,	NULL
Foster	NULL
City	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
analyzed	NULL
on	NULL
an	NULL
ABI	NULL
373A	NULL
DNA	NULL
Sequencer	NULL
.	NULL

Initial	NULL
homology	NULL
searches	NULL
were	NULL
performed	NULL
at	NULL
NCBI	NULL
against	NULL
the	NULL
GenBank	NULL
(	NULL
release	NULL
87.0	NULL
)	NULL
,	NULL
EMBL	NULL
(	NULL
release	NULL
39.0	NULL
)	NULL
,	NULL
and	NULL
SwissProt	NULL
(	NULL
release	NULL
30.0	NULL
)	NULL
databases	NULL
using	NULL
the	NULL
BLAST	NULL
network	NULL
service	NULL
.	NULL
``	NULL

Computer	NULL
analysis	NULL
of	NULL
nucleotide	NULL
sequences	NULL
was	NULL
performed	NULL
using	NULL
the	NULL
MOTIFS	NULL
and	NULL
FindPatterns	NULL
subroutines	NULL
of	NULL
the	NULL
Genetics	NULL
Computing	NULL
Group	NULL
(	NULL
GCG	NULL
;	NULL
version	NULL
8.0	NULL
)	NULL
software	NULL
.	NULL

Isolation	NULL
of	NULL
genomic	NULL
clones	NULL
.	NULL

The	NULL
2.65-kb	NULL
E3	NULL
cDNA	NULL
was	NULL
used	NULL
to	NULL
screen	NULL
2	NULL
x	NULL
10°	NULL
recombinants	NULL
of	NULL
a	NULL
murine	NULL
genomic	NULL
library	NULL
(	NULL
DNA	NULL
from	NULL
an	NULL
inbred	NULL
129Sy	NULL
mouse	NULL
inserted	NULL
into	NULL
the	NULL
vector	NULL
,	NULL
ADashID	NULL
,	NULL
provided	NULL
by	NULL
Glenn	NULL
Friedrich	NULL
(	NULL
Fred	NULL
Hutchinson	NULL
Cancer	NULL
Research	NULL
Center	NULL
)	NULL
.	NULL

After	NULL
three	NULL
rounds	NULL
of	NULL
high	NULL
stringency	NULL
screening	NULL
,	NULL
four	NULL
genomic	NULL
clones	NULL
consistently	NULL
hybridized	NULL
to	NULL
the	NULL
full-length	NULL
E3	NULL
cDNA	NULL
;	NULL
two	NULL
of	NULL
these	NULL
additionally	NULL
hybridized	NULL
to	NULL
a	NULL
probe	NULL
containing	NULL
0.2	NULL
kb	NULL
of	NULL
5	NULL
'	NULL
E3	NULL
cDNA	NULL
.	NULL

Clone	NULL
E3.5	NULL
was	NULL
restriction	NULL
mapped	NULL
and	NULL
subcloned	NULL
into	NULL
pBluescript	NULL
(	NULL
Stratagene	NULL
)	NULL
,	NULL
with	NULL
subclones	NULL
containing	NULL
exon	NULL
sequences	NULL
identified	NULL
by	NULL
Southern	NULL
blot	NULL
analysis	NULL
,	NULL
then	NULL
sequenced	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Plasmid	NULL
constructions	NULL
.	NULL

_	NULL
A	NULL
modified	NULL
pBluescript	NULL
,	NULL
pBS	NULL
(	NULL
HBgNcS	NULL
)	NULL
,	NULL
in	NULL
which	NULL
single	NULL
Bg/ll	NULL
and	NULL
Nco	NULL
I	NULL
sites	NULL
had	NULL
been	NULL
inserted	NULL
between	NULL
the	NULL
HindIII	NULL
and	NULL
Sai	NULL
I	NULL
sites	NULL
of	NULL
the	NULL
pBluescript	NULL
polylinker	NULL
,	NULL
was	NULL
created	NULL
using	NULL
complementary	NULL
oligonucleotides	NULL
.	NULL
``	NULL

The	NULL
E3.5	NULL
genomic	NULL
clone	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
murine	NULL
E3	NULL
exon	NULL
I	NULL
(	NULL
encoding	NULL
residues	NULL
1	NULL
through	NULL
29	NULL
)	NULL
,	NULL
flanked	NULL
by	NULL
3.5	NULL
kb	NULL
of	NULL
upstream	NULL
sequence	NULL
and	NULL
9	NULL
kb	NULL
of	NULL
the	NULL
first	NULL
intron	NULL
,	NULL
was	NULL
digested	NULL
with	NULL
EcoRV	NULL
and	NULL
Nco	NULL
I	NULL
,	NULL
with	NULL
a	NULL
resulting	NULL
0.9-kb	NULL
fragment	NULL
containing	NULL
the	NULL
5	NULL
'	NULL
untranslated	NULL
region	NULL
cloned	NULL
into	NULL
similarly	NULL
digested	NULL
pBS	NULL
(	NULL
HBgNcS	NULL
)	NULL
.	NULL

The	NULL
Neo	NULL
I	NULL
site	NULL
,	NULL
which	NULL
spans	NULL
the	NULL
initiating	NULL
ATG	NULL
of	NULL
the	NULL
murine	NULL
E3	NULL
gene	NULL
,	NULL
was	NULL
then	NULL
eliminated	NULL
by	NULL
digestion	NULL
with	NULL
mung	NULL
bean	NULL
nuclease	NULL
.	NULL

The	NULL
E3	NULL
genomic	NULL
fragment	NULL
was	NULL
released	NULL
by	NULL
BamHI	NULL
and	NULL
Sal	NULL
I	NULL
digestion	NULL
,	NULL
and	NULL
ligated	NULL
into	NULL
pUC19LUC®	NULL
to	NULL
produce	NULL
pO.7E3LUC	NULL
.	NULL

Unique	NULL
Bg/II	NULL
and	NULL
HindIII	NULL
sites	NULL
present	NULL
within	NULL
this	NULL
portion	NULL
of	NULL
the	NULL
promoter	NULL
were	NULL
used	NULL
to	NULL
generate	NULL
pODAE3LUC	NULL
and	NULL
p0.2E3LUC	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
pQ.4E3CAT	NULL
and	NULL
pO.2E3CAT	NULL
vectors	NULL
were	NULL
constructed	NULL
in	NULL
an	NULL
identical	NULL
manner	NULL
using	NULL
the	NULL
pCAT-enhancer	NULL
reporter	NULL
plasmid	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
.	NULL

p	NULL
(	NULL
-394	NULL
to	NULL
-373	NULL
mE3	NULL
)	NULL
;	NULL
T	NULL
KCAT	NULL
was	NULL
created	NULL
by	NULL
cloning	NULL
a	NULL
52-bp	NULL
fragment	NULL
,	NULL
(	NULL
-394	NULL
to	NULL
-373	NULL
mE3	NULL
)	NULL
,	NULL
into	NULL
HindlH	NULL
,	NULL
Sal	NULL
linearized	NULL
pTKCAT	NULL
.	NULL
``	NULL

This	NULL
double-stranded	NULL
(	NULL
-394	NULL
to	NULL
-373	NULL
mE3	NULL
)	NULL
;	NULL
fragment	NULL
was	NULL
synthesized	NULL
by	NULL
annealing	NULL
complementary	NULL
oligonucleotides	NULL
that	NULL
contain	NULL
direct	NULL
repeats	NULL
of	NULL
the	NULL
putative	NULL
murine	NULL
E3	NULL
RA	NULL
response	NULL
element	NULL
,	NULL
present	NULL
in	NULL
the	NULL
E3	NULL
promoter	NULL
between	NULL
nucleotides	NULL
-394	NULL
and	NULL
-378	NULL
(	NULL
as	NULL
underlined	NULL
)	NULL
,	NULL
flanked	NULL
by	NULL
HindIII	NULL
and	NULL
Saf	NULL
I	NULL
restriction	NULL
sites	NULL
included	NULL
for	NULL
subsequent	NULL
cloning	NULL
purposes	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
the	NULL
two	NULL
oligonucleotides	NULL
used	NULL
are	NULL
S'AGCTTACAGAGTGAGTTCCAGGACAGCCAGGAGTG-AGTTCCAGGACAGCCAG3	NULL
'	NULL
,	NULL
-	NULL
and	NULL
STCGACTGGCTGTCCT-GGAACTCACTCCTGGCTGTCCTGGAACTCACTCTGTAY	NULL
'	NULL
.	NULL

Transient	NULL
transfection	NULL
analysis	NULL
.	NULL

-	NULL
For	NULL
each	NULL
transfection	NULL
of	NULL
K562	NULL
,	NULL
Jurkat	NULL
and	NULL
Colo320-DM	NULL
cells	NULL
,	NULL
10°	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
and	NULL
resuspended	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
0.5	NULL
mL	NULL
HEPES-buffered	NULL
saline	NULL
.	NULL

A	NULL
50-ug	NULL
aliquot	NULL
of	NULL
test	NULL
plasmid	NULL
and	NULL
a	NULL
10-ug	NULL
aliquot	NULL
of	NULL
the	NULL
control	NULL
2519	NULL
plasmid	NULL
,	NULL
SV	NULL
;	NULL
,	NULL
CAT	NULL
,	NULL
``	NULL
was	NULL
added	NULL
,	NULL
then	NULL
the	NULL
cells	NULL
immediately	NULL
subjected	NULL
to	NULL
a	NULL
250-V	NULL
,	NULL
960-uF	NULL
pulse	NULL
using	NULL
a	NULL
BioRad	NULL
Gene	NULL
Pulser	NULL
,	NULL
and	NULL
placed	NULL
in	NULL
culture	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
FCS	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
obtained	NULL
for	NULL
luciferase	NULL
and	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
assays	NULL
40	NULL
hours	NULL
later	NULL
.	NULL

Transient	NULL
transfections	NULL
of	NULL
HL6O	NULL
cells	NULL
were	NULL
accomplished	NULL
using	NULL
a	NULL
variation	NULL
of	NULL
a	NULL
method	NULL
described	NULL
elsewhere	NULL
.	NULL
``	NULL

For	NULL
each	NULL
transfection	NULL
,	NULL
10°	NULL
cells	NULL
were	NULL
washed	NULL
in	NULL
chilled	NULL
OptiMem	NULL
buffer	NULL
(	NULL
GIBCO	NULL
,	NULL
Grand	NULL
Island	NULL
,	NULL
NY	NULL
)	NULL
,	NULL
and	NULL
resuspended	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
0.5	NULL
mL	NULL
.	NULL

A	NULL
50-4ug	NULL
aliquot	NULL
of	NULL
test	NULL
plasmid	NULL
was	NULL
added	NULL
,	NULL
then	NULL
incubated	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
10	NULL
minutes	NULL
.	NULL

Cells	NULL
were	NULL
subjected	NULL
to	NULL
a	NULL
300-V	NULL
,	NULL
960-uF	NULL
pulse	NULL
using	NULL
the	NULL
Gene	NULL
Pulser	NULL
,	NULL
placed	NULL
in	NULL
culture	NULL
medium	NULL
containing	NULL
stripped	NULL
FCS	NULL
,	NULL
and	NULL
harvested	NULL
for	NULL
CAT	NULL
assays	NULL
40	NULL
hours	NULL
later	NULL
.	NULL

Where	NULL
appropriate	NULL
,	NULL
RA	NULL
was	NULL
added	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
10	NULL
pmol/L	NULL
20	NULL
hours	NULL
after	NULL
transfection	NULL
.	NULL

Luciferase	NULL
and	NULL
CAT	NULL
assays	NULL
were	NULL
performed	NULL
essentially	NULL
as	NULL
described	NULL
previously	NULL
.	NULL
``	NULL

''	NULL
Cells	NULL
were	NULL
washed	NULL
twice	NULL
in	NULL
5	NULL
mL	NULL
chilled	NULL
0.1	NULL
mol/L	NULL
Tris-HCI	NULL
(	NULL
pH	NULL
7.8	NULL
)	NULL
,	NULL
resuspended	NULL
in	NULL
100	NULL
0.1	NULL
mol/L	NULL
Tris-HC	NULL
]	NULL
(	NULL
pH	NULL
7.8	NULL
)	NULL
;	NULL
1	NULL
mmol/L	NULL
DTT	NULL
;	NULL
0.1	NULL
mg/mL	NULL
BSA	NULL
,	NULL
and	NULL
lysed	NULL
by	NULL
several	NULL
rounds	NULL
of	NULL
rapid	NULL
freezing	NULL
and	NULL
thawing	NULL
.	NULL

After	NULL
centrifugation	NULL
at	NULL
15,0008	NULL
for	NULL
5	NULL
minutes	NULL
,	NULL
76	NULL
gL	NULL
of	NULL
each	NULL
extract	NULL
isolated	NULL
from	NULL
cells	NULL
transfected	NULL
with	NULL
luciferase-based	NULL
reporter	NULL
constructs	NULL
was	NULL
mixed	NULL
with	NULL
24	NULL
pL	NULL
46	NULL
mmol/L	NULL
MgCl1	NULL
;	NULL
;	NULL
25	NULL
mmol/L	NULL
ATP	NULL
,	NULL
and	NULL
assayed	NULL
for	NULL
luciferase	NULL
activity	NULL
for	NULL
a	NULL
period	NULL
of	NULL
10	NULL
seconds	NULL
after	NULL
injection	NULL
of	NULL
100	NULL
wL	NULL
0.3	NULL
mg/mL	NULL
luciferin	NULL
by	NULL
an	NULL
AutoLumat	NULL
LB953	NULL
luminometer	NULL
(	NULL
EG	NULL
&	NULL
G	NULL
Berthold	NULL
)	NULL
.	NULL

The	NULL
remaining	NULL
extract	NULL
was	NULL
incubated	NULL
at	NULL
56°C	NULL
for	NULL
15	NULL
minutes	NULL
,	NULL
then	NULL
centrifuged	NULL
briefly	NULL
.	NULL

A	NULL
20-zL	NULL
aliquot	NULL
of	NULL
the	NULL
supernatant	NULL
was	NULL
added	NULL
to	NULL
an	NULL
80-uL	NULL
mix	NULL
containing	NULL
18	NULL
ug	NULL
butyryl	NULL
coenzyme-A	NULL
,	NULL
0.15	NULL
uCi	NULL
(	NULL
NEN	NULL
)	NULL
,	NULL
and	NULL
0.1	NULL
moll	NULL
Tris-HCI	NULL
(	NULL
pH	NULL
7.8	NULL
)	NULL
.	NULL

After	NULL
incubation	NULL
at	NULL
37°C	NULL
for	NULL
2	NULL
hours	NULL
,	NULL
each	NULL
CAT	NULL
assay	NULL
was	NULL
extracted	NULL
with	NULL
200	NULL
LL	NULL
xylene	NULL
,	NULL
then	NULL
back-extracted	NULL
once	NULL
with	NULL
100	NULL
LL	NULL
TE	NULL
(	NULL
10	NULL
mmol/L	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
8.0	NULL
;	NULL
1	NULL
mmol/L	NULL
EDTA	NULL
)	NULL
,	NULL
added	NULL
to	NULL
2	NULL
mL	NULL
scintil-lant	NULL
and	NULL
counted	NULL
for	NULL
1	NULL
minute	NULL
.	NULL

Extracts	NULL
derived	NULL
from	NULL
cells	NULL
that	NULL
were	NULL
transfected	NULL
with	NULL
CAT-based	NULL
reporter	NULL
constructs	NULL
were	NULL
processed	NULL
essentially	NULL
as	NULL
above	NULL
,	NULL
with	NULL
the	NULL
exception	NULL
that	NULL
an	NULL
aliquot	NULL
of	NULL
cell	NULL
extract	NULL
containing	NULL
50	NULL
pg	NULL
total	NULL
protein	NULL
was	NULL
used	NULL
for	NULL
CAT	NULL
assay	NULL
analysis	NULL
.	NULL

The	NULL
protein	NULL
levels	NULL
of	NULL
each	NULL
extract	NULL
were	NULL
determined	NULL
before	NULL
CAT	NULL
assay	NULL
analysis	NULL
by	NULL
protein	NULL
determination	NULL
of	NULL
a	NULL
5-uL	NULL
sample	NULL
of	NULL
cell	NULL
extract	NULL
using	NULL
a	NULL
modified	NULL
Bradford	NULL
procedure	NULL
(	NULL
BioRad	NULL
Protein	NULL
Assay	NULL
)	NULL
.	NULL

GenBank	NULL
accession	NULL
numbers	NULL
.	NULL

-	NULL
The	NULL
GenBank	NULL
accession	NULL
nutaber	NULL
for	NULL
the	NULL
murine	NULL
E3	NULL
cDNA	NULL
sequence	NULL
is	NULL
U29539	NULL
,	NULL
and	NULL
for	NULL
the	NULL
murine	NULL
promoter	NULL
sequence	NULL
is	NULL
U29489	NULL
.	NULL

RESULTS	NULL
Identification	NULL
and	NULL
characterization	NULL
of	NULL
RA-inducible	NULL
immediate-early	NULL
genes	NULL
.	NULL

To	NULL
identify	NULL
novel	NULL
RA-inducible	NULL
sequences	NULL
,	NULL
we	NULL
initially	NULL
constructed	NULL
a	NULL
directional	NULL
cDNA	NULL
library	NULL
from	NULL
the	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
mRNA	NULL
of	NULL
MPRO-C	NULL
cells	NULL
treated	NULL
for	NULL
2.5	NULL
hours	NULL
with	NULL
all-trans	NULL
RA	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
CHX	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
CHX	NULL
allowed	NULL
us	NULL
to	NULL
restrict	NULL
our	NULL
analysis	NULL
to	NULL
RNA	NULL
species	NULL
that	NULL
are	NULL
stimulated	NULL
as	NULL
a	NULL
direct	NULL
response	NULL
to	NULL
RA	NULL
,	NULL
without	NULL
intervening	NULL
protein	NULL
synthesis	NULL
.	NULL

For	NULL
differential	NULL
screening	NULL
of	NULL
this	NULL
cDNA	NULL
library	NULL
,	NULL
we	NULL
used	NULL
cDNA	NULL
probes	NULL
synthesized	NULL
from	NULL
mRNA	NULL
from	NULL
uninduced	NULL
MPRO-B	NULL
cells	NULL
or	NULL
MPRO-C	NULL
cells	NULL
induced	NULL
to	NULL
differentiate	NULL
by	NULL
treatment	NULL
with	NULL
RA	NULL
and	NULL
CHX	NULL
for	NULL
2.5	NULL
hours	NULL
.	NULL

Forty-five	NULL
clones	NULL
of	NULL
the	NULL
40,000	NULL
clones	NULL
screened	NULL
exhibited	NULL
preferential	NULL
hybridization	NULL
to	NULL
the	NULL
cDNA	NULL
probe	NULL
derived	NULL
from	NULL
RA-	NULL
and	NULL
CHX-treated	NULL
MPRO-C	NULL
cells	NULL
.	NULL

After	NULL
several	NULL
rounds	NULL
of	NULL
screening	NULL
,	NULL
20	NULL
clones	NULL
with	NULL
a	NULL
strong	NULL
differential	NULL
hybridization	NULL
pattern	NULL
were	NULL
selected	NULL
for	NULL
further	NULL
analysis	NULL
.	NULL

Cross-hybridization	NULL
determined	NULL
that	NULL
these	NULL
clones	NULL
corresponded	NULL
to	NULL
12	NULL
discrete	NULL
cDNA	NULL
species	NULL
,	NULL
8	NULL
of	NULL
which	NULL
were	NULL
identified	NULL
as	NULL
novel	NULL
sequences	NULL
after	NULL
searches	NULL
of	NULL
the	NULL
GenBank	NULL
,	NULL
EMBL	NULL
,	NULL
and	NULL
SwissProt	NULL
databases	NULL
.	NULL

Six	NULL
displayed	NULL
significant	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2520	NULL
SCOTT	NULL
,	NULL
MUELLER	NULL
,	NULL
AND	NULL
COLLINS	NULL
Table	NULL
1	NULL
.	NULL

Summary	NULL
of	NULL
the	NULL
Sequence	NULL
Identity	NULL
and	NULL
Expression	NULL
Pattern	NULL
of	NULL
Eight	NULL
Differentially	NULL
Expressed	NULL
cDNA	NULL
Sequences	NULL
Analyzed	NULL
Northern	NULL
Blot	NULL
Analysis	NULL
MPRO-C	NULL
(	NULL
RA	NULL
+	NULL
CHX	NULL
)	NULL
Clone	NULL
Protein/Nucleotide	NULL
Homology	NULL
(	NULL
%	NULL
)	NULL
V	NULL
MPRO-B*	NULL
RA-	NULL
or	NULL
CHX-Inducible	NULL
?	NULL

A4	NULL
Rat	NULL
clathrin	NULL
light	NULL
chain	NULL
2	NULL
(	NULL
90	NULL
)	NULL
X2.43	NULL
RA	NULL
A7	NULL
Human	NULL
dUPT	NULL
pyrophosphatase	NULL
(	NULL
80	NULL
)	NULL
X3.11	NULL
Neither	NULL
B3	NULL
Human	NULL
expressed	NULL
sequence	NULL
tag	NULL
(	NULL
75	NULL
)	NULL
X3.82	NULL
Neither	NULL
C3	NULL
Ubiquitin	NULL
conjugating	NULL
enzymes	NULL
(	NULL
65	NULL
)	NULL
X2.29	NULL
Neither	NULL
D9	NULL
Novel	NULL
-	NULL
X2.02	NULL
RA	NULL
E3	NULL
Novel	NULL
-	NULL
xX3.06	NULL
RA	NULL
G1	NULL
Human	NULL
expressed	NULL
sequence	NULL
tag	NULL
(	NULL
75	NULL
)	NULL
X2.73	NULL
Neither	NULL
G4	NULL
Human	NULL
histone	NULL
HH	NULL
3.3	NULL
(	NULL
100	NULL
)	NULL
X4.51	NULL
CHX	NULL
®	NULL
Level	NULL
of	NULL
induction	NULL
calculated	NULL
using	NULL
densitometric	NULL
scans	NULL
of	NULL
Northern	NULL
blots	NULL
.	NULL

homology	NULL
to	NULL
database	NULL
sequences	NULL
,	NULL
with	NULL
4	NULL
(	NULL
A4	NULL
,	NULL
A7	NULL
,	NULL
C3	NULL
,	NULL
G4	NULL
)	NULL
being	NULL
probable	NULL
murine	NULL
homologs	NULL
of	NULL
rat	NULL
or	NULL
human	NULL
sequences	NULL
,	NULL
and	NULL
two	NULL
(	NULL
G1	NULL
,	NULL
B3	NULL
)	NULL
being	NULL
apparently	NULL
novel	NULL
members	NULL
of	NULL
two	NULL
multi-member	NULL
gene	NULL
families	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Two	NULL
clones	NULL
,	NULL
D9	NULL
and	NULL
E3	NULL
,	NULL
bore	NULL
no	NULL
significant	NULL
homology	NULL
to	NULL
database	NULL
sequences	NULL
,	NULL
suggesting	NULL
that	NULL
these	NULL
were	NULL
truly	NULL
unique	NULL
transcripts	NULL
.	NULL

To	NULL
ascertain	NULL
which	NULL
clones	NULL
corresponded	NULL
to	NULL
mRNAs	NULL
that	NULL
were	NULL
transcriptionally	NULL
upregulated	NULL
in	NULL
response	NULL
to	NULL
RA	NULL
,	NULL
each	NULL
of	NULL
the	NULL
12	NULL
cDNAs	NULL
was	NULL
used	NULL
to	NULL
probe	NULL
total	NULL
RNA	NULL
isolated	NULL
from	NULL
the	NULL
MPRO-B	NULL
and	NULL
MPRO-C	NULL
subclones	NULL
,	NULL
the	NULL
latter	NULL
of	NULL
which	NULL
was	NULL
treated	NULL
with	NULL
RA	NULL
and	NULL
CHX	NULL
for	NULL
2.5	NULL
hours	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
showed	NULL
that	NULL
three	NULL
transcripts	NULL
were	NULL
equally	NULL
abundant	NULL
in	NULL
these	NULL
RNA	NULL
populations	NULL
,	NULL
and	NULL
were	NULL
therefore	NULL
not	NULL
studied	NULL
.	NULL

Nine	NULL
sequences	NULL
were	NULL
preferentially	NULL
expressed	NULL
in	NULL
the	NULL
MPRO-C	NULL
RNA	NULL
population	NULL
,	NULL
with	NULL
transcript	NULL
level	NULL
differences	NULL
ranging	NULL
from	NULL
twofold	NULL
to	NULL
almost	NULL
fivefold	NULL
(	NULL
Fig	NULL
1A	NULL
)	NULL
.	NULL

To	NULL
rule	NULL
out	NULL
the	NULL
2	NULL
.	NULL

3.	NULL
io	NULL
di	NULL
dib	NULL
iv	NULL
4.	NULL
io	NULL
db	NULL
dib	NULL
iv	NULL
5.	NULL
i	NULL
ib	NULL
dil	NULL
iv	NULL
possibility	NULL
that	NULL
the	NULL
levels	NULL
of	NULL
these	NULL
transcripts	NULL
increase	NULL
in	NULL
response	NULL
to	NULL
CHX	NULL
rather	NULL
than	NULL
to	NULL
RA	NULL
,	NULL
we	NULL
hybridized	NULL
the	NULL
nine	NULL
cDNA	NULL
probes	NULL
to	NULL
total	NULL
RNA	NULL
obtained	NULL
from	NULL
MPRO-C	NULL
cells	NULL
incubated	NULL
for	NULL
2.5	NULL
hours	NULL
in	NULL
culture	NULL
medium	NULL
alone	NULL
,	NULL
medium	NULL
plus	NULL
RA	NULL
,	NULL
medium	NULL
plus	NULL
CHX	NULL
,	NULL
or	NULL
medium	NULL
plus	NULL
RA	NULL
and	NULL
CHX	NULL
.	NULL

Only	NULL
mRNAs	NULL
that	NULL
were	NULL
upregulated	NULL
in	NULL
response	NULL
to	NULL
RA	NULL
or	NULL
superinduced	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
RA	NULL
and	NULL
CHX	NULL
were	NULL
considered	NULL
for	NULL
further	NULL
analysis	NULL
.	NULL

These	NULL
Northern	NULL
blots	NULL
showed	NULL
that	NULL
the	NULL
G4	NULL
cDNA	NULL
,	NULL
which	NULL
encodes	NULL
the	NULL
murine	NULL
homolog	NULL
of	NULL
the	NULL
human	NULL
histone	NULL
variant	NULL
,	NULL
H3.3	NULL
,	NULL
was	NULL
induced	NULL
by	NULL
CHX	NULL
treatment	NULL
alone	NULL
(	NULL
Fig	NULL
1B5	NULL
)	NULL
.	NULL

Four	NULL
RNA	NULL
species	NULL
identified	NULL
as	NULL
more	NULL
abundant	NULL
in	NULL
MPRO-C	NULL
cells	NULL
relative	NULL
to	NULL
MPRO-B	NULL
cells	NULL
did	NULL
not	NULL
appear	NULL
to	NULL
be	NULL
RA-inducible	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
but	NULL
instead	NULL
varied	NULL
in	NULL
abundance	NULL
between	NULL
the	NULL
subclones	NULL
.	NULL

However	NULL
,	NULL
Northern	NULL
blot	NULL
analysis	NULL
identified	NULL
four	NULL
mRNA	NULL
species	NULL
that	NULL
appeared	NULL
to	NULL
be	NULL
upregulated	NULL
directly	NULL
by	NULL
RA	NULL
in	NULL
MPRO-C	NULL
cells	NULL
Fig	NULL
1	NULL
.	NULL

The	NULL
expression	NULL
patterns	NULL
of	NULL
five	NULL
cDNAs	NULL
isolated	NULL
by	NULL
differential	NULL
screening	NULL
.	NULL

(	NULL
A	NULL
)	NULL
The	NULL
expression	NULL
of	NULL
candidate	NULL
target	NULL
sequences	NULL
,	NULL
A4	NULL
(	NULL
1	NULL
)	NULL
,	NULL
D9	NULL
(	NULL
2	NULL
)	NULL
,	NULL
E3	NULL
(	NULL
3	NULL
)	NULL
,	NULL
F1	NULL
(	NULL
4	NULL
)	NULL
,	NULL
and	NULL
G4	NULL
(	NULL
5	NULL
)	NULL
,	NULL
were	NULL
examined	NULL
in	NULL
MPRO-B	NULL
cells	NULL
(	NULL
-	NULL
)	NULL
and	NULL
MPRO-C	NULL
cells	NULL
treated	NULL
with	NULL
10	NULL
wmol/L	NULL
RA	NULL
and	NULL
CHX	NULL
for	NULL
2.5	NULL
hours	NULL
(	NULL
+	NULL
)	NULL
,	NULL
using	NULL
the	NULL
appropriate	NULL
cDNAs	NULL
isolated	NULL
by	NULL
differential	NULL
screening	NULL
as	NULL
probes	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
RA-	NULL
and	NULL
CHX-inducibility	NULL
of	NULL
A4	NULL
(	NULL
1	NULL
)	NULL
,	NULL
D9	NULL
(	NULL
2	NULL
)	NULL
,	NULL
E3	NULL
(	NULL
3	NULL
)	NULL
,	NULL
F1	NULL
(	NULL
4	NULL
)	NULL
,	NULL
and	NULL
G4	NULL
(	NULL
5	NULL
)	NULL
transcripts	NULL
in	NULL
MPRO-C	NULL
cells	NULL
incubated	NULL
for	NULL
2.5	NULL
hours	NULL
in	NULL
serum	NULL
(	NULL
i	NULL
)	NULL
,	NULL
serum	NULL
plus	NULL
RA	NULL
(	NULL
ii	NULL
)	NULL
,	NULL
serum	NULL
plus	NULL
CHX	NULL
(	NULL
iii	NULL
)	NULL
,	NULL
or	NULL
serum	NULL
plus	NULL
RA	NULL
and	NULL
CHX	NULL
(	NULL
iv	NULL
)	NULL
,	NULL
was	NULL
examined	NULL
as	NULL
above	NULL
.	NULL

i	NULL
ii	NULL
iii	NULL
iv	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

HEMATOPOIETIC-SPECIFIC	NULL
TARGET	NULL
OF	NULL
RAR	NULL
«	NULL
Fig	NULL
2	NULL
.	NULL

The	NULL
murine	NULL
E3	NULL
cDNA	NULL
sequence	NULL
and	NULL
predicted	NULL
protein	NULL
.	NULL

The	NULL
2,466-nucleotide	NULL
E3	NULL
cDNA	NULL
contains	NULL
two	NULL
large	NULL
nonoverlapping	NULL
open	NULL
reading	NULL
frames	NULL
,	NULL
the	NULL
first	NULL
of	NULL
which	NULL
is	NULL
conceptually	NULL
translated	NULL
.	NULL

Six	NULL
potential	NULL
sites	NULL
for	NULL
phosphorylation	NULL
by	NULL
protein	NULL
kinase	NULL
C	NULL
or	NULL
casein	NULL
kinase	NULL
i	NULL
}	NULL
are	NULL
noted	NULL
{	NULL
in	NULL
bold	NULL
typeface	NULL
)	NULL
,	NULL
as	NULL
are	NULL
the	NULL
two	NULL
potential	NULL
N-myristylation	NULL
sites	NULL
.	NULL

The	NULL
second	NULL
open	NULL
reading	NULL
frame	NULL
lies	NULL
between	NULL
nucleotides	NULL
1324	NULL
and	NULL
1971	NULL
,	NULL
and	NULL
is	NULL
marked	NULL
by	NULL
underlining	NULL
,	NULL
as	NULL
is	NULL
the	NULL
single	NULL
ATTTA	NULL
-	NULL
destabilization	NULL
motif	NULL
and	NULL
the	NULL
intact	NULL
polyadeny	NULL
!	NULL

-	NULL
973	NULL
1054	NULL
1135	NULL
1216	NULL
1297	NULL
1378	NULL
1459	NULL
1540	NULL
1621	NULL
1702	NULL
1783	NULL
1864	NULL
1945	NULL
2026	NULL
2107	NULL
2188	NULL
2269	NULL
2350	NULL
2521	NULL
GTTACTCAGAGCACTCCGAAGAGGGGACTGCGCACCATGGCCTCCCGAGCAGCGCCGGTCAGACAGACATGCTCGITGTTIC	NULL
M	NULL
A	NULL
S	NULL
R	NULL
A	NULL
A	NULL
P	NULL
V	NULL
R	NULL
Q	NULL
T	NULL
C	NULL
C	NULL
CF	NULL
AACATCCGAGTCGCCACCATAGCCCTGGCCATTTACCACATAGTCATGAGTGTCCTGCTGTICATTGAGCATGTGGTGGAG	NULL
NOI	NULL
Ro	NULL
V	NULL
G	NULL
T	NULL
I	NULL
A	NULL
L	NULL
A	NULL
I	NULL
Y	NULL
H	NULL
I	NULL
V	NULL
M	NULL
S	NULL
V	NULL
L	NULL
L	NULL
F	NULL
.I	NULL
E	NULL
H	NULL
V	NULL
V	NULL
E	NULL
v	NULL
A	NULL
ROG	NULL
K	NULL
V	NULL
8	NULL
C	NULL
R	NULL
F	NULL
F	NULL
K	NULL
M	NULL
A	NULL
Y	NULL
L	NULL
R	NULL
M	NULL
A	NULL
D	NULL
L	NULL
L	NULL
S	NULL
S	NULL
F	NULL
L	NULL
L	NULL
ATTGGCGTGCTCTTCATCATCAGCATCAGCCTGCTGTTCGGCGTGGTCAAGAACCGGGAGAACGTACCTGATACCCTTCCTG	NULL
I	NULL
G	NULL
V	NULL
L	NULL
F	NULL
I	NULL
I	NULL
S	NULL
I	NULL
S	NULL
L	NULL
L	NULL
F	NULL
G	NULL
V	NULL
V	NULL
K	NULL
N	NULL
R	NULL
E	NULL
K	NULL
Y	NULL
L	NULL
I	NULL
P	NULL
F	NULL
L	NULL
TCCCTTCAAATCATGGACTTCCTGCICTGCCTGCTCACACTGCTGSGCTCCTACATCGAGTTGCCAGCGTACTTGAAGCTT	NULL
§	NULL
L	NULL
Q	NULL
I	NULL
M	NULL
D	NULL
F	NULL
L	NULL
L	NULL
C	NULL
L	NULL
L	NULL
T	NULL
L	NULL
L	NULL
G	NULL
8	NULL
¥	NULL
I	NULL
E	NULL
L	NULL
P	NULL
A	NULL
Y	NULL
L	NULL
K	NULL
L	NULL
A	NULL
R	NULL
S	NULL
R	NULL
P	NULL
G	NULL
P	NULL
S	NULL
K	NULL
V	NULL
P	NULL
L	NULL
M	NULL
T	NULL
L	NULL
Q	NULL
L	NULL
L	NULL
D	NULL
P	NULL
C	NULL
L	NULL
§	NULL
I	NULL
L	NULL
T	NULL
L	NULL
TGCAGCTCCTACATGGAAGTGCCCACCTACCTCAACTTCAAGTCCATGAACCACATGAATTACCTCCCAAGCCAGGAGGGT	NULL
C	NULL
s	NULL
s	NULL
Y	NULL
MoE	NULL
V	NULL
POT	NULL
Y	NULL
L	NULL
N	NULL
F	NULL
K	NULL
S	NULL
M	NULL
N	NULL
H	NULL
M	NULL
N	NULL
Y	NULL
L	NULL
P	NULL
S	NULL
Q	NULL
E	NULL
g	NULL
GCTGCCGCACAGCCAGTTCATCAACATGATGCTCATCTTCTCAGTGGCCTTTATCACCGTGCTCATCCTGAAGGTCTACATG	NULL
v	NULL
P	NULL
H	NULL
S	NULL
Q	NULL
F	NULL
I	NULL
N	NULL
M	NULL
M	NULL
L	NULL
I	NULL
F	NULL
Ss	NULL
V	NULL
A	NULL
F	NULL
I	NULL
T	NULL
V	NULL
L	NULL
I	NULL
L	NULL
K	NULL
V	NULL
Y	NULL
M	NULL
TTCAAGTGTGTGTACACATGCTACAAATTCTTGAAGCACATGAATTCGSCCATGGAGGACAGCAGCTCCAAGATGTTCCTC	NULL
FK	NULL
C	NULL
V	NULL
Y	NULL
T	NULL
C	NULL
Y	NULL
K	NULL
F	NULL
L	NULL
K	NULL
H	NULL
M	NULL
N	NULL
8	NULL
A	NULL
M	NULL
E	NULL
D	NULL
S	NULL
S	NULL
S	NULL
K	NULL
M	NULL
F	NULL
L	NULL
AAGGTGGCTCTGCC	NULL
@	NULL
TCCTACGAGGAAGCCTTGTCTCTGCCCCCTAAGACTCCAGAGGGGGACCCTGCACCACCCCCaATAC	NULL
KV	NULL
A	NULL
L	NULL
P	NULL
s	NULL
Y	NULL
E	NULL
E	NULL
A	NULL
L	NULL
S	NULL
L	NULL
PP	NULL
K	NULL
T	NULL
PE	NULL
G	NULL
D	NULL
P	NULL
A	NULL
P	NULL
P	NULL
P	NULL
Y	NULL
TCAGAAGTGTGATCCCCACCAGGCCTTTAGCCCTTGGGCTGGGAGAGGCAGAACTTCCTCCTCCTeCTTCTTCACTTIGGT	NULL
§	NULL
E	NULL
v	NULL
*	NULL
CAACTGAGTCACCCTGGGCTCAGTGACCCTTTGCGGCTCAGGATACTCAGCCTAGCAGCCCGTCTCGTCTICCATCAGCAGT	NULL
GACACTTGTTCAGAGCGCAGCCATAGGAACTTAGGCTCGCCTTTGCTTAACAGCTACCGGCTTGATCTGTITTGGCCAGGCAG	NULL
CAGCAGGAAGAGAATCTGGCCAAGCAATAGTTCCTGGTGTCAGTTTATACTCAGCTGTCAGACGACAGGATGGGTCATGAT	NULL
TGTGGTGCCCGTTTGCCACCTCCAGTACCCCAAAGAGTGTACAAACAAAACAATTCCTTCAAATAGCTTGCTTﬁAATAGCG	NULL
Iﬂxﬂxﬂ3ﬂEBAAIAA3SCg1EEECAIGAGCCACTGGTCHGATGGGAAGCTGTCCﬂ1ﬂHEHTCAGTCAAGTGTTEIISﬂGGG	NULL
GTTGCTTCAGCTTGCTTGCCCTGGGCTACGCTCAGGGGATGGCAGCTTTGGACGTTGGCCGCCCTGGGGGTGGCTeTCTeTC	NULL
ACTATGGCTGCCCAGTTGGGGCAGGCTAGCCTATGSGCTGTGAAGACTTGGCCAGAGTCATGTGTTCTATGGTGGCAGCAA	NULL
GAGGGTCAGTTCATATGCCTCTGCTGGCTTTTCTATCGCTAGGGGTTGCTAGGGGTTGCTAGGGATCTACACCCTGCCTGT	NULL
GGGTGTAGATGGGGCTGCAGGGCTGAAAAGTTCCCACTGTACCTGTGTCATTGCTTGTGTATGACTTGGAAGAAGGCCCAA	NULL
ation	NULL
signal	NULL
.	NULL

2431	NULL
(	NULL
Figs	NULL
1B1	NULL
,	NULL
1B2	NULL
,	NULL
1B3	NULL
,	NULL
1B4	NULL
)	NULL
.	NULL

Upregulation	NULL
of	NULL
these	NULL
was	NULL
independent	NULL
of	NULL
de	NULL
novo	NULL
protein	NULL
synthesis	NULL
,	NULL
suggesting	NULL
that	NULL
transcription	NULL
of	NULL
these	NULL
sequences	NULL
may	NULL
be	NULL
induced	NULL
directly	NULL
by	NULL
RARa	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
have	NULL
chosen	NULL
to	NULL
examine	NULL
the	NULL
E3	NULL
cDNA	NULL
sequence	NULL
in	NULL
further	NULL
detail	NULL
.	NULL

Sequence	NULL
analysis	NULL
of	NULL
the	NULL
murine	NULL
E3	NULL
cDNA	NULL
.	NULL

-	NULL
The	NULL
E3	NULL
cDNA	NULL
isolated	NULL
by	NULL
differential	NULL
screening	NULL
was	NULL
1.2	NULL
kb	NULL
in	NULL
length	NULL
,	NULL
whereas	NULL
Northern	NULL
blot	NULL
analysis	NULL
indicated	NULL
that	NULL
this	NULL
transcript	NULL
was	NULL
approximately	NULL
2.5	NULL
kb	NULL
in	NULL
length	NULL
.	NULL

To	NULL
isolate	NULL
the	NULL
full-length	NULL
cDNA	NULL
,	NULL
the	NULL
original	NULL
E3	NULL
cDNA	NULL
was	NULL
used	NULL
to	NULL
probe	NULL
50,000	NULL
recombinants	NULL
of	NULL
a	NULL
primary	NULL
murine	NULL
myeloid	NULL
cDNA	NULL
library	NULL
constructed	NULL
for	NULL
this	NULL
purpose	NULL
from	NULL
the	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*®	NULL
mRNA	NULL
of	NULL
32D	NULL
c13	NULL
cells	NULL
.	NULL

Seven	NULL
clones	NULL
consistently	NULL
hybridized	NULL
to	NULL
the	NULL
1.2	NULL
kb	NULL
E3	NULL
cDNA	NULL
probe	NULL
after	NULL
three	NULL
rounds	NULL
of	NULL
screening	NULL
,	NULL
with	NULL
the	NULL
longest	NULL
insert	NULL
obtained	NULL
being	NULL
2,466	NULL
nucleotides	NULL
in	NULL
length	NULL
(	NULL
Fig	NULL
2	NULL
)	NULL
.	NULL

The	NULL
E3	NULL
cDNA	NULL
sequence	NULL
contains	NULL
two	NULL
large	NULL
nonoverlapping	NULL
open	NULL
reading	NULL
frames	NULL
,	NULL
the	NULL
first	NULL
of	NULL
which	NULL
(	NULL
ORFA	NULL
)	NULL
is	NULL
preceded	NULL
by	NULL
an	NULL
untranslated	NULL
leader	NULL
sequence	NULL
of	NULL
36	NULL
nucleotides	NULL
.	NULL

The	NULL
sequence	NULL
surrounding	NULL
the	NULL
first	NULL
potential	NULL
initiating	NULL
ATG	NULL
codon	NULL
is	NULL
in	NULL
close	NULL
agreement	NULL
with	NULL
the	NULL
consensus	NULL
sequence	NULL
for	NULL
these	NULL
sites	NULL
,	NULL
``	NULL
and	NULL
is	NULL
followed	NULL
by	NULL
an	NULL
open	NULL
reading	NULL
frame	NULL
of	NULL
783	NULL
nucleotides	NULL
that	NULL
potentially	NULL
encodes	NULL
a	NULL
261-residue	NULL
polypeptide	NULL
with	NULL
a	NULL
predicted	NULL
mass	NULL
of	NULL
29.6	NULL
kD	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
predicted	NULL
ORFA	NULL
protein	NULL
by	NULL
the	NULL
GCG	NULL
subroutine	NULL
MOTIFS	NULL
identified	NULL
two	NULL
potential	NULL
sites	NULL
for	NULL
protein	NULL
kinase	NULL
C-mediated	NULL
phosphorylation	NULL
,	NULL
**	NULL
and	NULL
four	NULL
potential	NULL
sites	NULL
for	NULL
phosphorylation	NULL
by	NULL
casein	NULL
kinase	NULL
II	NULL
.	NULL
``	NULL

N-myristylation	NULL
sites	NULL
at	NULL
resi-	NULL
TAAAGCAACTGCAAGCTTTAAAAAAAAAAAAAAAAA	NULL
dues	NULL
83	NULL
and	NULL
177	NULL
were	NULL
identified	NULL
as	NULL
the	NULL
only	NULL
other	NULL
structural	NULL
motifs	NULL
present	NULL
within	NULL
this	NULL
open	NULL
reading	NULL
frame	NULL
.	NULL
``	NULL

Computer-assisted	NULL
hydropathy	NULL
analysis	NULL
indicated	NULL
that	NULL
the	NULL
ORFA	NULL
polypeptide	NULL
consists	NULL
of	NULL
a	NULL
series	NULL
of	NULL
strongly	NULL
hydrophobic	NULL
domains	NULL
,	NULL
dictated	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
high	NULL
number	NULL
of	NULL
hydrophobic	NULL
residues	NULL
and	NULL
a	NULL
concordant	NULL
under-representation	NULL
of	NULL
hydrophilic	NULL
residues	NULL
,	NULL
excepting	NULL
25	NULL
serine	NULL
residues	NULL
.	NULL

ORFA	NULL
is	NULL
terminated	NULL
by	NULL
an	NULL
in-frame	NULL
stop	NULL
codon	NULL
present	NULL
at	NULL
nucleotide	NULL
820	NULL
that	NULL
is	NULL
followed	NULL
by	NULL
506	NULL
nucleotides	NULL
of	NULL
untranslated	NULL
sequence	NULL
,	NULL
and	NULL
a	NULL
second	NULL
open	NULL
reading	NULL
frame	NULL
(	NULL
ORFB	NULL
)	NULL
initiated	NULL
by	NULL
an	NULL
imperfect	NULL
Kozak	NULL
sequence	NULL
.	NULL

ORFB	NULL
potentially	NULL
encodes	NULL
a	NULL
polypeptide	NULL
of	NULL
215	NULL
amino	NULL
acids	NULL
with	NULL
a	NULL
predicted	NULL
molecular	NULL
weight	NULL
of	NULL
22.7	NULL
kD	NULL
,	NULL
and	NULL
is	NULL
distinguished	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
thirteen	NULL
repeats	NULL
of	NULL
a	NULL
36-nucleo-tide	NULL
sequence	NULL
.	NULL

As	NULL
these	NULL
are	NULL
in-frame	NULL
relative	NULL
to	NULL
the	NULL
initiating	NULL
ATG	NULL
,	NULL
the	NULL
putative	NULL
ORFB	NULL
polypeptide	NULL
would	NULL
include	NULL
13	NULL
direct	NULL
repeats	NULL
of	NULL
a	NULL
proline-	NULL
and	NULL
histidine-rich	NULL
sequence	NULL
,	NULL
GAPPTTHW-SAHH	NULL
.	NULL

After	NULL
the	NULL
ORFB	NULL
termination	NULL
codon	NULL
at	NULL
nucleotide	NULL
1969	NULL
,	NULL
there	NULL
is	NULL
a	NULL
further	NULL
494	NULL
nucleotides	NULL
of	NULL
untranslated	NULL
sequence	NULL
that	NULL
includes	NULL
a	NULL
single	NULL
ATTTA	NULL
destabilization	NULL
motif	NULL
,	NULL
which	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
confer	NULL
instability	NULL
on	NULL
the	NULL
transcripts	NULL
of	NULL
many	NULL
transiently	NULL
expressed	NULL
sequences	NULL
,	NULL
including	NULL
those	NULL
of	NULL
various	NULL
cyto-kines	NULL
and	NULL
immediate-early	NULL
response	NULL
proteins	NULL
.	NULL
``	NULL

The	NULL
3	NULL
'	NULL
untranslated	NULL
region	NULL
ends	NULL
with	NULL
a	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
tail	NULL
of	NULL
at	NULL
least	NULL
17	NULL
adenosine	NULL
residues	NULL
preceded	NULL
by	NULL
an	NULL
intact	NULL
AATAAA	NULL
polyadenylation	NULL
signal	NULL
.	NULL
``	NULL

Database	NULL
homology	NULL
searches	NULL
indicated	NULL
the	NULL
predicted	NULL
261-	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2522	NULL
residue	NULL
ORFA	NULL
protein	NULL
is	NULL
unique	NULL
,	NULL
with	NULL
28	NULL
%	NULL
identity	NULL
and	NULL
52	NULL
%	NULL
similarity	NULL
to	NULL
a	NULL
233-residue	NULL
putative	NULL
protein	NULL
encoded	NULL
by	NULL
the	NULL
humORF13	NULL
cDNA	NULL
(	NULL
GenBank	NULL
accession	NULL
no	NULL
.	NULL

D14696	NULL
)	NULL
.	NULL

Similar	NULL
homology	NULL
searches	NULL
suggested	NULL
the	NULL
predicted	NULL
ORFB	NULL
polypeptide	NULL
is	NULL
also	NULL
unique	NULL
,	NULL
with	NULL
38	NULL
%	NULL
identity	NULL
and	NULL
46	NULL
%	NULL
similarity	NULL
to	NULL
a	NULL
developmentally	NULL
regulated	NULL
Trypanosoma	NULL
cruzi	NULL
neuraminidase	NULL
(	NULL
GenBank	NULL
accession	NULL
no	NULL
.	NULL

M61732	NULL
)	NULL
,	NULL
``	NULL
``	NULL
although	NULL
this	NULL
homology	NULL
was	NULL
limited	NULL
to	NULL
similarities	NULL
between	NULL
a	NULL
long	NULL
tandem-repeat	NULL
domain	NULL
within	NULL
the	NULL
neuraminidase	NULL
that	NULL
consists	NULL
of	NULL
a	NULL
variable	NULL
number	NULL
of	NULL
repeats	NULL
with	NULL
the	NULL
consensus	NULL
,	NULL
STPSTPXDSSAH	NULL
,	NULL
and	NULL
the	NULL
proline/histidine	NULL
repeats	NULL
present	NULL
within	NULL
the	NULL
ORFB	NULL
polypeptide	NULL
.	NULL

Although	NULL
both	NULL
E3	NULL
open	NULL
reading	NULL
frames	NULL
encode	NULL
potential	NULL
polypeptides	NULL
with	NULL
homology	NULL
to	NULL
one	NULL
other	NULL
protein	NULL
,	NULL
several	NULL
observations	NULL
suggest	NULL
the	NULL
ORFA	NULL
encodes	NULL
the	NULL
E3	NULL
protein	NULL
.	NULL

Although	NULL
probes	NULL
specific	NULL
to	NULL
either	NULL
open	NULL
reading	NULL
frame	NULL
detected	NULL
transcripts	NULL
on	NULL
low-stringency	NULL
Northern	NULL
blots	NULL
of	NULL
human	NULL
HL6O	NULL
RNA	NULL
,	NULL
the	NULL
human	NULL
transcript	NULL
detected	NULL
by	NULL
the	NULL
ORFA	NULL
probe	NULL
was	NULL
of	NULL
similar	NULL
size	NULL
to	NULL
the	NULL
murine	NULL
E3	NULL
transcript	NULL
,	NULL
whereas	NULL
the	NULL
human	NULL
transcript	NULL
detected	NULL
by	NULL
the	NULL
ORFB	NULL
probe	NULL
was	NULL
at	NULL
least	NULL
7	NULL
kb	NULL
in	NULL
length	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
low-stringency	NULL
screening	NULL
of	NULL
an	NULL
HL60	NULL
eDNA	NULL
library	NULL
with	NULL
the	NULL
ORFA	NULL
cDNA	NULL
probe	NULL
led	NULL
to	NULL
the	NULL
isolation	NULL
of	NULL
two	NULL
2.1-kb	NULL
cDNAs	NULL
that	NULL
contain	NULL
a	NULL
single	NULL
large	NULL
open	NULL
reading	NULL
frame	NULL
that	NULL
is	NULL
82	NULL
%	NULL
homologous	NULL
at	NULL
the	NULL
nucleotide	NULL
level	NULL
to	NULL
the	NULL
murine	NULL
E3	NULL
ORFA	NULL
(	NULL
L.M.S	NULL
.	NULL

,	NULL
S.J.C	NULL
.	NULL

,	NULL
unpublished	NULL
)	NULL
.	NULL

This	NULL
open	NULL
reading	NULL
frame	NULL
encodes	NULL
a	NULL
262-residue	NULL
polypeptide	NULL
with	NULL
80	NULL
%	NULL
identity	NULL
and	NULL
90	NULL
%	NULL
similarity	NULL
to	NULL
the	NULL
murine	NULL
E3	NULL
ORFA	NULL
polypeptide	NULL
.	NULL

There	NULL
was	NULL
no	NULL
appreciable	NULL
homology	NULL
to	NULL
the	NULL
murine	NULL
ORFB	NULL
present	NULL
within	NULL
the	NULL
human	NULL
cDNA	NULL
sequence	NULL
.	NULL

The	NULL
E3	NULL
transcript	NULL
is	NULL
restricted	NULL
to	NULL
hematopoietic	NULL
cell	NULL
types	NULL
.	NULL

RNAs	NULL
were	NULL
isolated	NULL
from	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
adult	NULL
mouse	NULL
tissues	NULL
,	NULL
including	NULL
the	NULL
gut	NULL
,	NULL
heart	NULL
,	NULL
kidney	NULL
,	NULL
liver	NULL
,	NULL
lung	NULL
,	NULL
BM	NULL
.	NULL

skeletal	NULL
muscle	NULL
,	NULL
pancreas	NULL
,	NULL
skin	NULL
,	NULL
spleen	NULL
,	NULL
and	NULL
thymus	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
of	NULL
10-ug	NULL
RNA	NULL
samples	NULL
from	NULL
each	NULL
tissue	NULL
showed	NULL
that	NULL
E3	NULL
transcripts	NULL
could	NULL
be	NULL
detected	NULL
at	NULL
significant	NULL
levels	NULL
in	NULL
the	NULL
BM	NULL
and	NULL
spleen	NULL
,	NULL
with	NULL
a	NULL
much	NULL
lower	NULL
level	NULL
present	NULL
in	NULL
the	NULL
thymus	NULL
(	NULL
Fig	NULL
3A	NULL
;	NULL
lanes	NULL
6	NULL
,	NULL
10	NULL
,	NULL
and	NULL
11	NULL
)	NULL
.	NULL

The	NULL
restricted	NULL
expression	NULL
pattern	NULL
observed	NULL
suggested	NULL
that	NULL
E3	NULL
expression	NULL
may	NULL
be	NULL
limited	NULL
to	NULL
cells	NULL
of	NULL
hematopoietic	NULL
origin	NULL
,	NULL
as	NULL
all	NULL
nonhematopoietic	NULL
tissues	NULL
examined	NULL
did	NULL
not	NULL
contain	NULL
detectable	NULL
levels	NULL
of	NULL
the	NULL
E3	NULL
mRNA	NULL
.	NULL

To	NULL
examine	NULL
this	NULL
apparently	NULL
restricted	NULL
expression	NULL
pattern	NULL
further	NULL
,	NULL
a	NULL
variety	NULL
of	NULL
murine	NULL
cell	NULL
lines	NULL
were	NULL
examined	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
E3	NULL
transcripts	NULL
(	NULL
Fig	NULL
3B	NULL
)	NULL
.	NULL

Once	NULL
again	NULL
,	NULL
E3	NULL
transcripts	NULL
were	NULL
limited	NULL
to	NULL
cells	NULL
of	NULL
the	NULL
myeloid	NULL
,	NULL
erythroid	NULL
,	NULL
and	NULL
B-lymphoid	NULL
lineages	NULL
,	NULL
with	NULL
no	NULL
E3	NULL
mRNA	NULL
detected	NULL
in	NULL
fibroblast	NULL
cells	NULL
.	NULL

Interestingly	NULL
,	NULL
within	NULL
various	NULL
hematopoietic	NULL
lineages	NULL
E3	NULL
levels	NULL
were	NULL
regulated	NULL
either	NULL
positively	NULL
or	NULL
negatively	NULL
by	NULL
the	NULL
application	NULL
of	NULL
various	NULL
differentiating	NULL
agents	NULL
.	NULL

For	NULL
example	NULL
,	NULL
induction	NULL
of	NULL
erythroid	NULL
differentiation	NULL
in	NULL
EML	NULL
cells	NULL
``	NULL
by	NULL
exposure	NULL
to	NULL
erythropoietin	NULL
resulted	NULL
in	NULL
significant	NULL
reduction	NULL
in	NULL
E3	NULL
mRNA	NULL
levels	NULL
(	NULL
lanes	NULL
6	NULL
through	NULL
8	NULL
)	NULL
,	NULL
as	NULL
did	NULL
the	NULL
HMBA-mediated	NULL
induction	NULL
of	NULL
erythroid	NULL
differentiation	NULL
in	NULL
MEL	NULL
cells	NULL
(	NULL
lanes	NULL
11	NULL
through	NULL
14	NULL
)	NULL
.	NULL

E3	NULL
transcription	NULL
was	NULL
upregulated	NULL
during	NULL
myeloid	NULL
differentiation	NULL
specifically	NULL
in	NULL
response	NULL
to	NULL
RA	NULL
,	NULL
as	NULL
observed	NULL
in	NULL
MPRO	NULL
cells	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
,	NULL
with	NULL
E3	NULL
levels	NULL
remaining	NULL
constant	NULL
in	NULL
32D	NULL
c13	NULL
cells	NULL
induced	NULL
to	NULL
differentiate	NULL
by	NULL
G-CSF	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
observation	NULL
that	NULL
there	NULL
is	NULL
a	NULL
twofold	NULL
difference	NULL
in	NULL
the	NULL
levels	NULL
of	NULL
E3	NULL
mRNA	NULL
present	NULL
between	NULL
the	NULL
relatively	NULL
immature	NULL
SP2	NULL
SCOTT	NULL
,	NULL
MUELLER	NULL
,	NULL
AND	NULL
COLLINS	NULL
A	NULL
1	NULL
2	NULL
3	NULL
4	NULL
50	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5°	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
15	NULL
16	NULL
whew	NULL
an	NULL
t	NULL
a	NULL
~	NULL
>	NULL
-	NULL
dpat	NULL
@	NULL
-	NULL
t	NULL
f	NULL
od	NULL
a	NULL
Fig	NULL
3	NULL
.	NULL

-	NULL
Tissue	NULL
distribution	NULL
of	NULL
the	NULL
E3	NULL
transcript	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Aliquots	NULL
of	NULL
RNA	NULL
,	NULL
isolated	NULL
from	NULL
the	NULL
(	NULL
1	NULL
)	NULL
gut	NULL
,	NULL
(	NULL
2	NULL
)	NULL
heart	NULL
,	NULL
(	NULL
3	NULL
)	NULL
kidney	NULL
,	NULL
(	NULL
4	NULL
)	NULL
liver	NULL
,	NULL
(	NULL
5	NULL
)	NULL
lung	NULL
,	NULL
(	NULL
6	NULL
)	NULL
BM	NULL
,	NULL
(	NULL
7	NULL
)	NULL
skeletal	NULL
muscle	NULL
,	NULL
(	NULL
8	NULL
)	NULL
pancreas	NULL
,	NULL
(	NULL
9	NULL
)	NULL
skin	NULL
,	NULL
(	NULL
10	NULL
)	NULL
spleen	NULL
,	NULL
and	NULL
(	NULL
11	NULL
)	NULL
thymus	NULL
of	NULL
a	NULL
146-day	NULL
adult	NULL
mouse	NULL
,	NULL
were	NULL
examined	NULL
for	NULL
E3	NULL
transcripts	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
,	NULL
using	NULL
the	NULL
full-length	NULL
murine	NULL
E3	NULL
cDNA	NULL
probe	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Murine	NULL
cell-lines	NULL
,	NULL
including	NULL
MPRO	NULL
cells	NULL
(	NULL
1	NULL
)	NULL
exposed	NULL
to	NULL
10	NULL
jumol/L	NULL
RA	NULL
for	NULL
1	NULL
day	NULL
(	NULL
2	NULL
)	NULL
,	NULL
32D	NULL
c13	NULL
(	NULL
3	NULL
)	NULL
induced	NULL
by	NULL
G-CSF	NULL
for	NULL
2	NULL
days	NULL
(	NULL
4	NULL
)	NULL
or	NULL
4	NULL
days	NULL
(	NULL
5	NULL
)	NULL
,	NULL
EML	NULL
cells	NULL
(	NULL
6	NULL
)	NULL
induced	NULL
by	NULL
Epo	NULL
for	NULL
3	NULL
days	NULL
(	NULL
7	NULL
)	NULL
or	NULL
5	NULL
days	NULL
(	NULL
8	NULL
)	NULL
,	NULL
SP2	NULL
(	NULL
9	NULL
)	NULL
,	NULL
MPC-11	NULL
(	NULL
10	NULL
)	NULL
,	NULL
MEL	NULL
FLDS-19	NULL
cells	NULL
(	NULL
11	NULL
)	NULL
induced	NULL
by	NULL
4	NULL
mmol/	NULL
L	NULL
HMBA	NULL
for	NULL
4	NULL
days	NULL
(	NULL
12	NULL
)	NULL
,	NULL
MEL	NULL
F3	NULL
cells	NULL
(	NULL
13	NULL
)	NULL
induced	NULL
by	NULL
4	NULL
mmol/L	NULL
HMBA	NULL
for	NULL
4	NULL
days	NULL
(	NULL
14	NULL
)	NULL
,	NULL
NIH-3T3	NULL
(	NULL
15	NULL
)	NULL
and	NULL
L	NULL
skin	NULL
fibroblasts	NULL
(	NULL
16	NULL
)	NULL
,	NULL
were	NULL
examined	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
E3	NULL
transcripts	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
,	NULL
using	NULL
the	NULL
full-length	NULL
murine	NULL
E3	NULL
cDNA	NULL
as	NULL
probe	NULL
.	NULL

The	NULL
ethidium	NULL
bromide-stained	NULL
gels	NULL
are	NULL
included	NULL
for	NULL
normalization	NULL
purposes	NULL
.	NULL

cells	NULL
and	NULL
the	NULL
more	NULL
mature	NULL
Ig-secreting	NULL
MPC-11	NULL
cells	NULL
(	NULL
lanes	NULL
9	NULL
and	NULL
10	NULL
)	NULL
suggests	NULL
that	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
E3	NULL
transcription	NULL
is	NULL
developmentally	NULL
regulated	NULL
during	NULL
B	NULL
lymphogenesis	NULL
.	NULL

RA	NULL
induction	NULL
of	NULL
E3	NULL
transcription	NULL
.	NULL

-	NULL
Direct	NULL
evidence	NULL
that	NULL
the	NULL
murine	NULL
E3	NULL
is	NULL
an	NULL
immediate-early	NULL
gene	NULL
and	NULL
therefore	NULL
a	NULL
possible	NULL
direct	NULL
target	NULL
of	NULL
RA	NULL
receptors	NULL
was	NULL
obtained	NULL
by	NULL
examining	NULL
the	NULL
kinetics	NULL
of	NULL
E3	NULL
transcript	NULL
accumulation	NULL
in	NULL
MPRO	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
RA	NULL
.	NULL

These	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
media	NULL
containing	NULL
serum	NULL
,	NULL
then	NULL
exposed	NULL
to	NULL
10	NULL
Lwmol/L	NULL
RA	NULL
for	NULL
different	NULL
periods	NULL
of	NULL
time	NULL
,	NULL
and	NULL
harvested	NULL
for	NULL
RNA	NULL
(	NULL
Fig	NULL
4A	NULL
)	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
showed	NULL
that	NULL
E3	NULL
transcript	NULL
levels	NULL
increase	NULL
in	NULL
an	NULL
immediate-early	NULL
response	NULL
to	NULL
RA	NULL
,	NULL
peaking	NULL
after	NULL
approximately	NULL
60	NULL
minutes	NULL
,	NULL
then	NULL
decreasing	NULL
toward	NULL
steady-state	NULL
levels	NULL
within	NULL
4	NULL
hours	NULL
of	NULL
the	NULL
addition	NULL
of	NULL
RA	NULL
.	NULL

Interestingly	NULL
,	NULL
after	NULL
only	NULL
15	NULL
minutes	NULL
of	NULL
exposure	NULL
,	NULL
the	NULL
level	NULL
of	NULL
E3	NULL
mRNA	NULL
increased	NULL
,	NULL
suggesting	NULL
a	NULL
rapid	NULL
transcriptional	NULL
induc-tion	NULL
.	NULL

The	NULL
observation	NULL
that	NULL
maximal	NULL
E3	NULL
levels	NULL
were	NULL
threefold	NULL
that	NULL
in	NULL
nontreated	NULL
MPRO	NULL
cells	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
Northern	NULL
blot	NULL
analysis	NULL
presented	NULL
in	NULL
Fig	NULL
1	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

HEMATOPOIETIC-SPECIFIC	NULL
TARGET	NULL
OF	NULL
RAR	NULL
2523	NULL
Fig	NULL
4	NULL
.	NULL

-	NULL
RA-inducibility	NULL
of	NULL
E3	NULL
transcription	NULL
.	NULL

(	NULL
A	NULL
)	NULL
The	NULL
kinetics	NULL
of	NULL
E3	NULL
accumulation	NULL
in	NULL
MPRO	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
RA	NULL
exposure	NULL
were	NULL
examined	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
with	NULL
the	NULL
full-length	NULL
murine	NULL
E3	NULL
cDNA	NULL
probe	NULL
.	NULL

MPRO	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
media	NULL
containing	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
1	NULL
)	NULL
,	NULL
with	NULL
10	NULL
mol/L	NULL
RA	NULL
added	NULL
for	NULL
15	NULL
minutes	NULL
(	NULL
2	NULL
)	NULL
,	NULL
30	NULL
minutes	NULL
(	NULL
3	NULL
)	NULL
,	NULL
1	NULL
hour	NULL
(	NULL
4	NULL
)	NULL
,	NULL
2	NULL
hours	NULL
(	NULL
5	NULL
)	NULL
,	NULL
or	NULL
4	NULL
hours	NULL
(	NULL
6	NULL
)	NULL
before	NULL
harvesting	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
E3	NULL
mRNA	NULL
levels	NULL
were	NULL
examined	NULL
in	NULL
RA-responsive	NULL
HL60	NULL
cells	NULL
(	NULL
1	NULL
)	NULL
exposed	NULL
to	NULL
10	NULL
wmol/L	NULL
RA	NULL
for	NULL
24	NULL
hours	NULL
(	NULL
2	NULL
)	NULL
,	NULL
48	NULL
hours	NULL
(	NULL
3	NULL
)	NULL
,	NULL
or	NULL
72	NULL
hours	NULL
(	NULL
4	NULL
)	NULL
,	NULL
in	NULL
RA-resistant	NULL
HL6OR	NULL
cells	NULL
(	NULL
5	NULL
)	NULL
exposed	NULL
to	NULL
10	NULL
mol/L	NULL
RA	NULL
for	NULL
24	NULL
hours	NULL
(	NULL
6	NULL
)	NULL
,	NULL
and	NULL
in	NULL
HL6OR	NULL
cells	NULL
stably	NULL
transfected	NULL
with	NULL
RAR	NULL
«	NULL
(	NULL
7	NULL
)	NULL
exposed	NULL
to	NULL
10	NULL
mol/L	NULL
RA	NULL
for	NULL
24	NULL
hours	NULL
(	NULL
8	NULL
)	NULL
.	NULL

A	NULL
0.7-kb	NULL
EcoRl	NULL
fragment	NULL
of	NULL
the	NULL
2.2-kb	NULL
human	NULL
E3	NULL
cDNA	NULL
was	NULL
used	NULL
as	NULL
probe	NULL
.	NULL

The	NULL
ethidium	NULL
bromide-stained	NULL
gels	NULL
are	NULL
included	NULL
for	NULL
normalization	NULL
purposes	NULL
.	NULL

We	NULL
have	NULL
used	NULL
cells	NULL
of	NULL
the	NULL
RA-resistant	NULL
HLGOR	NULL
cell	NULL
line	NULL
to	NULL
further	NULL
demonstrate	NULL
the	NULL
RA-dependent	NULL
transcription	NULL
of	NULL
the	NULL
E3	NULL
gene	NULL
.	NULL

HL6OR	NULL
cells	NULL
are	NULL
unable	NULL
to	NULL
respond	NULL
to	NULL
RA	NULL
because	NULL
of	NULL
the	NULL
presence	NULL
of	NULL
reduced-affinity	NULL
RARa	NULL
molecules	NULL
produced	NULL
by	NULL
a	NULL
point	NULL
mutation	NULL
in	NULL
the	NULL
RARa	NULL
gene	NULL
.	NULL
'	NULL

''	NULL
The	NULL
E3	NULL
transcript	NULL
level	NULL
in	NULL
HL6OR	NULL
cells	NULL
was	NULL
directly	NULL
compared	NULL
with	NULL
that	NULL
in	NULL
the	NULL
parental	NULL
HL6O	NULL
cells	NULL
and	NULL
in	NULL
a	NULL
variant	NULL
HL6OR	NULL
cell	NULL
line	NULL
generated	NULL
by	NULL
retroviral-mediated	NULL
transduction	NULL
of	NULL
a	NULL
functional	NULL
RARa	NULL
gene	NULL
into	NULL
HL6OR	NULL
cells	NULL
(	NULL
Fig	NULL
4B	NULL
)	NULL
.	NULL

E3	NULL
transcript	NULL
levels	NULL
in	NULL
HL60	NULL
cells	NULL
were	NULL
induced	NULL
several-fold	NULL
following	NULL
exposure	NULL
to	NULL
RA	NULL
for	NULL
24	NULL
hours	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
E3	NULL
transcript	NULL
level	NULL
in	NULL
HL6OR	NULL
cells	NULL
failed	NULL
to	NULL
increase	NULL
after	NULL
24	NULL
hours	NULL
exposure	NULL
to	NULL
RA	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
,	NULL
whereas	NULL
HL6OR	NULL
cells	NULL
transduced	NULL
with	NULL
RARa	NULL
displayed	NULL
a	NULL
significant	NULL
increase	NULL
in	NULL
E3	NULL
mRNA	NULL
levels	NULL
after	NULL
24	NULL
hours	NULL
exposure	NULL
to	NULL
RA	NULL
(	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
suggest	NULL
that	NULL
RA	NULL
and	NULL
RARa	NULL
play	NULL
a	NULL
direct	NULL
role	NULL
in	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
E3	NULL
in	NULL
the	NULL
HL60	NULL
myeloid	NULL
leukemia	NULL
cell	NULL
line	NULL
.	NULL

The	NULL
E3	NULL
promoter	NULL
directs	NULL
tissue-specific	NULL
transcription	NULL
.	NULL

The	NULL
full-length	NULL
E3	NULL
cDNA	NULL
was	NULL
used	NULL
to	NULL
isolate	NULL
E3	NULL
genomic	NULL
clones	NULL
from	NULL
a	NULL
murine	NULL
genomic	NULL
library	NULL
.	NULL

After	NULL
three	NULL
rounds	NULL
of	NULL
screening	NULL
,	NULL
four	NULL
clones	NULL
hybridized	NULL
to	NULL
the	NULL
full-length	NULL
cDNA	NULL
,	NULL
of	NULL
which	NULL
two	NULL
also	NULL
hybridized	NULL
to	NULL
a	NULL
probe	NULL
containing	NULL
the	NULL
extreme	NULL
5	NULL
'	NULL
portion	NULL
of	NULL
this	NULL
cDNA	NULL
,	NULL
indicating	NULL
they	NULL
were	NULL
likely	NULL
to	NULL
contain	NULL
at	NULL
least	NULL
part	NULL
of	NULL
the	NULL
E3	NULL
promoter	NULL
.	NULL

Clones	NULL
E3.5	NULL
and	NULL
E3.20	NULL
,	NULL
which	NULL
contain	NULL
14	NULL
kb	NULL
of	NULL
murine	NULL
DNA	NULL
that	NULL
overlap	NULL
by	NULL
5	NULL
kb	NULL
,	NULL
were	NULL
restriction	NULL
mapped	NULL
,	NULL
subcloned	NULL
,	NULL
then	NULL
sequenced	NULL
.	NULL

Clone	NULL
E3.5	NULL
includes	NULL
approximately	NULL
3.5	NULL
kb	NULL
of	NULL
genomic	NULL
sequence	NULL
upstream	NULL
of	NULL
the	NULL
first	NULL
exon	NULL
,	NULL
part	NULL
of	NULL
which	NULL
is	NULL
presented	NULL
in	NULL
Fig	NULL
5	NULL
.	NULL

This	NULL
region	NULL
features	NULL
numerous	NULL
elements	NULL
characteristic	NULL
of	NULL
eukaryotic	NULL
promoters	NULL
and	NULL
their	NULL
regulatory	NULL
regions	NULL
.	NULL

A	NULL
TATA	NULL
box	NULL
(	NULL
TATAAA	NULL
)	NULL
is	NULL
apparent	NULL
beginning	NULL
41	NULL
bases	NULL
upstream	NULL
of	NULL
the	NULL
putative	NULL
transcription	NULL
initiation	NULL
site	NULL
at	NULL
position	NULL
+1	NULL
,	NULL
which	NULL
was	NULL
located	NULL
by	NULL
primer	NULL
extension	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
location	NULL
of	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
210	NULL
bp	NULL
up	NULL
stream	NULL
of	NULL
the	NULL
initiating	NULL
ATG	NULL
indicated	NULL
that	NULL
the	NULL
full-length	NULL
E3	NULL
transcript	NULL
is	NULL
2,640	NULL
nucleotides	NULL
in	NULL
length	NULL
,	NULL
174	NULL
nucleotides	NULL
longer	NULL
than	NULL
the	NULL
cDNA	NULL
sequence	NULL
presented	NULL
in	NULL
Fig	NULL
2	NULL
.	NULL

The	NULL
5	NULL
'	NULL
untranslated	NULL
region	NULL
contains	NULL
three	NULL
termination	NULL
codons	NULL
,	NULL
one	NULL
of	NULL
which	NULL
is	NULL
in-frame	NULL
relative	NULL
to	NULL
ORFA	NULL
,	NULL
suggesting	NULL
the	NULL
first	NULL
methionine	NULL
present	NULL
in	NULL
Fig	NULL
2	NULL
is	NULL
the	NULL
initiating	NULL
methionine	NULL
.	NULL

Analysis	NULL
of	NULL
this	NULL
promoter	NULL
sequence	NULL
has	NULL
identified	NULL
multiple	NULL
potential	NULL
regulatory	NULL
elements	NULL
,	NULL
including	NULL
the	NULL
DNA-binding	NULL
motifs	NULL
for	NULL
E2	NULL
,	NULL
``	NULL
TCF2a	NULL
,	NULL
``	NULL
AP2	NULL
,	NULL
``	NULL
IRF1	NULL
and	NULL
IRF2	NULL
,	NULL
``	NULL
~°	NULL
and	NULL
GATA	NULL
family	NULL
``	NULL
``	NULL
transcription	NULL
factors	NULL
.	NULL

Unique	NULL
potential	NULL
binding	NULL
sites	NULL
for	NULL
NFB	NULL
,	NULL
``	NULL
and	NULL
SRF	NULL
``	NULL
are	NULL
located	NULL
farther	NULL
upstream	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
promoter	NULL
contains	NULL
several	NULL
regions	NULL
of	NULL
repetitive	NULL
DNA	NULL
,	NULL
including	NULL
two	NULL
arrays	NULL
containing	NULL
multimers	NULL
of	NULL
an	NULL
AC	NULL
dinucleotide	NULL
repeat	NULL
,	NULL
and	NULL
a	NULL
region	NULL
upstream	NULL
of	NULL
the	NULL
TATA	NULL
box	NULL
that	NULL
contains	NULL
16	NULL
direct	NULL
repeats	NULL
of	NULL
the	NULL
pentameric	NULL
sequence	NULL
,	NULL
CA	NULL
(	NULL
A/G	NULL
)	NULL
AC	NULL
.	NULL

A	NULL
potential	NULL
RA	NULL
response	NULL
element	NULL
consisting	NULL
of	NULL
two	NULL
half-sites	NULL
,	NULL
GAGTGA	NULL
and	NULL
AGGACA	NULL
,	NULL
separated	NULL
by	NULL
5	NULL
bp	NULL
can	NULL
be	NULL
identified	NULL
between	NULL
nucleotides	NULL
-394	NULL
and	NULL
-378	NULL
.	NULL

There	NULL
is	NULL
a	NULL
third	NULL
potential	NULL
half-site	NULL
located	NULL
5	NULL
bases	NULL
downstream	NULL
of	NULL
the	NULL
second	NULL
,	NULL
giving	NULL
this	NULL
response	NULL
element	NULL
a	NULL
structure	NULL
similar	NULL
to	NULL
that	NULL
present	NULL
in	NULL
the	NULL
murine	NULL
laminin	NULL
B1	NULL
gene	NULL
,	NULL
which	NULL
consists	NULL
of	NULL
two	NULL
closely	NULL
arranged	NULL
half-sites	NULL
separated	NULL
from	NULL
a	NULL
third	NULL
by	NULL
14	NULL
bases	NULL
.	NULL
``	NULL

To	NULL
show	NULL
that	NULL
the	NULL
E3	NULL
promoter	NULL
is	NULL
transcriptionally	NULL
active	NULL
in	NULL
certain	NULL
cell	NULL
types	NULL
,	NULL
three	NULL
luciferase-based	NULL
reporter	NULL
plasmids	NULL
were	NULL
constructed	NULL
.	NULL

An	NULL
EcoRV/Nco	NULL
I	NULL
restriction	NULL
fragment	NULL
of	NULL
this	NULL
promoter	NULL
corresponding	NULL
to	NULL
the	NULL
sequence	NULL
-703	NULL
to	NULL
+209	NULL
was	NULL
ligated	NULL
into	NULL
pUCI9LUC	NULL
to	NULL
generate	NULL
pO.7E3LUC	NULL
,	NULL
with	NULL
the	NULL
Bg/II	NULL
(	NULL
-428	NULL
)	NULL
and	NULL
HindIII	NULL
(	NULL
-221	NULL
)	NULL
restriction	NULL
sites	NULL
present	NULL
used	NULL
to	NULL
make	NULL
pO.4E3LUC	NULL
and	NULL
pO.2E3LUC	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
6A	NULL
)	NULL
.	NULL

Aliquots	NULL
of	NULL
each	NULL
construct	NULL
were	NULL
transiently	NULL
transfected	NULL
into	NULL
three	NULL
cell	NULL
lines	NULL
:	NULL
the	NULL
E3-positive	NULL
myeloid/erythroid	NULL
K562	NULL
cell-line	NULL
,	NULL
and	NULL
two	NULL
E3-negative	NULL
cell-lines	NULL
,	NULL
Jurkat	NULL
(	NULL
T	NULL
lymphoid	NULL
)	NULL
and	NULL
Colo320-DM	NULL
(	NULL
colonic	NULL
epithelium	NULL
)	NULL
.	NULL

There	NULL
was	NULL
a	NULL
high	NULL
level	NULL
of	NULL
reporter	NULL
ac	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2524	NULL
SCOTT	NULL
,	NULL
MUELLER	NULL
,	NULL
AND	NULL
COLLINS	NULL
-711	NULL
-	NULL
AATATCTGATATCCAGAATATCTGATATGTGACTCCCATGAAAGCCGTCGGCCGACCCCTGCGACAGGTTA	NULL
EcoRV	NULL
-642	NULL
-	NULL
TGATCCACAGGTTGAGAATTACTACTCTAGAGCCAGTTGGCCTCCGTTCCAGTCCCCACTCCTTTTPAG	NULL
~573	NULL
_	NULL
ACTATCTTGGTGACTGCAAGGGAGAAATGGCTTCATCCTGTGCCTCCATTTTTTCATCTGTGCAGTGGG	NULL
E2A	NULL
-504	NULL
.	NULL

.	NULL

CATAAGAATAGCACCTCCTCCTGGCAAGTGACAGTATACGCCTTTAATCCCAACACTTGSTAGGGAGAA	NULL
Fig	NULL
5	NULL
.	NULL

Nucleotide	NULL
sequence	NULL
GATA	NULL
IRF	NULL
of	NULL
the	NULL
murine	NULL
E3	NULL
promoter	NULL
.	NULL

Ap	NULL
--	NULL
435	NULL
-	NULL
GACGCCAGATCTCTATAAGTTTGACGGCCACCCTGCTCTACAGAGTCACTTCCAGCACAGCCAGGGCTCA	NULL
proximately	NULL
1	NULL
kb	NULL
f	NULL
)	NULL
,	NULL
the	NULL
mﬁri	NULL
;	NULL
BglII	NULL
RARE	NULL
RARE	NULL
h	NULL
-366	NULL
-	NULL
ACAAAGAAACCoTacccoccccopecceaccocAaAAcCAaAAccAAAccAcaccacaccAaAccaaaceaa	NULL
_	NULL
£3	NULL
Promoter	NULL
was	NULL
determined	NULL
by	NULL
Ap2	NULL
direct	NULL
sequence	NULL
analysis	NULL
of	NULL
the	NULL
-297	NULL
-	NULL
AcCAAAcCcAAACCAAACeAAACCAAACcAAACcaAAccaAAcAGTeceTccctecAAcAccccAceraa	NULL
-	NULL
@	NULL
enomic	NULL
clone	NULL
E3.5	NULL
.	NULL

The	NULL
TATA	NULL
box	NULL
is	NULL
underlined	NULL
,	NULL
as	NULL
is	NULL
the	NULL
Kozak	NULL
-228	NULL
-	NULL
CGAGCTAAGCTTCACAGCATCTCGAAGGAGCAGTTTACTGCAGACGCTACTGTTTTTACAAccAGACAcAr	NULL
-	NULL
Sequence	NULL
that	NULL
includes	NULL
the	NULL
ini-HindIII	NULL
tiating	NULL
ATG	NULL
and	NULL
a	NULL
number	NULL
of	NULL
po	NULL
--	NULL
159	NULL
-	NULL
TPEAGTPTGAATCCTTCCATTAGAACTACTGTTTCATTAGGCACAGATTTCCATATCGGATTCTPP	NULL
»	NULL
PPc	NULL
__	NULL
tential	NULL
transcription	NULL
factor	NULL
DNA-binding	NULL
recognition	NULL
sequences	NULL
,	NULL
-90	NULL
_	NULL
TAGAAAACGGCTTCTAGCGCGCTCTTCAGCATCCAGCAACCACAGCTCCATATAAATcCGaaccccacec	NULL
_	NULL
identified	NULL
using	NULL
the	NULL
GCG	NULL
subrou-SP1	NULL
TCF-20	NULL
TATA	NULL
BOX	NULL
tine	NULL
FindPatterns	NULL
,	NULL
that	NULL
includes	NULL
-21	NULL
-	NULL
-	NULL
E2A	NULL
,	NULL
Sp1	NULL
,	NULL
and	NULL
members	NULL
of	NULL
the	NULL
+1	NULL
GATA	NULL
,	NULL
RAR	NULL
,	NULL
and	NULL
(	NULL
RF	NULL
families	NULL
.	NULL

49	NULL
-	NULL
TCCCTCCCCTGCAGCTECTACAACCCAGACTTACAGACCTGGCCCCTACCGTCTGAGGGCAAGCCCCAA	NULL
-	NULL
The	NULL
single	NULL
transcription	NULL
initia-EZA	NULL
tion	NULL
site	NULL
mapped	NULL
by	NULL
primer	NULL
ex-118	NULL
-	NULL
CTGACCCACGCCAGCCTCTGocTTCcTcTrTTITGTTCTECTGTGGGCCCAAGACTCCTTACTCAGAGCA	NULL
_-	NULL
tension	NULL
is	NULL
identified	NULL
by	NULL
bold	NULL
let-IRF	NULL
AP2	NULL
tering	NULL
.	NULL

Multiple	NULL
repeats	NULL
of	NULL
the	NULL
187	NULL
-	NULL
CTCCGAAGAGGGGACTGCGCACCATG	NULL
pentamer	NULL
CA	NULL
(	NULL
A/G	NULL
)	NULL
AC	NULL
are	NULL
in	NULL
ital-KOZAK	NULL
ics	NULL
.	NULL

tivity	NULL
detected	NULL
for	NULL
all	NULL
three	NULL
E3-based	NULL
reporter	NULL
constructs	NULL
transfected	NULL
into	NULL
K562	NULL
cells	NULL
(	NULL
Fig	NULL
6B	NULL
)	NULL
.	NULL

The	NULL
constructs	NULL
pQO.7E3LUC	NULL
and	NULL
pO.4E3LUC	NULL
were	NULL
significantly	NULL
more	NULL
active	NULL
in	NULL
K562	NULL
cells	NULL
than	NULL
in	NULL
either	NULL
Colo320-DM	NULL
or	NULL
Jurkat	NULL
cells	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
tissue	NULL
distribution	NULL
of	NULL
the	NULL
E3	NULL
transcript	NULL
.	NULL

Interestingly	NULL
,	NULL
pQ.4E3LUC	NULL
was	NULL
at	NULL
least	NULL
two	NULL
times	NULL
more	NULL
active	NULL
in	NULL
K562	NULL
cells	NULL
than	NULL
was	NULL
pO.7E3LUC	NULL
,	NULL
suggesting	NULL
that	NULL
part	NULL
of	NULL
the	NULL
promoter	NULL
present	NULL
in	NULL
pO.7E3LUC	NULL
but	NULL
not	NULL
in	NULL
p0.4E3LUC	NULL
may	NULL
negatively	NULL
regulate	NULL
E3	NULL
transcription	NULL
in	NULL
K562	NULL
cells	NULL
.	NULL

Removal	NULL
of	NULL
a	NULL
further	NULL
200	NULL
bp	NULL
from	NULL
the	NULL
5	NULL
'	NULL
region	NULL
of	NULL
the	NULL
E3	NULL
promoter	NULL
,	NULL
to	NULL
generate	NULL
pO.2E3LUC	NULL
,	NULL
resulted	NULL
in	NULL
a	NULL
sevenfold	NULL
reduction	NULL
in	NULL
promoter	NULL
activity	NULL
,	NULL
an	NULL
effect	NULL
that	NULL
is	NULL
possibly	NULL
mediated	NULL
by	NULL
the	NULL
potential	NULL
RA	NULL
response	NULL
element	NULL
.	NULL

Although	NULL
the	NULL
E3	NULL
promoter	NULL
constructs	NULL
were	NULL
transcriptionally	NULL
active	NULL
in	NULL
Jurkat	NULL
and	NULL
Colo320-DM	NULL
cells	NULL
,	NULL
which	NULL
do	NULL
not	NULL
appear	NULL
to	NULL
express	NULL
E3	NULL
,	NULL
the	NULL
activity	NULL
of	NULL
each	NULL
construct	NULL
was	NULL
only	NULL
several-fold	NULL
that	NULL
of	NULL
the	NULL
minimal	NULL
promoter	NULL
construct	NULL
,	NULL
pTKLUC	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
E3	NULL
transcription	NULL
is	NULL
normally	NULL
prevented	NULL
in	NULL
colonic	NULL
epithelial	NULL
cells	NULL
and	NULL
T	NULL
lymphocytes	NULL
by	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
repressor	NULL
molecule	NULL
that	NULL
was	NULL
unable	NULL
to	NULL
function	NULL
in	NULL
these	NULL
in	NULL
vitro	NULL
assays	NULL
.	NULL

The	NULL
inclusion	NULL
of	NULL
flanking	NULL
sequences	NULL
further	NULL
upstream	NULL
or	NULL
downstream	NULL
of	NULL
the	NULL
E3	NULL
gene	NULL
may	NULL
facilitate	NULL
the	NULL
mapping	NULL
of	NULL
DNA	NULL
elements	NULL
that	NULL
mediate	NULL
the	NULL
repression	NULL
of	NULL
E3	NULL
transcription	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

The	NULL
murine	NULL
E3	NULL
promoter	NULL
is	NULL
RA	NULL
responsive	NULL
.	NULL

The	NULL
RA-inducibility	NULL
of	NULL
the	NULL
E3	NULL
promoter	NULL
was	NULL
explored	NULL
by	NULL
transfection	NULL
of	NULL
the	NULL
pO.A4E3CAT	NULL
and	NULL
pO.2E3CAT	NULL
constructs	NULL
into	NULL
HL6O	NULL
and	NULL
HL6OR	NULL
cells	NULL
(	NULL
Fig	NULL
7A	NULL
)	NULL
.	NULL

pOQ.A4E3CAT	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
potential	NULL
RA	NULL
response	NULL
element	NULL
,	NULL
had	NULL
a	NULL
high	NULL
level	NULL
of	NULL
reporter	NULL
activity	NULL
in	NULL
HL60	NULL
cells	NULL
cultured	NULL
in	NULL
stripped	NULL
serum	NULL
,	NULL
being	NULL
75-fold	NULL
more	NULL
active	NULL
than	NULL
pTKCAT	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
pO.4E3CAT	NULL
increased	NULL
2.3-fold	NULL
after	NULL
exposure	NULL
of	NULL
the	NULL
transfected	NULL
HL6O	NULL
cells	NULL
to	NULL
RA	NULL
,	NULL
suggesting	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
functional	NULL
RA	NULL
response	NULL
element	NULL
within	NULL
this	NULL
construct	NULL
.	NULL

The	NULL
degree	NULL
of	NULL
E3	NULL
induction	NULL
observed	NULL
is	NULL
consistent	NULL
with	NULL
previous	NULL
Northern	NULL
blot	NULL
analysis	NULL
(	NULL
Figs	NULL
1	NULL
and	NULL
4	NULL
)	NULL
,	NULL
which	NULL
demonstrated	NULL
that	NULL
E3	NULL
transcript	NULL
levels	NULL
treble	NULL
after	NULL
RA	NULL
exposure	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
no	NULL
RA-induced	NULL
enhancement	NULL
of	NULL
pO.4E3CAT	NULL
was	NULL
noted	NULL
in	NULL
transfected	NULL
HL6GOR	NULL
cells	NULL
,	NULL
which	NULL
harbor	NULL
nonfunctional	NULL
RARa	NULL
mol-ecules	NULL
.	NULL

Removal	NULL
of	NULL
the	NULL
promoter	NULL
region	NULL
that	NULL
includes	NULL
the	NULL
putative	NULL
RA	NULL
response	NULL
element	NULL
abolished	NULL
the	NULL
RA-induced	NULL
increase	NULL
in	NULL
reporter	NULL
activity	NULL
in	NULL
HL60	NULL
cells	NULL
,	NULL
effectively	NULL
localizing	NULL
the	NULL
sequence	NULL
responsible	NULL
for	NULL
RA	NULL
responsiveness	NULL
to	NULL
within	NULL
nucleotides	NULL
-428	NULL
and	NULL
-221	NULL
of	NULL
the	NULL
E3	NULL
promoter	NULL
(	NULL
Fig	NULL
7A	NULL
)	NULL
.	NULL

The	NULL
RA-inducibility	NULL
of	NULL
the	NULL
E3	NULL
promoter	NULL
was	NULL
paralleled	NULL
by	NULL
that	NULL
of	NULL
the	NULL
putative	NULL
RA	NULL
response	NULL
element	NULL
itself	NULL
,	NULL
which	NULL
was	NULL
tested	NULL
by	NULL
transient	NULL
transfection	NULL
of	NULL
p	NULL
(	NULL
-394	NULL
to	NULL
-373	NULL
mE3	NULL
)	NULL
;	NULL
TKCAT	NULL
(	NULL
Fig	NULL
7B	NULL
)	NULL
.	NULL

This	NULL
reporter	NULL
construct	NULL
contains	NULL
two	NULL
direct	NULL
repeats	NULL
of	NULL
the	NULL
putative	NULL
E3	NULL
RA	NULL
response	NULL
element	NULL
cloned	NULL
upstream	NULL
of	NULL
the	NULL
minimal	NULL
pTKCAT	NULL
reporter	NULL
construct	NULL
.	NULL

p	NULL
(	NULL
RRE	NULL
)	NULL
,	NULL
TKCAT	NULL
,	NULL
which	NULL
contains	NULL
four	NULL
direct	NULL
repeats	NULL
of	NULL
the	NULL
RA	NULL
response	NULL
element	NULL
,	NULL
and	NULL
pTKCAT	NULL
were	NULL
included	NULL
for	NULL
comparative	NULL
purposes	NULL
.	NULL

In	NULL
HL60	NULL
cells	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
stripped	NULL
serum	NULL
,	NULL
p	NULL
(	NULL
RRE	NULL
)	NULL
,	NULL
TKCAT	NULL
and	NULL
p	NULL
(	NULL
-394	NULL
to	NULL
-373	NULL
mE3	NULL
)	NULL
;	NULL
TKCAT	NULL
had	NULL
similar	NULL
reporter	NULL
activities	NULL
to	NULL
that	NULL
of	NULL
the	NULL
pTKCAT	NULL
construct	NULL
.	NULL

However	NULL
,	NULL
there	NULL
was	NULL
a	NULL
significant	NULL
increase	NULL
in	NULL
the	NULL
reporter	NULL
activities	NULL
of	NULL
both	NULL
constructs	NULL
following	NULL
the	NULL
application	NULL
of	NULL
10	NULL
pmol/L	NULL
RA	NULL
for	NULL
24	NULL
hours	NULL
.	NULL

In	NULL
three	NULL
experiments	NULL
,	NULL
p	NULL
(	NULL
RRE	NULL
)	NULL
,	NULL
TKCAT	NULL
had	NULL
a	NULL
mean	NULL
increase	NULL
in	NULL
reporter	NULL
activity	NULL
of	NULL
9.4-fold	NULL
after	NULL
exposure	NULL
to	NULL
RA	NULL
,	NULL
whereas	NULL
p	NULL
(	NULL
~394	NULL
to	NULL
-373	NULL
mE3	NULL
)	NULL
;	NULL
TKCAT	NULL
had	NULL
a	NULL
more	NULL
modest	NULL
2.4-fold	NULL
increase	NULL
in	NULL
reporter	NULL
activity	NULL
.	NULL

The	NULL
RA-responsiveness	NULL
of	NULL
the	NULL
p	NULL
(	NULL
-394	NULL
to	NULL
-373	NULL
mE3	NULL
)	NULL
;	NULL
TKCAT	NULL
reporter	NULL
construct	NULL
was	NULL
very	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
pO.4E3CAT	NULL
,	NULL
suggesting	NULL
that	NULL
this	NULL
region	NULL
of	NULL
the	NULL
murine	NULL
E3	NULL
promoter	NULL
is	NULL
primarily	NULL
responsible	NULL
for	NULL
the	NULL
upregulation	NULL
of	NULL
E3	NULL
transcription	NULL
observed	NULL
in	NULL
response	NULL
to	NULL
RA	NULL
.	NULL

DISCUSSION	NULL
RA	NULL
and	NULL
its	NULL
receptor	NULL
,	NULL
RARa	NULL
,	NULL
have	NULL
been	NULL
implicated	NULL
in	NULL
hematopoietic	NULL
regulation	NULL
by	NULL
multiple	NULL
lines	NULL
of	NULL
evidence	NULL
,	NULL
al	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

HEMATOPOIETIC-SPECIFIC	NULL
TARGET	NULL
OF	NULL
RAR	NULL
2525	NULL
A	NULL
te	NULL
GAGTGA	NULL
...	NULL
..AGGACA	NULL
+1	NULL
r	NULL
(	NULL
T	NULL
T	NULL
T	NULL
-703	NULL
428	NULL
321	NULL
41	NULL
+209	NULL
EcoRV	NULL
Bglll	NULL
TATA	NULL
Neo	NULL
!	NULL

0.7E3LUC	NULL
#	NULL
(	NULL
&	NULL
{	NULL
Eve	NULL
)	NULL
0.4E3LUC	NULL
#	NULL
*	NULL
-	NULL
{	NULL
Euc	NULL
]	NULL
0.2E3LUC	NULL
04E3CAT	NULL
P	NULL
(	NULL
&	NULL
CAT	NULL
0.2E3CAT	NULL
CAT	NULL
Fig	NULL
6	NULL
.	NULL

The	NULL
E3	NULL
promoter	NULL
constructs	NULL
are	NULL
transcriptionally	NULL
active	NULL
in	NULL
hematopoietic	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
The	NULL
structural	NULL
features	NULL
of	NULL
the	NULL
murine	NULL
E3	NULL
promoter	NULL
region	NULL
used	NULL
to	NULL
construct	NULL
the	NULL
five	NULL
E3	NULL
reporter	NULL
plasmids	NULL
is	NULL
de-picted	NULL
.	NULL

The	NULL
locations	NULL
of	NULL
the	NULL
TATA	NULL
box	NULL
and	NULL
transcription	NULL
initiation	NULL
site	NULL
are	NULL
indicated	NULL
,	NULL
as	NULL
are	NULL
the	NULL
EcoRV	NULL
,	NULL
and	NULL
HindIll	NULL
restriction	NULL
sites	NULL
used	NULL
to	NULL
construct	NULL
p0.7E3LUC	NULL
,	NULL
p0.4E3LUC	NULL
,	NULL
p0.4E3CAT	NULL
,	NULL
p0.2E3LUC	NULL
,	NULL
and	NULL
p0.2E3CAT	NULL
.	NULL

The	NULL
position	NULL
of	NULL
the	NULL
putative	NULL
RA	NULL
response	NULL
element	NULL
is	NULL
indicated	NULL
by	NULL
the	NULL
solid	NULL
box	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
reporter	NULL
activity	NULL
of	NULL
three	NULL
constructs	NULL
introduced	NULL
into	NULL
the	NULL
indicated	NULL
cell	NULL
lines	NULL
is	NULL
displayed	NULL
.	NULL

In	NULL
each	NULL
case	NULL
,	NULL
the	NULL
mean	NULL
relative	NULL
light	NULL
units	NULL
(	NULL
RLU	NULL
)	NULL
measured	NULL
in	NULL
four	NULL
experiments	NULL
,	NULL
after	NULL
normalization	NULL
of	NULL
the	NULL
CAT	NULL
levels	NULL
,	NULL
is	NULL
presented	NULL
,	NULL
with	NULL
the	NULL
mean	NULL
RLUs	NULL
measured	NULL
for	NULL
pTKLUC	NULL
set	NULL
arbitrarily	NULL
at	NULL
1.0.	NULL
though	NULL
the	NULL
mechanisms	NULL
by	NULL
which	NULL
RA	NULL
exerts	NULL
its	NULL
effect	NULL
on	NULL
granulocytic	NULL
differentiation	NULL
remain	NULL
unclear	NULL
.	NULL

It	NULL
is	NULL
anticipated	NULL
that	NULL
the	NULL
identification	NULL
of	NULL
genes	NULL
that	NULL
are	NULL
transcriptionally	NULL
regulated	NULL
directly	NULL
by	NULL
RARa	NULL
or	NULL
by	NULL
RAR/RXR	NULL
heterodimers	NULL
during	NULL
RA-induced	NULL
granulocytic	NULL
differentiation	NULL
may	NULL
assist	NULL
in	NULL
elucidation	NULL
of	NULL
the	NULL
processes	NULL
involved	NULL
in	NULL
differentiation	NULL
.	NULL

Here	NULL
we	NULL
report	NULL
the	NULL
isolation	NULL
of	NULL
a	NULL
candidate	NULL
gene	NULL
exhibiting	NULL
early	NULL
RA-induced	NULL
upregulation	NULL
during	NULL
promyelocytic	NULL
differentiation	NULL
.	NULL

The	NULL
number	NULL
of	NULL
genes	NULL
identified	NULL
as	NULL
being	NULL
induced	NULL
by	NULL
RA	NULL
in	NULL
an	NULL
immediate-early	NULL
manner	NULL
is	NULL
surprisingly	NULL
low	NULL
,	NULL
although	NULL
differential	NULL
screening	NULL
has	NULL
successfully	NULL
identified	NULL
several	NULL
RA-inducible	NULL
transcripts	NULL
.	NULL
``	NULL

However	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
many	NULL
of	NULL
these	NULL
sequences	NULL
are	NULL
regulated	NULL
as	NULL
an	NULL
indirect	NULL
response	NULL
to	NULL
RA	NULL
,	NULL
as	NULL
they	NULL
were	NULL
isolated	NULL
by	NULL
strategies	NULL
that	NULL
favor	NULL
the	NULL
itentifica-tion	NULL
of	NULL
delayed-response	NULL
transcripts	NULL
.	NULL

RA-inducible	NULL
transcripts	NULL
have	NULL
been	NULL
identified	NULL
in	NULL
several	NULL
hematopoietic	NULL
cell-types	NULL
,	NULL
°*	NULL
``	NULL
``	NULL
``	NULL
``	NULL
although	NULL
in	NULL
most	NULL
instances	NULL
it	NULL
is	NULL
also	NULL
unclear	NULL
whether	NULL
these	NULL
are	NULL
the	NULL
direct	NULL
targets	NULL
of	NULL
RARa	NULL
.	NULL

Analysis	NULL
of	NULL
two	NULL
RA-inducible	NULL
genes	NULL
,	NULL
CD18	NULL
and	NULL
CD11b	NULL
,	NULL
has	NULL
failed	NULL
to	NULL
identify	NULL
classic	NULL
RA	NULL
response	NULL
elements	NULL
within	NULL
their	NULL
respective	NULL
promoter	NULL
regions	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
transcriptional	NULL
upregulation	NULL
observed	NULL
in	NULL
response	NULL
to	NULL
RA	NULL
may	NULL
be	NULL
mediated	NULL
by	NULL
factors	NULL
other	NULL
than	NULL
RA	NULL
receptors	NULL
.	NULL

``	NULL
*	NULL
``	NULL
``	NULL
The	NULL
paucity	NULL
of	NULL
RA	NULL
target	NULL
genes	NULL
identified	NULL
by	NULL
differential	NULL
04E3LUC	NULL
E	NULL
I	NULL
6	NULL
:	NULL
a*	NULL
o	NULL
2E3LuUC	NULL
[	NULL
*	NULL
TKLUC	NULL
0	NULL
20	NULL
40	NULL
60	NULL
80	NULL
Relative	NULL
light	NULL
units	NULL
screening	NULL
techniques	NULL
may	NULL
result	NULL
from	NULL
the	NULL
inherent	NULL
limitations	NULL
of	NULL
analysing	NULL
large	NULL
representative	NULL
cDNA	NULL
libraries	NULL
,	NULL
and	NULL
may	NULL
be	NULL
complicated	NULL
by	NULL
the	NULL
requirement	NULL
that	NULL
cells	NULL
be	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
serum	NULL
,	NULL
which	NULL
contains	NULL
physiologically	NULL
significant	NULL
levels	NULL
of	NULL
RA	NULL
.	NULL

Presumably	NULL
,	NULL
the	NULL
level	NULL
of	NULL
serum	NULL
RA	NULL
is	NULL
sufficient	NULL
to	NULL
induce	NULL
transcription	NULL
of	NULL
RA-inducible	NULL
genes	NULL
,	NULL
preventing	NULL
their	NULL
subsequent	NULL
isolation	NULL
by	NULL
this	NULL
method	NULL
.	NULL

Unfor-tunately	NULL
,	NULL
the	NULL
procedures	NULL
available	NULL
to	NULL
remove	NULL
endogenous	NULL
RA	NULL
inadvertently	NULL
remove	NULL
other	NULL
serum	NULL
constituents	NULL
important	NULL
for	NULL
continued	NULL
growth	NULL
of	NULL
most	NULL
cells	NULL
.	NULL

To	NULL
avoid	NULL
this	NULL
problem	NULL
,	NULL
we	NULL
have	NULL
instead	NULL
made	NULL
use	NULL
of	NULL
the	NULL
promyelocytic	NULL
MPRO	NULL
cell	NULL
line	NULL
,	NULL
which	NULL
is	NULL
particularly	NULL
suited	NULL
for	NULL
differential	NULL
screening	NULL
because	NULL
its	NULL
cells	NULL
remain	NULL
arrested	NULL
as	NULL
promyelocytes	NULL
when	NULL
cultured	NULL
under	NULL
normal	NULL
serum	NULL
conditions	NULL
,	NULL
but	NULL
may	NULL
be	NULL
rapidly	NULL
induced	NULL
to	NULL
differentiate	NULL
into	NULL
granulocytes	NULL
by	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
concentration	NULL
of	NULL
RA	NULL
present	NULL
to	NULL
10	NULL
mol/L	NULL
.	NULL

With	NULL
this	NULL
inducible	NULL
system	NULL
,	NULL
nine	NULL
differentially	NULL
expressed	NULL
sequences	NULL
were	NULL
isolated	NULL
from	NULL
a	NULL
cDNA	NULL
library	NULL
constructed	NULL
from	NULL
the	NULL
mRNA	NULL
of	NULL
MPRO	NULL
cells	NULL
treated	NULL
for	NULL
2.5	NULL
hours	NULL
with	NULL
RA	NULL
and	NULL
CHX	NULL
,	NULL
four	NULL
of	NULL
which	NULL
appear	NULL
to	NULL
be	NULL
regulated	NULL
directly	NULL
by	NULL
RARa	NULL
in	NULL
MPRO	NULL
cells	NULL
.	NULL

Transcript	NULL
levels	NULL
of	NULL
one	NULL
of	NULL
these	NULL
genes	NULL
,	NULL
which	NULL
we	NULL
have	NULL
named	NULL
E3	NULL
,	NULL
trebled	NULL
in	NULL
response	NULL
to	NULL
RA	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
CHX	NULL
,	NULL
implying	NULL
that	NULL
E3	NULL
may	NULL
be	NULL
a	NULL
direct	NULL
target	NULL
of	NULL
the	NULL
activated	NULL
RARa	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2526	NULL
SCOTT	NULL
,	NULL
MUELLER	NULL
,	NULL
AND	NULL
COLLINS	NULL
A	NULL
HL60	NULL
5	NULL
0.4E3CAT	NULL
0.2E3CAT	NULL
TKCAT	NULL
HLGOR	NULL
E	NULL
04B3CAT	NULL
—l	NULL
[	NULL
i	NULL
]	NULL
[	NULL
CJ	NULL
-10uMRA	NULL
0.2E3CAT	NULL
TKCAT	NULL
I	NULL
R	NULL
suoumn	NULL
ra	NULL
-m	NULL
--	NULL
f	NULL
--	NULL
--	NULL
f	NULL
--	NULL
--	NULL
f	NULL
--	NULL
--	NULL
f	NULL
--	NULL
--	NULL
--	NULL
~-r	NULL
0	NULL
20000	NULL
40000	NULL
:	NULL
60000	NULL
80000	NULL
100000	NULL
120000	NULL
Relative	NULL
CAT	NULL
units	NULL
B	NULL
Fig	NULL
7	NULL
.	NULL

The	NULL
E3	NULL
promoter	NULL
is	NULL
induced	NULL
by	NULL
RA	NULL
via	NULL
an	NULL
RA	NULL
response	NULL
element	NULL
.	NULL

(	NULL
A	NULL
)	NULL
The	NULL
reporter	NULL
activity	NULL
of	NULL
two	NULL
constructs	NULL
introduced	NULL
into	NULL
HL60	NULL
or	NULL
HL6OR	NULL
cells	NULL
,	NULL
(	NULL
RRE	NULL
)	NULL
,	NULL
-TKCAT	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
10	NULL
mol/L	NULL
RA	NULL
,	NULL
is_d_is-played	NULL
.	NULL

In	NULL
each	NULL
case	NULL
,	NULL
the	NULL
mean	NULL
of	NULL
the	NULL
CAT	NULL
activity	NULL
measured	NULL
in	NULL
four	NULL
experiments	NULL
,	NULL
after	NULL
normalization	NULL
(	NULL
-394	NULL
to	NULL
-373	NULL
mE3	NULL
)	NULL
;	NULL
-TKCAT	NULL
[	NULL
J	NULL
-10uM	NULL
RA	NULL
of	NULL
the	NULL
protein	NULL
levels	NULL
,	NULL
is	NULL
presented	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Reporter	NULL
activity	NULL
of	NULL
p	NULL
(	NULL
-394	NULL
to	NULL
-373	NULL
mE3	NULL
)	NULL
,	NULL
;	NULL
TKCAT	NULL
,	NULL
p	NULL
(	NULL
RRE	NULL
)	NULL
,	NULL
TKCAT	NULL
,	NULL
ar	NULL
(	NULL
Ge	NULL
and	NULL
pTKCAT	NULL
introduced	NULL
into	NULL
HL60	NULL
or	NULL
HL6OR	NULL
cells	NULL
,	NULL
in	NULL
TKCAT	NULL
m	NULL
Ra	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
10	NULL
umol/L	NULL
RA	NULL
,	NULL
is	NULL
displayed	NULL
.	NULL

In	NULL
each	NULL
case	NULL
,	NULL
the	NULL
mean	NULL
of	NULL
the	NULL
CAT	NULL
activity	NULL
0	NULL
500	NULL
1000	NULL
1500	NULL
2000	NULL
2500	NULL
3000	NULL
measured	NULL
in	NULL
four	NULL
experiments	NULL
,	NULL
after	NULL
normalization	NULL
Relative	NULL
CAT	NULL
units	NULL
The	NULL
E3	NULL
transcript	NULL
encodes	NULL
a	NULL
potentially	NULL
phosphorylated	NULL
protein	NULL
with	NULL
a	NULL
high	NULL
proportion	NULL
of	NULL
hydrophobic	NULL
residues	NULL
that	NULL
are	NULL
arranged	NULL
in	NULL
a	NULL
series	NULL
of	NULL
five	NULL
strongly	NULL
hydrophobic	NULL
domains	NULL
,	NULL
homologous	NULL
to	NULL
those	NULL
found	NULL
in	NULL
polytopic	NULL
transmembrane	NULL
proteins	NULL
.	NULL
``	NULL

''	NULL
Although	NULL
we	NULL
have	NULL
yet	NULL
to	NULL
identify	NULL
the	NULL
subcellular	NULL
location	NULL
of	NULL
the	NULL
E3	NULL
protein	NULL
,	NULL
a	NULL
model	NULL
for	NULL
its	NULL
mem-brane-associated	NULL
organization	NULL
can	NULL
be	NULL
constructed	NULL
based	NULL
on	NULL
the	NULL
assumption	NULL
that	NULL
its	NULL
five	NULL
hydrophobic	NULL
segments	NULL
correspond	NULL
to	NULL
transmembrane	NULL
domains	NULL
.	NULL

This	NULL
model	NULL
would	NULL
orientate	NULL
the	NULL
E3	NULL
protein	NULL
such	NULL
that	NULL
the	NULL
amino-	NULL
and	NULL
carboxy-termini	NULL
and	NULL
the	NULL
potential	NULL
N-myristylation	NULL
sites	NULL
would	NULL
extend	NULL
into	NULL
the	NULL
extracellular	NULL
or	NULL
luminal	NULL
side	NULL
of	NULL
the	NULL
membrane	NULL
.	NULL

Four	NULL
of	NULL
the	NULL
six	NULL
potential	NULL
serine	NULL
phosphorylation	NULL
sites	NULL
would	NULL
therefore	NULL
be	NULL
positioned	NULL
on	NULL
the	NULL
cytoplasmic	NULL
side	NULL
of	NULL
the	NULL
membrane	NULL
,	NULL
with	NULL
residues	NULL
Serl13	NULL
and	NULL
Serl53	NULL
being	NULL
located	NULL
within	NULL
separate	NULL
hydrophobic	NULL
regions	NULL
that	NULL
may	NULL
render	NULL
these	NULL
sites	NULL
functionally	NULL
inactive	NULL
.	NULL

The	NULL
suggestion	NULL
that	NULL
an	NULL
immediate-early	NULL
response	NULL
gene	NULL
encodes	NULL
a	NULL
membrane-spanning	NULL
protein	NULL
is	NULL
not	NULL
without	NULL
precedent	NULL
,	NULL
as	NULL
several	NULL
transmembrane	NULL
proteins	NULL
have	NULL
been	NULL
identified	NULL
as	NULL
primary	NULL
response	NULL
sequences	NULL
.	NULL

The	NULL
growth	NULL
arrest-specific	NULL
Gas-3	NULL
transcript	NULL
is	NULL
negatively	NULL
regulated	NULL
in	NULL
NIH-3T3	NULL
cells	NULL
in	NULL
an	NULL
immediate-early	NULL
response	NULL
to	NULL
serum	NULL
exposure	NULL
,	NULL
and	NULL
encodes	NULL
a	NULL
glycosylated	NULL
protein	NULL
that	NULL
contains	NULL
transmembrane	NULL
domains	NULL
with	NULL
homology	NULL
to	NULL
the	NULL
bovine	NULL
NADH-ubiquinone	NULL
oxydoreductase	NULL
chain	NULL
I	NULL
.	NULL
``	NULL

''	NULL
Similarly	NULL
,	NULL
the	NULL
mf	NULL
transcript	NULL
,	NULL
which	NULL
of	NULL
the	NULL
protein	NULL
levels	NULL
,	NULL
is	NULL
presented	NULL
.	NULL

encodes	NULL
a	NULL
protein	NULL
with	NULL
homology	NULL
to	NULL
human	NULL
tissue	NULL
factor	NULL
,	NULL
a	NULL
glycosylated	NULL
transmembrane	NULL
protein	NULL
that	NULL
initiates	NULL
the	NULL
blood	NULL
clotting	NULL
cascade	NULL
after	NULL
injury	NULL
,	NULL
``	NULL
``	NULL
was	NULL
isolated	NULL
as	NULL
an	NULL
immediate-early	NULL
sequence	NULL
that	NULL
is	NULL
transcriptionally	NULL
upregulated	NULL
in	NULL
response	NULL
to	NULL
exposure	NULL
to	NULL
serum	NULL
,	NULL
fibroblast	NULL
growth	NULL
factor	NULL
,	NULL
and	NULL
platelet-derived	NULL
growth	NULL
factor	NULL
.	NULL

E3	NULL
transcripts	NULL
were	NULL
detected	NULL
in	NULL
the	NULL
marrow	NULL
,	NULL
thymus	NULL
,	NULL
and	NULL
spleen	NULL
,	NULL
and	NULL
in	NULL
myeloid	NULL
,	NULL
erythroid	NULL
,	NULL
and	NULL
B-lymphoid	NULL
cell-lines	NULL
,	NULL
suggesting	NULL
its	NULL
expression	NULL
may	NULL
be	NULL
restricted	NULL
to	NULL
hematopoietic	NULL
lineages	NULL
.	NULL

Functional	NULL
studies	NULL
of	NULL
the	NULL
E3	NULL
promoter	NULL
also	NULL
suggest	NULL
that	NULL
E3	NULL
is	NULL
preferentially	NULL
transcribed	NULL
in	NULL
hematopoietic	NULL
cells	NULL
.	NULL

Luciferase-based	NULL
constructs	NULL
containing	NULL
portions	NULL
of	NULL
the	NULL
E3	NULL
promoter	NULL
were	NULL
introduced	NULL
into	NULL
the	NULL
E3-positive	NULL
K562	NULL
cell-line	NULL
,	NULL
and	NULL
into	NULL
the	NULL
Colo320-DM	NULL
and	NULL
Jurkat	NULL
cell-lines	NULL
,	NULL
where	NULL
E3	NULL
transcripts	NULL
are	NULL
undetectable	NULL
.	NULL

These	NULL
reporter	NULL
plasmids	NULL
were	NULL
significantly	NULL
more	NULL
active	NULL
in	NULL
K562	NULL
cells	NULL
than	NULL
in	NULL
Colo320-DM	NULL
and	NULL
Jurkat	NULL
cells	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
distribution	NULL
of	NULL
the	NULL
E3	NULL
transcript	NULL
.	NULL

This	NULL
tissue-specific	NULL
transcription	NULL
may	NULL
be	NULL
caused	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
multiple	NULL
potential	NULL
regulatory	NULL
elements	NULL
within	NULL
the	NULL
promoter	NULL
that	NULL
are	NULL
frequently	NULL
observed	NULL
in	NULL
the	NULL
promoters	NULL
of	NULL
many	NULL
genes	NULL
expressed	NULL
in	NULL
hematopoietic	NULL
cells	NULL
,	NULL
such	NULL
as	NULL
the	NULL
DNA-binding	NULL
motifs	NULL
for	NULL
the	NULL
E2A	NULL
,	NULL
NFkB	NULL
,	NULL
SRF	NULL
,	NULL
GATA	NULL
,	NULL
AP2	NULL
,	NULL
and	NULL
ETS	NULL
transcription	NULL
factors	NULL
.	NULL

The	NULL
functional	NULL
significance	NULL
of	NULL
these	NULL
elements	NULL
has	NULL
not	NULL
been	NULL
examined	NULL
to	NULL
date	NULL
,	NULL
although	NULL
it	NULL
is	NULL
tempting	NULL
to	NULL
speculate	NULL
that	NULL
their	NULL
pres	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

HEMATOPOIETIC-SPECIFIC	NULL
TARGET	NULL
OF	NULL
ence	NULL
may	NULL
direct	NULL
the	NULL
pattern	NULL
of	NULL
transcription	NULL
observed	NULL
in	NULL
particular	NULL
cell	NULL
lineages	NULL
.	NULL

For	NULL
instance	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
one	NULL
or	NULL
more	NULL
GATA	NULL
factors	NULL
are	NULL
responsible	NULL
for	NULL
the	NULL
transcriptional	NULL
downregulation	NULL
of	NULL
E3	NULL
observed	NULL
during	NULL
erythroid	NULL
differentiation	NULL
.	NULL

Removal	NULL
of	NULL
a	NULL
segment	NULL
of	NULL
the	NULL
E3	NULL
promoter	NULL
that	NULL
includes	NULL
a	NULL
GATA	NULL
binding	NULL
site	NULL
results	NULL
in	NULL
a	NULL
threefold	NULL
increase	NULL
in	NULL
reporter	NULL
activity	NULL
,	NULL
suggesting	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
negative	NULL
regulatory	NULL
element	NULL
within	NULL
this	NULL
region	NULL
.	NULL

The	NULL
suggestion	NULL
that	NULL
GATA	NULL
factors	NULL
negatively	NULL
regulate	NULL
E3	NULL
transcription	NULL
as	NULL
erythroid	NULL
cells	NULL
undergo	NULL
differentiation	NULL
is	NULL
also	NULL
consistent	NULL
with	NULL
the	NULL
observation	NULL
that	NULL
in	NULL
vitro	NULL
induction	NULL
of	NULL
erythroid	NULL
differentiation	NULL
in	NULL
EML	NULL
and	NULL
MEL	NULL
cells	NULL
results	NULL
in	NULL
a	NULL
significant	NULL
reduction	NULL
in	NULL
E3	NULL
levels	NULL
.	NULL

In	NULL
promyelocytic	NULL
MPRO	NULL
cells	NULL
,	NULL
E3	NULL
transcription	NULL
is	NULL
regulated	NULL
by	NULL
RA	NULL
in	NULL
an	NULL
immediate-early	NULL
manner	NULL
,	NULL
with	NULL
transcript	NULL
levels	NULL
increasing	NULL
within	NULL
15	NULL
minutes	NULL
'	NULL
exposure	NULL
to	NULL
RA	NULL
,	NULL
peaking	NULL
after	NULL
60	NULL
minutes	NULL
'	NULL
exposure	NULL
,	NULL
and	NULL
returning	NULL
to	NULL
steady-state	NULL
levels	NULL
after	NULL
several	NULL
hours	NULL
.	NULL

E3	NULL
levels	NULL
also	NULL
increase	NULL
in	NULL
HL60	NULL
cells	NULL
following	NULL
several	NULL
days	NULL
'	NULL
exposure	NULL
to	NULL
RA	NULL
,	NULL
suggesting	NULL
a	NULL
biphasic	NULL
induction	NULL
comprising	NULL
separate	NULL
primary	NULL
and	NULL
secondary	NULL
phases	NULL
.	NULL

Transfection	NULL
analysis	NULL
of	NULL
the	NULL
E3	NULL
promoter	NULL
showed	NULL
that	NULL
the	NULL
increase	NULL
in	NULL
E3	NULL
transcription	NULL
after	NULL
RA	NULL
exposure	NULL
is	NULL
mediated	NULL
by	NULL
an	NULL
RA	NULL
response	NULL
element	NULL
present	NULL
between	NULL
nucleotides	NULL
-394	NULL
and	NULL
-378	NULL
.	NULL

Several	NULL
features	NULL
of	NULL
this	NULL
sequence	NULL
initially	NULL
suggested	NULL
that	NULL
it	NULL
mediates	NULL
the	NULL
RA-inducibility	NULL
of	NULL
E3	NULL
transcription	NULL
observed	NULL
.	NULL

First	NULL
,	NULL
the	NULL
nucleotide	NULL
sequence	NULL
gagt-gagttccaggaca	NULL
is	NULL
very	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
promoter	NULL
elements	NULL
shown	NULL
to	NULL
mediate	NULL
the	NULL
transcriptional	NULL
regulation	NULL
by	NULL
steroid/	NULL
thyroid	NULL
hormone	NULL
family	NULL
dimers	NULL
,	NULL
including	NULL
the	NULL
rat	NULL
vitamin	NULL
D	NULL
response	NULL
element	NULL
,	NULL
gggtgaatgaggaca	NULL
,	NULL
present	NULL
within	NULL
the	NULL
osteocalcin	NULL
gene	NULL
,	NULL
and	NULL
the	NULL
thyroid	NULL
hormone	NULL
response	NULL
element	NULL
,	NULL
aggtgacaggaggaca	NULL
,	NULL
located	NULL
within	NULL
the	NULL
rat	NULL
myosin	NULL
heavy	NULL
chain	NULL
a	NULL
promoter	NULL
.	NULL
``	NULL

Interestingly	NULL
,	NULL
each	NULL
E3	NULL
half-site	NULL
is	NULL
also	NULL
very	NULL
similar	NULL
to	NULL
several	NULL
candidate	NULL
response	NULL
elements	NULL
isolated	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
in	NULL
vivo	NULL
binding	NULL
to	NULL
RARa	NULL
dimers	NULL
.	NULL
``	NULL

Secondly	NULL
,	NULL
the	NULL
5-base	NULL
spacing	NULL
between	NULL
E3	NULL
RA	NULL
response	NULL
element	NULL
half-sites	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
preferentially	NULL
bind	NULL
RAR	NULL
homodimers	NULL
and	NULL
heterodimers	NULL
.	NULL
``	NULL

Finally	NULL
,	NULL
the	NULL
location	NULL
of	NULL
this	NULL
element	NULL
relative	NULL
to	NULL
the	NULL
TATA	NULL
box	NULL
is	NULL
consistent	NULL
with	NULL
that	NULL
of	NULL
many	NULL
RA	NULL
response	NULL
elements	NULL
characterized	NULL
to	NULL
date	NULL
.	NULL

Transfection	NULL
of	NULL
the	NULL
pO.4E3CAT	NULL
reporter	NULL
construct	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
RA	NULL
response	NULL
element	NULL
,	NULL
clearly	NULL
demonstrated	NULL
the	NULL
RA-inducibility	NULL
of	NULL
this	NULL
promoter	NULL
in	NULL
HL6O	NULL
cells	NULL
,	NULL
with	NULL
the	NULL
reporter	NULL
activity	NULL
increasing	NULL
2.3-fold	NULL
after	NULL
exposure	NULL
to	NULL
RA	NULL
.	NULL

Introduction	NULL
of	NULL
this	NULL
construct	NULL
into	NULL
HL6OR	NULL
cells	NULL
,	NULL
which	NULL
lack	NULL
functional	NULL
RARa	NULL
molecules	NULL
,	NULL
confirmed	NULL
that	NULL
the	NULL
inducibility	NULL
of	NULL
E3	NULL
reporter	NULL
activity	NULL
observed	NULL
in	NULL
HL6O0	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
RA	NULL
is	NULL
mediated	NULL
by	NULL
RARa	NULL
.	NULL

Transfection	NULL
of	NULL
pO.2E3CAT	NULL
into	NULL
HL60	NULL
cells	NULL
showed	NULL
that	NULL
removal	NULL
of	NULL
the	NULL
region	NULL
of	NULL
the	NULL
promoter	NULL
that	NULL
includes	NULL
the	NULL
putative	NULL
RA	NULL
response	NULL
element	NULL
abolishes	NULL
the	NULL
RA-induced	NULL
increase	NULL
in	NULL
activity	NULL
observed	NULL
in	NULL
HL6O0	NULL
cells	NULL
with	NULL
pO.4E3CAT	NULL
.	NULL

Although	NULL
removal	NULL
of	NULL
this	NULL
region	NULL
suggests	NULL
the	NULL
sequence	NULL
between	NULL
nucleotides	NULL
-394	NULL
and	NULL
-378	NULL
mediates	NULL
the	NULL
response	NULL
to	NULL
RA	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
other	NULL
sequences	NULL
within	NULL
the	NULL
promoter	NULL
are	NULL
responsible	NULL
for	NULL
the	NULL
inducibility	NULL
.	NULL

For	NULL
example	NULL
,	NULL
recent	NULL
characterization	NULL
of	NULL
the	NULL
regions	NULL
flanking	NULL
the	NULL
HOXBI1	NULL
gene	NULL
has	NULL
identified	NULL
two	NULL
sequences	NULL
with	NULL
no	NULL
homology	NULL
to	NULL
known	NULL
RA	NULL
response	NULL
elements	NULL
that	NULL
are	NULL
necessary	NULL
for	NULL
the	NULL
RA-inducibility	NULL
of	NULL
HOXB1	NULL
.	NULL

'*	NULL
'	NULL
``	NULL
These	NULL
elements	NULL
presum-	NULL
2527	NULL
ably	NULL
mediate	NULL
the	NULL
response	NULL
to	NULL
RA	NULL
by	NULL
binding	NULL
distinct	NULL
transcriptional	NULL
regulators	NULL
that	NULL
are	NULL
themselves	NULL
RA-inducible	NULL
.	NULL

With	NULL
this	NULL
in	NULL
mind	NULL
,	NULL
we	NULL
have	NULL
localized	NULL
the	NULL
RA	NULL
response	NULL
element	NULL
to	NULL
nucleotides	NULL
-394	NULL
and	NULL
-378	NULL
of	NULL
the	NULL
E3	NULL
promoter	NULL
by	NULL
transfection	NULL
of	NULL
p	NULL
(	NULL
-394	NULL
to	NULL
-373	NULL
mE3	NULL
)	NULL
;	NULL
TKCAT	NULL
,	NULL
which	NULL
includes	NULL
tandem	NULL
repeats	NULL
of	NULL
a	NULL
17-bp	NULL
region	NULL
containing	NULL
the	NULL
putative	NULL
RA	NULL
response	NULL
element	NULL
cloned	NULL
upstream	NULL
of	NULL
the	NULL
minimal	NULL
promoter	NULL
construct	NULL
,	NULL
pTKCAT	NULL
.	NULL

In	NULL
HL60	NULL
cells	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
stripped	NULL
serum	NULL
,	NULL
this	NULL
construct	NULL
has	NULL
a	NULL
low	NULL
level	NULL
of	NULL
reporter	NULL
activity	NULL
that	NULL
is	NULL
comparable	NULL
to	NULL
that	NULL
of	NULL
pTKCAT	NULL
alone	NULL
,	NULL
which	NULL
increases	NULL
2.4-fold	NULL
after	NULL
exposure	NULL
to	NULL
RA	NULL
.	NULL

In	NULL
comparison	NULL
,	NULL
the	NULL
activity	NULL
of	NULL
p	NULL
(	NULL
RRE	NULL
)	NULL
,	NULL
TKCAT	NULL
,	NULL
a	NULL
reporter	NULL
construct	NULL
containing	NULL
four	NULL
repeats	NULL
of	NULL
the	NULL
murine	NULL
RAR	NULL
RA	NULL
response	NULL
element	NULL
,	NULL
increases	NULL
ninefold	NULL
in	NULL
response	NULL
to	NULL
RA	NULL
.	NULL

Although	NULL
the	NULL
function	NULL
of	NULL
the	NULL
E3	NULL
protein	NULL
is	NULL
unclear	NULL
,	NULL
it	NULL
is	NULL
anticipated	NULL
that	NULL
the	NULL
identification	NULL
of	NULL
this	NULL
gene	NULL
will	NULL
assist	NULL
in	NULL
elucidating	NULL
the	NULL
molecular	NULL
processes	NULL
involved	NULL
in	NULL
RA-induced	NULL
granulocytic	NULL
differentiation	NULL
.	NULL

As	NULL
it	NULL
is	NULL
an	NULL
RARa	NULL
target	NULL
during	NULL
normal	NULL
development	NULL
,	NULL
E3	NULL
may	NULL
also	NULL
prove	NULL
to	NULL
be	NULL
a	NULL
useful	NULL
tool	NULL
for	NULL
studying	NULL
the	NULL
cellular	NULL
implications	NULL
of	NULL
the	NULL
presence	NULL
of	NULL
abnormal	NULL
RARa	NULL
proteins	NULL
during	NULL
terminal	NULL
myeloid	NULL
differentiation	NULL
.	NULL

It	NULL
is	NULL
currently	NULL
unclear	NULL
whether	NULL
the	NULL
PML/RARa	NULL
hybrid	NULL
protein	NULL
acts	NULL
as	NULL
a	NULL
positive	NULL
or	NULL
negative	NULL
regulatory	NULL
factor	NULL
in	NULL
leukemic	NULL
blast	NULL
cells	NULL
present	NULL
in	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
cases	NULL
.	NULL

Although	NULL
PML/RARa	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
differ	NULL
from	NULL
RARa	NULL
in	NULL
its	NULL
ability	NULL
to	NULL
regulate	NULL
transcription	NULL
of	NULL
the	NULL
AP	NULL
]	NULL
gene	NULL
,	NULL
by	NULL
acting	NULL
as	NULL
a	NULL
transcriptional	NULL
activator	NULL
as	NULL
opposed	NULL
to	NULL
a	NULL
transcriptional	NULL
repressor	NULL
,	NULL
``	NULL
transfection	NULL
analysis	NULL
of	NULL
RA	NULL
response	NULL
elements	NULL
in	NULL
cells	NULL
expressing	NULL
PML/RARa	NULL
suggests	NULL
this	NULL
protein	NULL
can	NULL
activate	NULL
or	NULL
repress	NULL
transcription	NULL
of	NULL
particular	NULL
target	NULL
sequences	NULL
.	NULL

``	NULL
*	NULL
``	NULL
``	NULL
``	NULL
'	NULL
Therefore	NULL
,	NULL
we	NULL
are	NULL
currently	NULL
exploring	NULL
the	NULL
regulation	NULL
of	NULL
E3	NULL
in	NULL
promyelocytic	NULL
leukemia	NULL
cells	NULL
expressing	NULL
the	NULL
PML/RARa	NULL
protein	NULL
.	NULL

ACKNOWLEDGMENT	NULL
The	NULL
authors	NULL
acknowledge	NULL
Drs	NULL
V.	NULL
Seewaldt	NULL
,	NULL
G.	NULL
Filippova	NULL
,	NULL
V.	NULL
Loba-nenkov	NULL
,	NULL
and	NULL
W.	NULL
Hokanson	NULL
for	NULL
many	NULL
helpful	NULL
discussions	NULL
.	NULL

We	NULL
thank	NULL
Dr	NULL
S.	NULL
Tsai	NULL
for	NULL
providing	NULL
the	NULL
MPRO	NULL
BK/RF	NULL
(	NULL
MPRO-B	NULL
)	NULL
and	NULL
MPRO-C	NULL
cell	NULL
lines	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Mangelsdorf	NULL
DJ	NULL
,	NULL
Evans	NULL
RM	NULL
:	NULL
Retinoid	NULL
receptors	NULL
as	NULL
transcription	NULL
factors	NULL
,	NULL
in	NULL
Yamamoto	NULL
KR	NULL
,	NULL
McKnight	NULL
S	NULL
(	NULL
eds	NULL
)	NULL
:	NULL
Transcriptional	NULL
Regulation	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
,	NULL
1991	NULL
2	NULL
.	NULL

Mangelsdorf	NULL
DJ	NULL
,	NULL
Ong	NULL
ES	NULL
,	NULL
Dyck	NULL
JA	NULL
,	NULL
Evans	NULL
RM	NULL
:	NULL
A	NULL
nuclear	NULL
receptor	NULL
that	NULL
identifies	NULL
a	NULL
novel	NULL
retinoic	NULL
acid	NULL
response	NULL
pathway	NULL
.	NULL

Nature	NULL
345:224	NULL
,	NULL
1990	NULL
3	NULL
.	NULL

Leroy	NULL
P	NULL
,	NULL
Nakshatri	NULL
H	NULL
,	NULL
Chambon	NULL
P	NULL
:	NULL
Mouse	NULL
retinoic	NULL
acid	NULL
receptor	NULL
«	NULL
2	NULL
isoform	NULL
is	NULL
transcribed	NULL
from	NULL
a	NULL
promoter	NULL
that	NULL
contains	NULL
a	NULL
retinoic	NULL
acid	NULL
response	NULL
element	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
88:10138	NULL
,	NULL
1991	NULL
4.	NULL
de	NULL
The	NULL
H	NULL
,	NULL
Vivanco-Ruiz	NULL
M	NULL
,	NULL
Tiollais	NULL
P	NULL
,	NULL
Stunnenberg	NULL
H	NULL
,	NULL
Dejean	NULL
A	NULL
:	NULL
Identification	NULL
of	NULL
a	NULL
retinoic	NULL
acid	NULL
response	NULL
element	NULL
in	NULL
the	NULL
retinoic	NULL
acid	NULL
receptor	NULL
3	NULL
gene	NULL
.	NULL

Nature	NULL
343:177	NULL
,	NULL
1990	NULL
5	NULL
.	NULL

Sucov	NULL
HM	NULL
,	NULL
Murakami	NULL
KK	NULL
,	NULL
Evans	NULL
RM	NULL
:	NULL
Characterisation	NULL
of	NULL
an	NULL
autoregulated	NULL
response	NULL
element	NULL
in	NULL
the	NULL
mouse	NULL
retinoic	NULL
acid	NULL
receptor	NULL
type	NULL
3	NULL
gene	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
87:5392	NULL
,	NULL
1990	NULL
6	NULL
.	NULL

Smith	NULL
SM	NULL
,	NULL
Nakshatri	NULL
H	NULL
,	NULL
Leroy	NULL
P	NULL
,	NULL
Rees	NULL
J	NULL
,	NULL
Chambon	NULL
P	NULL
:	NULL
A	NULL
retinoic	NULL
acid	NULL
response	NULL
element	NULL
is	NULL
present	NULL
in	NULL
the	NULL
mouse	NULL
cellular	NULL
retinol	NULL
binding	NULL
protein	NULL
I	NULL
(	NULL
mCRBPI	NULL
)	NULL
promoter	NULL
.	NULL

EMBO	NULL
J	NULL
10:2223	NULL
,	NULL
1991	NULL
7	NULL
.	NULL

Durand	NULL
B	NULL
,	NULL
Saunders	NULL
M	NULL
,	NULL
Leroy	NULL
P	NULL
,	NULL
Leid	NULL
M	NULL
,	NULL
Chambon	NULL
P	NULL
:	NULL
All	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2528	NULL
trans	NULL
and	NULL
9-cis	NULL
retinoic	NULL
acid	NULL
induction	NULL
of	NULL
CRABPII	NULL
transcription	NULL
is	NULL
mediated	NULL
by	NULL
RAR-RXR	NULL
heterodimers	NULL
bound	NULL
by	NULL
DR1	NULL
and	NULL
DR2	NULL
repeated	NULL
motifs	NULL
.	NULL

Cell	NULL
71:73	NULL
,	NULL
1992	NULL
8	NULL
.	NULL

Mangelsdorf	NULL
DJ	NULL
,	NULL
Umesono	NULL
K	NULL
,	NULL
Kliewer	NULL
SA	NULL
,	NULL
Borgmeyer	NULL
U	NULL
,	NULL
Ong	NULL
ES	NULL
,	NULL
Evans	NULL
RM	NULL
:	NULL
A	NULL
direct	NULL
repeat	NULL
in	NULL
the	NULL
cellular	NULL
retinol-binding	NULL
protein	NULL
type	NULL
II	NULL
gene	NULL
confers	NULL
differential	NULL
regulation	NULL
by	NULL
RXR	NULL
and	NULL
RAR	NULL
.	NULL

Cell	NULL
66:555	NULL
,	NULL
1991	NULL
9	NULL
.	NULL

Langston	NULL
AW	NULL
,	NULL
Gudas	NULL
LJ	NULL
:	NULL
Identification	NULL
of	NULL
a	NULL
retinoic	NULL
acid	NULL
responsive	NULL
enhancer	NULL
3	NULL
'	NULL
of	NULL
the	NULL
murine	NULL
homeobox	NULL
gene	NULL
HoxJ.6	NULL
.	NULL

Mech	NULL
Dev	NULL
38:217	NULL
,	NULL
1992	NULL
10	NULL
.	NULL

Ogura	NULL
T	NULL
,	NULL
Evans	NULL
RM	NULL
:	NULL
A	NULL
retinoic	NULL
acid-triggered	NULL
cascade	NULL
of	NULL
HOXBI	NULL
gene	NULL
activation	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
92:387	NULL
,	NULL
1995	NULL
11	NULL
.	NULL

Ogura	NULL
T	NULL
,	NULL
Evans	NULL
RM	NULL
:	NULL
Evidence	NULL
for	NULL
two	NULL
distinct	NULL
retinoic	NULL
acid	NULL
response	NULL
pathways	NULL
for	NULL
HOXBI	NULL
gene	NULL
regulation	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
92:392	NULL
,	NULL
1995	NULL
12	NULL
.	NULL

Studer	NULL
M	NULL
,	NULL
Popperl	NULL
H	NULL
,	NULL
Marshall	NULL
H	NULL
,	NULL
Kuroiwa	NULL
A	NULL
,	NULL
Krumlauf	NULL
R	NULL
:	NULL
Role	NULL
of	NULL
a	NULL
conserved	NULL
retinoic	NULL
acid	NULL
response	NULL
element	NULL
in	NULL
rhombomere	NULL
restriction	NULL
of	NULL
Hoxb-1	NULL
.	NULL

Science	NULL
265:1728	NULL
,	NULL
1994	NULL
13	NULL
.	NULL

Suva	NULL
LJ	NULL
,	NULL
Towler	NULL
DA	NULL
,	NULL
Harada	NULL
S	NULL
,	NULL
Gaub	NULL
MP	NULL
,	NULL
Rodan	NULL
GA	NULL
:	NULL
Characterization	NULL
of	NULL
retinoic	NULL
acid-	NULL
and	NULL
cell-dependent	NULL
sequences	NULL
which	NULL
regulate	NULL
zif268	NULL
gene	NULL
expression	NULL
in	NULL
osteoblastic	NULL
cells	NULL
.	NULL

Mol	NULL
Endocrinol	NULL
8:1507	NULL
,	NULL
1994	NULL
14	NULL
.	NULL

Forman	NULL
BM	NULL
,	NULL
Casanova	NULL
J	NULL
,	NULL
Raaka	NULL
BM	NULL
,	NULL
Ghysdael	NULL
J	NULL
,	NULL
Samuels	NULL
HH	NULL
:	NULL
Half-site	NULL
spacing	NULL
and	NULL
orientation	NULL
determines	NULL
whether	NULL
thyroid	NULL
hormone	NULL
and	NULL
retinoic	NULL
acid	NULL
receptors	NULL
and	NULL
related	NULL
factors	NULL
bind	NULL
to	NULL
DNA	NULL
response	NULL
elements	NULL
as	NULL
monomers	NULL
,	NULL
homodimers	NULL
or	NULL
heterodimers	NULL
.	NULL

Mol	NULL
Endocrinol	NULL
6:429	NULL
,	NULL
1992	NULL
15	NULL
.	NULL

Nagpal	NULL
S	NULL
,	NULL
Saunders	NULL
M	NULL
,	NULL
Kastner	NULL
P	NULL
,	NULL
Durand	NULL
B	NULL
,	NULL
Nakshatri	NULL
H	NULL
,	NULL
Chambon	NULL
P	NULL
:	NULL
Promoter	NULL
context-	NULL
and	NULL
response	NULL
element-dependent	NULL
specificity	NULL
of	NULL
the	NULL
transcriptional	NULL
activation	NULL
and	NULL
modulating	NULL
functions	NULL
of	NULL
retinoic	NULL
acid	NULL
receptors	NULL
.	NULL

Cell	NULL
70:1007	NULL
,	NULL
1992	NULL
16	NULL
.	NULL

Breitman	NULL
TR	NULL
,	NULL
Selonick	NULL
S	NULL
,	NULL
Collins	NULL
SJ	NULL
;	NULL
Induction	NULL
of	NULL
differentiation	NULL
of	NULL
the	NULL
human	NULL
promyelocytic	NULL
leukemia	NULL
cell	NULL
line	NULL
(	NULL
HL60	NULL
)	NULL
by	NULL
retinoic	NULL
acid	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
77:2936	NULL
,	NULL
1980	NULL
17	NULL
.	NULL

Collins	NULL
SJ	NULL
,	NULL
Robertson	NULL
KA	NULL
,	NULL
Mueller	NULL
L	NULL
:	NULL
Retinoic	NULL
acid-induced	NULL
granulocytic	NULL
differentiation	NULL
of	NULL
HL60	NULL
myeloid	NULL
leukemia	NULL
cells	NULL
is	NULL
mediated	NULL
directly	NULL
through	NULL
the	NULL
retinoic	NULL
acid	NULL
receptor	NULL
(	NULL
RAR-a	NULL
)	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
10:2154	NULL
,	NULL
1990	NULL
18	NULL
.	NULL

Robertson	NULL
KA	NULL
,	NULL
Emami	NULL
B	NULL
,	NULL
Collins	NULL
SJ	NULL
:	NULL
Retinoic	NULL
acid-resistant	NULL
HL6GOR	NULL
cells	NULL
harbor	NULL
a	NULL
point	NULL
mutation	NULL
in	NULL
the	NULL
retinoic	NULL
acid	NULL
receptor	NULL
ligand-binding	NULL
domain	NULL
that	NULL
confers	NULL
dominant	NULL
negative	NULL
activity	NULL
.	NULL

Blood	NULL
80:1885	NULL
,	NULL
1992	NULL
19	NULL
.	NULL

Tsai	NULL
S	NULL
,	NULL
Bartelmez	NULL
S	NULL
,	NULL
Heyman	NULL
R	NULL
,	NULL
Damm	NULL
K	NULL
,	NULL
Evans	NULL
R	NULL
,	NULL
Collins	NULL
SJ	NULL
;	NULL
A	NULL
mutated	NULL
retinoic	NULL
acid	NULL
receptor-	NULL
exhibiting	NULL
dominant-negative	NULL
activity	NULL
alters	NULL
the	NULL
lineage	NULL
development	NULL
of	NULL
a	NULL
multipotent	NULL
hematopoietic	NULL
cell	NULL
line	NULL
.	NULL

Genes	NULL
Dev	NULL
6:2258	NULL
,	NULL
1992	NULL
20	NULL
.	NULL

Tsai	NULL
S	NULL
,	NULL
Collins	NULL
SJ	NULL
:	NULL
A	NULL
dominant	NULL
negative	NULL
retinoic	NULL
acid	NULL
receptor	NULL
blocks	NULL
neutrophil	NULL
differentiation	NULL
at	NULL
the	NULL
promyelocyte	NULL
stage	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
90:7153	NULL
,	NULL
1993	NULL
21	NULL
.	NULL

Chomienne	NULL
C	NULL
,	NULL
Ballerini	NULL
P	NULL
,	NULL
Balitrand	NULL
N	NULL
,	NULL
Daniel	NULL
M	NULL
,	NULL
Fenaux	NULL
P	NULL
,	NULL
Castaigne	NULL
S	NULL
,	NULL
Degos	NULL
L	NULL
:	NULL
All-trans	NULL
retinoic	NULL
acid	NULL
in	NULL
acute	NULL
promyelocytic	NULL
leukemias	NULL
.	NULL

II	NULL
.	NULL

In	NULL
vitro	NULL
studies	NULL
:	NULL
Structure-function	NULL
relationship	NULL
.	NULL

Blood	NULL
76:1710	NULL
,	NULL
1990	NULL
22	NULL
.	NULL

Castaigne	NULL
S	NULL
,	NULL
Chomienne	NULL
C	NULL
,	NULL
Daniel	NULL
MT	NULL
,	NULL
Ballerini	NULL
P	NULL
,	NULL
Berger	NULL
R	NULL
,	NULL
Fenaux	NULL
P	NULL
,	NULL
Degos	NULL
L	NULL
;	NULL
All-trans	NULL
retinoic	NULL
acid	NULL
in	NULL
acute	NULL
promyelocytic	NULL
leukemias	NULL
.	NULL

I	NULL
.	NULL

Clinical	NULL
results	NULL
.	NULL

Blood	NULL
76:1704	NULL
,	NULL
1990	NULL
23	NULL
.	NULL

Huang	NULL
ME	NULL
,	NULL
Ye	NULL
YC	NULL
,	NULL
Chen	NULL
SR	NULL
,	NULL
Chai	NULL
JR	NULL
,	NULL
Lu	NULL
JX	NULL
,	NULL
Zhoa	NULL
L	NULL
,	NULL
Gu	NULL
HT	NULL
,	NULL
Wang	NULL
ZY	NULL
:	NULL
Use	NULL
of	NULL
all-trans	NULL
retinoic	NULL
acid	NULL
in	NULL
the	NULL
treatment	NULL
of	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
.	NULL

Blood	NULL
72:567	NULL
,	NULL
1988	NULL
24	NULL
.	NULL

Alcalay	NULL
M	NULL
,	NULL
Zangrilli	NULL
D	NULL
,	NULL
Pandolfi	NULL
PP	NULL
,	NULL
Longo	NULL
L	NULL
,	NULL
Mencarelli	NULL
A	NULL
,	NULL
Giacommucci	NULL
A	NULL
,	NULL
Rocchi	NULL
M	NULL
,	NULL
Biondi	NULL
A	NULL
,	NULL
Rambaldi	NULL
A	NULL
,	NULL
Lo	NULL
Coco	NULL
F	NULL
,	NULL
Diverio	NULL
D	NULL
,	NULL
Donti	NULL
E	NULL
,	NULL
Grignani	NULL
F	NULL
,	NULL
Pelicci	NULL
PG	NULL
:	NULL
Translocation	NULL
breakpoint	NULL
of	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
lies	NULL
within	NULL
the	NULL
retinoic	NULL
acid	NULL
receptor	NULL
a	NULL
locus	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
88:1977	NULL
,	NULL
1991	NULL
25	NULL
.	NULL

Barrow	NULL
J	NULL
,	NULL
Goddard	NULL
AD	NULL
,	NULL
Sheer	NULL
D	NULL
,	NULL
Solomon	NULL
E	NULL
:	NULL
Molecular	NULL
SCOTT	NULL
,	NULL
MUELLER	NULL
,	NULL
AND	NULL
COLLINS	NULL
analysis	NULL
of	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
breakpoint	NULL
cluster	NULL
region	NULL
on	NULL
chromosome	NULL
17	NULL
.	NULL

Science	NULL
249:1577	NULL
,	NULL
1990	NULL
26	NULL
.	NULL

Chen	NULL
Z	NULL
,	NULL
Brand	NULL
NJ	NULL
,	NULL
Chen	NULL
A	NULL
,	NULL
Chen	NULL
SJ	NULL
,	NULL
Tong	NULL
JH	NULL
,	NULL
Wang	NULL
ZY	NULL
,	NULL
Waxman	NULL
J	NULL
,	NULL
Zelent	NULL
A	NULL
:	NULL
Fusion	NULL
between	NULL
a	NULL
novel	NULL
Kruppel-like	NULL
zinc	NULL
finger	NULL
gene	NULL
and	NULL
the	NULL
retinoic	NULL
acid	NULL
receptor	NULL
a	NULL
locus	NULL
due	NULL
to	NULL
a	NULL
variant	NULL
t	NULL
(	NULL
11	NULL
;	NULL
17	NULL
)	NULL
translocation	NULL
associated	NULL
with	NULL
acute	NULL
promyelocytic	NULL
leukae-mia	NULL
.	NULL

EMBO	NULL
J	NULL
12:1161	NULL
,	NULL
1993	NULL
27.	NULL
de	NULL
The	NULL
H	NULL
,	NULL
Chomienne	NULL
C	NULL
,	NULL
Lanotte	NULL
M	NULL
,	NULL
Degos	NULL
L	NULL
,	NULL
Dejean	NULL
A	NULL
:	NULL
The	NULL
t	NULL
(	NULL
15	NULL
;	NULL
17	NULL
)	NULL
translocation	NULL
of	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
fuses	NULL
the	NULL
retinoic	NULL
acid	NULL
receptor	NULL
a	NULL
gene	NULL
to	NULL
a	NULL
novel	NULL
transcribed	NULL
locus	NULL
.	NULL

Nature	NULL
347:558	NULL
,	NULL
1990	NULL
28.	NULL
de	NULL
The	NULL
H	NULL
,	NULL
Lavau	NULL
C	NULL
,	NULL
Marchio	NULL
A	NULL
,	NULL
Chomienne	NULL
C	NULL
,	NULL
Degos	NULL
L	NULL
,	NULL
Dejean	NULL
A	NULL
:	NULL
The	NULL
PML-RARa	NULL
fusion	NULL
mRNA	NULL
generated	NULL
by	NULL
the	NULL
t	NULL
(	NULL
15	NULL
;	NULL
17	NULL
)	NULL
translocation	NULL
in	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
encodes	NULL
a	NULL
functionally	NULL
altered	NULL
RAR	NULL
.	NULL

Cell	NULL
66:675	NULL
,	NULL
1991	NULL
29	NULL
.	NULL

Kakizuka	NULL
A	NULL
,	NULL
Millet	NULL
WH	NULL
,	NULL
Umesono	NULL
K	NULL
,	NULL
Warnell	NULL
RP	NULL
,	NULL
Frankel	NULL
SR	NULL
,	NULL
Murty	NULL
VVVS	NULL
,	NULL
Dmitrovsky	NULL
E	NULL
,	NULL
Evans	NULL
R	NULL
:	NULL
Chromosomal	NULL
translocation	NULL
t	NULL
(	NULL
15	NULL
;	NULL
17	NULL
)	NULL
in	NULL
human	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
fuses	NULL
RARa	NULL
with	NULL
a	NULL
novel	NULL
transcription	NULL
factor	NULL
,	NULL
PML	NULL
.	NULL

Cell	NULL
66:663	NULL
,	NULL
1991	NULL
30	NULL
.	NULL

Kastner	NULL
P	NULL
,	NULL
Perez	NULL
A	NULL
,	NULL
Lutz	NULL
Y	NULL
,	NULL
Rochette-Egly	NULL
C	NULL
,	NULL
Gaub	NULL
MP	NULL
,	NULL
Durand	NULL
B	NULL
,	NULL
Lanotte	NULL
M	NULL
,	NULL
Berger	NULL
R	NULL
,	NULL
Chambon	NULL
P	NULL
:	NULL
Structure	NULL
,	NULL
localization	NULL
and	NULL
transcriptional	NULL
properties	NULL
of	NULL
two	NULL
classes	NULL
of	NULL
retinoic	NULL
acid	NULL
receptor	NULL
a	NULL
fusion	NULL
proteins	NULL
in	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
(	NULL
APL	NULL
)	NULL
:	NULL
Structural	NULL
similarities	NULL
with	NULL
a	NULL
new	NULL
family	NULL
of	NULL
oncoproteins	NULL
.	NULL

EMBO	NULL
J	NULL
11:629	NULL
,	NULL
1992	NULL
31	NULL
.	NULL

Pandolfi	NULL
PP	NULL
,	NULL
Grignani	NULL
F	NULL
,	NULL
Alcalay	NULL
M	NULL
,	NULL
Mencarelli	NULL
A	NULL
,	NULL
Biondi	NULL
A	NULL
,	NULL
Lo	NULL
Coco	NULL
F	NULL
,	NULL
Grignani	NULL
F	NULL
,	NULL
Pelicci	NULL
PG	NULL
:	NULL
Structure	NULL
and	NULL
origin	NULL
of	NULL
the	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
myl/RARa	NULL
cDNA	NULL
and	NULL
characterisation	NULL
of	NULL
its	NULL
retinoid	NULL
binding	NULL
and	NULL
transactivation	NULL
properties	NULL
.	NULL

Oncogene	NULL
6:1285	NULL
,	NULL
1991	NULL
32	NULL
.	NULL

Goddard	NULL
AD	NULL
,	NULL
Barrow	NULL
J	NULL
,	NULL
Freemont	NULL
PS	NULL
,	NULL
Solomon	NULL
E	NULL
:	NULL
Characterization	NULL
of	NULL
a	NULL
zinc	NULL
finger	NULL
gene	NULL
disrupted	NULL
by	NULL
the	NULL
t	NULL
(	NULL
15	NULL
;	NULL
17	NULL
)	NULL
in	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
.	NULL

Science	NULL
254:1371	NULL
,	NULL
1991	NULL
33	NULL
.	NULL

Mu	NULL
ZM	NULL
,	NULL
Chin	NULL
KV	NULL
,	NULL
Liu	NULL
JH	NULL
,	NULL
Lozano	NULL
G	NULL
,	NULL
Chang	NULL
KS	NULL
:	NULL
PML	NULL
,	NULL
a	NULL
growth	NULL
suppressor	NULL
disrupted	NULL
in	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
14:6858	NULL
,	NULL
1994	NULL
34	NULL
.	NULL

Chirgwin	NULL
JM	NULL
,	NULL
Przybyla	NULL
AA	NULL
,	NULL
MacDonald	NULL
RJ	NULL
,	NULL
Rutter	NULL
WJ	NULL
:	NULL
Isolation	NULL
of	NULL
biologically	NULL
active	NULL
ribonucleic	NULL
acid	NULL
from	NULL
sources	NULL
enriched	NULL
in	NULL
ribonuclease	NULL
.	NULL

Biochemistry	NULL
18:5294	NULL
,	NULL
1979	NULL
35	NULL
.	NULL

Altshul	NULL
SF	NULL
,	NULL
Gish	NULL
W	NULL
,	NULL
Miller	NULL
W	NULL
,	NULL
Myers	NULL
EW	NULL
,	NULL
Lipman	NULL
DJ	NULL
:	NULL
Basic	NULL
local	NULL
alignment	NULL
search	NULL
tool	NULL
.	NULL

J	NULL
Mol	NULL
Biol	NULL
215:403	NULL
,	NULL
1990	NULL
36	NULL
.	NULL

Nuchprayoon	NULL
I	NULL
,	NULL
Meyers	NULL
S	NULL
,	NULL
Scott	NULL
LM	NULL
,	NULL
Suzow	NULL
J	NULL
,	NULL
Hiebert	NULL
S	NULL
,	NULL
Friedman	NULL
AD	NULL
:	NULL
PEBP2/CBF	NULL
,	NULL
the	NULL
murine	NULL
homolog	NULL
of	NULL
the	NULL
human	NULL
myeloid	NULL
AML1	NULL
and	NULL
proto-oncogenes	NULL
,	NULL
regulates	NULL
the	NULL
murine	NULL
myeloperoxidase	NULL
and	NULL
neutrophil	NULL
elastase	NULL
genes	NULL
in	NULL
immature	NULL
myeloid	NULL
cells	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
14:5558	NULL
,	NULL
1994	NULL
37.	NULL
van	NULL
Zonneveld	NULL
AJ	NULL
,	NULL
Curriden	NULL
S	NULL
$	NULL
,	NULL
Loskutoff	NULL
DJ	NULL
:	NULL
Type	NULL
I	NULL
plasmin-ogen	NULL
activator	NULL
inhibitor	NULL
gene	NULL
:	NULL
Functional	NULL
analysis	NULL
and	NULL
glucocorticoid	NULL
regulation	NULL
of	NULL
its	NULL
promoter	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
85:5525	NULL
,	NULL
1988	NULL
38	NULL
.	NULL

Suzow	NULL
J	NULL
,	NULL
Friedman	NULL
AD	NULL
:	NULL
The	NULL
murine	NULL
myeloperoxidase	NULL
promoter	NULL
contains	NULL
several	NULL
functional	NULL
elements	NULL
,	NULL
one	NULL
of	NULL
which	NULL
binds	NULL
a	NULL
cell	NULL
type-restricted	NULL
transcription	NULL
factor	NULL
,	NULL
myeloid	NULL
nuclear	NULL
factor	NULL
1	NULL
(	NULL
MyNF1	NULL
)	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
13:2141	NULL
,	NULL
1993	NULL
39	NULL
.	NULL

Ishida	NULL
S	NULL
,	NULL
Shudo	NULL
K	NULL
,	NULL
Takada	NULL
S	NULL
,	NULL
Koike	NULL
K	NULL
:	NULL
;	NULL
Transcription	NULL
from	NULL
the	NULL
P2	NULL
promoter	NULL
of	NULL
human	NULL
proto-oncogene	NULL
myc	NULL
is	NULL
suppressed	NULL
by	NULL
retinoic	NULL
acid	NULL
through	NULL
an	NULL
interaction	NULL
between	NULL
the	NULL
E2F	NULL
element	NULL
and	NULL
its	NULL
binding	NULL
proteins	NULL
.	NULL

Cell	NULL
Growth	NULL
Diff	NULL
5:287	NULL
,	NULL
1994	NULL
40	NULL
.	NULL

Kozak	NULL
M	NULL
:	NULL
Downstream	NULL
secondary	NULL
structure	NULL
facilitates	NULL
recognition	NULL
of	NULL
initiator	NULL
codons	NULL
by	NULL
eukaryotic	NULL
ribosomes	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
87:8301	NULL
,	NULL
1990	NULL
41	NULL
.	NULL

Kishimoto	NULL
A	NULL
,	NULL
Nishiyama	NULL
K	NULL
,	NULL
Nakanishi	NULL
H	NULL
,	NULL
Uratsuji	NULL
Y	NULL
,	NULL
Nomura	NULL
Y	NULL
,	NULL
Takeyama	NULL
Y	NULL
,	NULL
Nishizuka	NULL
Y	NULL
:	NULL
Studies	NULL
on	NULL
the	NULL
phosphorylation	NULL
of	NULL
myelin	NULL
basic	NULL
protein	NULL
by	NULL
protein	NULL
kinase	NULL
C	NULL
and	NULL
adenosine	NULL
3',5'-mono-phosphate-dependent	NULL
protein	NULL
kinase	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
260:2492	NULL
,	NULL
1985	NULL
42	NULL
.	NULL

Woodgett	NULL
JR	NULL
,	NULL
Gould	NULL
KL	NULL
,	NULL
Hunter	NULL
T	NULL
:	NULL
Substrate	NULL
specificity	NULL
of	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

HEMATOPOIETIC-SPECIFIC	NULL
TARGET	NULL
OF	NULL
RAR	NULL
protein	NULL
kinase	NULL
C.	NULL
Use	NULL
of	NULL
synthetic	NULL
peptides	NULL
corresponding	NULL
to	NULL
physiological	NULL
sites	NULL
as	NULL
probes	NULL
for	NULL
substrate	NULL
recognition	NULL
requirements	NULL
.	NULL

Eur	NULL
J	NULL
Biochem	NULL
161:177	NULL
,	NULL
1986	NULL
43	NULL
.	NULL

Pinna	NULL
LA	NULL
:	NULL
Casein	NULL
kinase	NULL
2	NULL
:	NULL
An	NULL
'eminence	NULL
grise	NULL
'	NULL
in	NULL
cellular	NULL
regulation	NULL
?	NULL

Biochim	NULL
Biophys	NULL
Acta	NULL
1054:267	NULL
,	NULL
1990	NULL
44	NULL
.	NULL

Grand	NULL
RJA	NULL
:	NULL
Acylation	NULL
of	NULL
viral	NULL
and	NULL
eukaryotic	NULL
proteins	NULL
.	NULL

Biochem	NULL
J	NULL
258:625	NULL
,	NULL
1989	NULL
45	NULL
.	NULL

Towler	NULL
DA	NULL
,	NULL
Gordon	NULL
JI	NULL
,	NULL
Adams	NULL
SP	NULL
,	NULL
Glaser	NULL
L	NULL
:	NULL
The	NULL
biology	NULL
and	NULL
enzymology	NULL
of	NULL
eukaryotic	NULL
protein	NULL
acylation	NULL
.	NULL

Annu	NULL
Rev	NULL
Biochem	NULL
57:69	NULL
,	NULL
1988	NULL
46	NULL
.	NULL

Caput	NULL
D	NULL
,	NULL
Beutler	NULL
B	NULL
,	NULL
Hartog	NULL
K	NULL
,	NULL
Thayer	NULL
R	NULL
,	NULL
Brown-Shimer	NULL
S	NULL
,	NULL
Cerami	NULL
A	NULL
:	NULL
Identification	NULL
of	NULL
a	NULL
common	NULL
nucleotide	NULL
sequence	NULL
in	NULL
the	NULL
3'-untranslated	NULL
region	NULL
of	NULL
mRNA	NULL
molecules	NULL
specifying	NULL
inflammatory	NULL
mediators	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
83:1670	NULL
,	NULL
1986	NULL
47	NULL
.	NULL

Chen	NULL
C	NULL
,	NULL
Shyu	NULL
A	NULL
:	NULL
Selective	NULL
degradation	NULL
of	NULL
early-response	NULL
gene	NULL
mRNAs	NULL
:	NULL
Functional	NULL
analyses	NULL
of	NULL
sequence	NULL
features	NULL
of	NULL
the	NULL
AU-rich	NULL
elements	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
14:8471	NULL
,	NULL
1994	NULL
48	NULL
.	NULL

Shaw	NULL
G	NULL
,	NULL
Kamen	NULL
R	NULL
:	NULL
A	NULL
conserved	NULL
AU	NULL
sequence	NULL
from	NULL
the	NULL
3	NULL
'	NULL
untranslated	NULL
region	NULL
of	NULL
GM-CSF	NULL
mediates	NULL
selective	NULL
mRNA	NULL
degrada-tion	NULL
.	NULL

Cell	NULL
46:659	NULL
,	NULL
1986	NULL
49	NULL
.	NULL

Sheets	NULL
MD	NULL
,	NULL
Ogg	NULL
SC	NULL
,	NULL
Wickens	NULL
MP	NULL
:	NULL
Point	NULL
mutations	NULL
in	NULL
AAU-AAA	NULL
and	NULL
the	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
addition	NULL
site	NULL
:	NULL
Effects	NULL
on	NULL
the	NULL
accuracy	NULL
and	NULL
efficiency	NULL
of	NULL
cleavage	NULL
and	NULL
polyadenylation	NULL
in	NULL
vitro	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
13:1905	NULL
,	NULL
1990	NULL
f	NULL
50	NULL
.	NULL

Pereira	NULL
MEA	NULL
,	NULL
Mejia	NULL
JS	NULL
,	NULL
Ortega-Barria	NULL
E	NULL
,	NULL
Matzilevich	NULL
D	NULL
,	NULL
Pri-oli	NULL
RP	NULL
:	NULL
The	NULL
Trypanosoma	NULL
cruzi	NULL
neuraminidase	NULL
contains	NULL
sequences	NULL
similar	NULL
to	NULL
bacterial	NULL
neuraminidases	NULL
,	NULL
YWTD	NULL
repeats	NULL
of	NULL
the	NULL
low	NULL
density	NULL
lipoprotein	NULL
receptor	NULL
,	NULL
and	NULL
type	NULL
III	NULL
modules	NULL
of	NULL
fibronectin	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
174:179	NULL
,	NULL
1991	NULL
51	NULL
.	NULL

Tsai	NULL
S	NULL
,	NULL
Bartelmez	NULL
S	NULL
,	NULL
Sitnicka	NULL
E	NULL
,	NULL
Collins	NULL
SJ	NULL
:	NULL
Lymphohemato-poietic	NULL
progenitors	NULL
immortalized	NULL
by	NULL
a	NULL
retroviral	NULL
vector	NULL
harboring	NULL
a	NULL
dominant	NULL
negative	NULL
retinoic	NULL
acid	NULL
receptor	NULL
can	NULL
recapitulate	NULL
lymphoid	NULL
myeloid	NULL
,	NULL
and	NULL
erythroid	NULL
development	NULL
.	NULL

Genes	NULL
Dev	NULL
8:2831	NULL
,	NULL
1994	NULL
52	NULL
.	NULL

Murre	NULL
C	NULL
,	NULL
McCaw	NULL
PS	NULL
,	NULL
Baltimore	NULL
D	NULL
:	NULL
A	NULL
new	NULL
DNA	NULL
binding	NULL
and	NULL
dimerisation	NULL
motif	NULL
in	NULL
immunoglobin	NULL
enhancer	NULL
binding	NULL
daughterless	NULL
,	NULL
MyoD	NULL
and	NULL
mye	NULL
proteins	NULL
.	NULL

Cell	NULL
56:777	NULL
,	NULL
1989	NULL
53	NULL
.	NULL

Ho	NULL
IC	NULL
,	NULL
Yang	NULL
LH	NULL
,	NULL
Molle	NULL
G	NULL
,	NULL
Leiden	NULL
JM	NULL
:	NULL
A	NULL
T-cell-specific	NULL
transcriptional	NULL
enhancer	NULL
element	NULL
3	NULL
'	NULL
of	NULL
C	NULL
a	NULL
in	NULL
the	NULL
human	NULL
T-cell	NULL
receptor	NULL
a	NULL
locus	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
86:6714	NULL
,	NULL
1989	NULL
54	NULL
.	NULL

Williams	NULL
T	NULL
,	NULL
Tjian	NULL
R	NULL
:	NULL
Analysis	NULL
of	NULL
the	NULL
DNA-binding	NULL
and	NULL
activation	NULL
properties	NULL
of	NULL
the	NULL
human	NULL
transcription	NULL
factor	NULL
AP-2	NULL
.	NULL

Genes	NULL
Dev	NULL
5:670	NULL
,	NULL
1991	NULL
55	NULL
.	NULL

Fujita	NULL
T	NULL
,	NULL
Shibuya	NULL
H	NULL
,	NULL
Hotta	NULL
H	NULL
,	NULL
Yamanishi	NULL
K	NULL
,	NULL
Tanaguchi	NULL
T	NULL
:	NULL
gene	NULL
regulation	NULL
:	NULL
Tandemly	NULL
repeated	NULL
sequences	NULL
of	NULL
a	NULL
synthetic	NULL
6	NULL
bp	NULL
oligomer	NULL
function	NULL
as	NULL
a	NULL
virus-inducible	NULL
enhancer	NULL
.	NULL

Cell	NULL
49:357	NULL
,	NULL
1987	NULL
56	NULL
.	NULL

Miyamoto	NULL
M	NULL
,	NULL
Fujita	NULL
T	NULL
,	NULL
Kimura	NULL
Y	NULL
,	NULL
Maruyama	NULL
M	NULL
,	NULL
Harada	NULL
H	NULL
,	NULL
Sudo	NULL
Y	NULL
,	NULL
Miyata	NULL
T	NULL
,	NULL
Taniguchi	NULL
T	NULL
:	NULL
Regulated	NULL
expression	NULL
of	NULL
a	NULL
gene	NULL
encoding	NULL
a	NULL
nuclear	NULL
factor	NULL
,	NULL
IRF-1	NULL
,	NULL
that	NULL
specifically	NULL
binds	NULL
to	NULL
IFN-8	NULL
gene	NULL
regulatory	NULL
elements	NULL
.	NULL

Cell	NULL
54:903	NULL
,	NULL
1988	NULL
57	NULL
.	NULL

Martin	NULL
DI	NULL
,	NULL
Orkin	NULL
SH	NULL
:	NULL
Transcriptional	NULL
activation	NULL
and	NULL
DNA	NULL
binding	NULL
by	NULL
the	NULL
erythroid	NULL
factor	NULL
GF-1/NF-El/Eryf	NULL
1	NULL
.	NULL

Genes	NULL
Dev	NULL
4:1886	NULL
,	NULL
1990	NULL
58	NULL
.	NULL

Meyers	NULL
S	NULL
,	NULL
Downing	NULL
JR	NULL
,	NULL
Hiebert	NULL
SW	NULL
:	NULL
Identification	NULL
of	NULL
AML1	NULL
and	NULL
the	NULL
(	NULL
8	NULL
;	NULL
21	NULL
)	NULL
translocation	NULL
protein	NULL
(	NULL
AML-1/ETO	NULL
)	NULL
as	NULL
sequence-specific	NULL
DNA-binding	NULL
proteins	NULL
:	NULL
The	NULL
runt	NULL
homology	NULL
domain	NULL
is	NULL
required	NULL
for	NULL
DNA	NULL
binding	NULL
and	NULL
protein-protein	NULL
interactions	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
13:6336	NULL
,	NULL
1993	NULL
59	NULL
.	NULL

Kunsch	NULL
C	NULL
,	NULL
Ruben	NULL
SM	NULL
,	NULL
Rosen	NULL
CA	NULL
:	NULL
Selection	NULL
of	NULL
optimal	NULL
Rel	NULL
DNA	NULL
binding	NULL
motifs	NULL
:	NULL
Interaction	NULL
of	NULL
both	NULL
subunits	NULL
of	NULL
with	NULL
DNA	NULL
is	NULL
required	NULL
for	NULL
transcriptional	NULL
activation	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
12:4412	NULL
,	NULL
1992	NULL
60	NULL
.	NULL

Nolan	NULL
GP	NULL
,	NULL
Ghosh	NULL
S	NULL
,	NULL
Liou	NULL
HC	NULL
,	NULL
Tempst	NULL
P	NULL
,	NULL
Baltimore	NULL
D	NULL
:	NULL
DNA	NULL
binding	NULL
and	NULL
Ix	NULL
}	NULL
inhibition	NULL
of	NULL
the	NULL
cloned	NULL
p65	NULL
subunit	NULL
of	NULL
NF-kappa	NULL
B	NULL
,	NULL
a	NULL
rel-related	NULL
polypeptide	NULL
.	NULL

Cell	NULL
64:961	NULL
,	NULL
1991	NULL
2529	NULL
61	NULL
.	NULL

Norman	NULL
C	NULL
,	NULL
Runswick	NULL
M	NULL
,	NULL
Pollock	NULL
R	NULL
,	NULL
Treisman	NULL
R	NULL
:	NULL
Isolation	NULL
and	NULL
properties	NULL
of	NULL
cDNA	NULL
clones	NULL
encoding	NULL
SRF	NULL
,	NULL
a	NULL
transcription	NULL
factor	NULL
that	NULL
binds	NULL
to	NULL
the	NULL
c-fos	NULL
serum	NULL
response	NULL
element	NULL
.	NULL

Cell	NULL
55:989	NULL
,	NULL
1988	NULL
62	NULL
.	NULL

Vasios	NULL
GW	NULL
,	NULL
Gold	NULL
JD	NULL
,	NULL
Petkovich	NULL
M	NULL
,	NULL
Chambon	NULL
P	NULL
,	NULL
Gudas	NULL
LJ	NULL
:	NULL
A	NULL
retinoic	NULL
acid-responsive	NULL
element	NULL
is	NULL
present	NULL
in	NULL
the	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
of	NULL
the	NULL
laminin	NULL
B1	NULL
gene	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
86:9099	NULL
,	NULL
1989	NULL
63	NULL
.	NULL

Astigianos	NULL
S	NULL
,	NULL
Barkai	NULL
U	NULL
,	NULL
Abarzua	NULL
P	NULL
,	NULL
Tan	NULL
SC	NULL
,	NULL
Harper	NULL
MI	NULL
,	NULL
Sherman	NULL
MI	NULL
:	NULL
Changes	NULL
in	NULL
gene	NULL
expression	NULL
following	NULL
exposure	NULL
to	NULL
nulli-SCCI	NULL
murine	NULL
embryonal	NULL
carcinoma	NULL
cells	NULL
to	NULL
inducers	NULL
of	NULL
differ-entiation	NULL
:	NULL
Characterization	NULL
of	NULL
a	NULL
down-regulated	NULL
mRNA	NULL
.	NULL

Differentiation	NULL
46:61	NULL
,	NULL
1991	NULL
64	NULL
.	NULL

Fraij	NULL
BM	NULL
,	NULL
Birckbichler	NULL
PJ	NULL
,	NULL
Patterson	NULL
MK	NULL
,	NULL
Lee	NULL
KN	NULL
,	NULL
Gonzales	NULL
RA	NULL
:	NULL
A	NULL
retinoic	NULL
acid-inducible	NULL
mRNA	NULL
from	NULL
human	NULL
erythroleukemia	NULL
cells	NULL
encodes	NULL
a	NULL
novel	NULL
tissue	NULL
transglutaminase	NULL
homologue	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
267:22616	NULL
,	NULL
1992	NULL
65	NULL
.	NULL

Hosler	NULL
BA	NULL
,	NULL
LaRosa	NULL
GJ	NULL
,	NULL
Grippo	NULL
JF	NULL
,	NULL
Gudas	NULL
LJ	NULL
:	NULL
Expression	NULL
of	NULL
REX-1	NULL
,	NULL
a	NULL
gene	NULL
containing	NULL
zinc	NULL
finger	NULL
motifs	NULL
,	NULL
is	NULL
rapidly	NULL
reduced	NULL
by	NULL
retinoic	NULL
acid	NULL
in	NULL
F9	NULL
teratocarcinoma	NULL
cells	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
9:5623	NULL
,	NULL
1989	NULL
66	NULL
.	NULL

LaRosa	NULL
GJ	NULL
,	NULL
Gudas	NULL
LJ	NULL
:	NULL
An	NULL
early	NULL
effect	NULL
of	NULL
retinoic	NULL
acid	NULL
:	NULL
Cloning	NULL
of	NULL
an	NULL
mRNA	NULL
(	NULL
Era-1	NULL
)	NULL
exhibiting	NULL
rapid	NULL
and	NULL
protein	NULL
synthesis-independent	NULL
induction	NULL
during	NULL
teratocarcinoma	NULL
stem	NULL
cell	NULL
differentiation	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
85:329	NULL
,	NULL
1988	NULL
67	NULL
.	NULL

Levine	NULL
RA	NULL
,	NULL
LaRosa	NULL
GJ	NULL
,	NULL
Gudas	NULL
LJ	NULL
:	NULL
Isolation	NULL
of	NULL
cDNA	NULL
clones	NULL
for	NULL
genes	NULL
exhibiting	NULL
reduced	NULL
expression	NULL
after	NULL
differentiation	NULL
of	NULL
murine	NULL
teratocarcinoma	NULL
stem	NULL
cells	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
4:2142	NULL
,	NULL
1984	NULL
68	NULL
.	NULL

Smits	NULL
HL	NULL
,	NULL
Floyd	NULL
EE	NULL
,	NULL
Jetten	NULL
AM	NULL
:	NULL
Molecular	NULL
cloning	NULL
of	NULL
gene	NULL
sequences	NULL
regulated	NULL
during	NULL
squamous	NULL
differentiation	NULL
of	NULL
tracheal	NULL
epithelial	NULL
cells	NULL
and	NULL
controlled	NULL
by	NULL
retinoic	NULL
acid	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
7:4017	NULL
,	NULL
1987	NULL
69	NULL
.	NULL

Bhatti	NULL
L	NULL
,	NULL
Sidell	NULL
N	NULL
:	NULL
Transcriptional	NULL
regulation	NULL
by	NULL
retinoic	NULL
acid	NULL
of	NULL
interleukin-2	NULL
a	NULL
receptors	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
.	NULL

Immunology	NULL
81:273	NULL
,	NULL
1994	NULL
70	NULL
.	NULL

Burn	NULL
TC	NULL
,	NULL
Petrovick	NULL
MS	NULL
,	NULL
Hohaus	NULL
S	NULL
,	NULL
Rollins	NULL
BJ	NULL
,	NULL
Tenen	NULL
DG	NULL
:	NULL
Monocyte	NULL
chemoattractant	NULL
protein-1	NULL
gene	NULL
is	NULL
expressed	NULL
in	NULL
activated	NULL
neutrophils	NULL
and	NULL
retinoic	NULL
acid-induced	NULL
human	NULL
myeloid	NULL
cell	NULL
lines	NULL
.	NULL

Blood	NULL
84:2776	NULL
,	NULL
1994	NULL
71	NULL
.	NULL

Drach	NULL
J	NULL
,	NULL
Zhao	NULL
S	NULL
,	NULL
Malavasi	NULL
F	NULL
,	NULL
Mehta	NULL
K	NULL
:	NULL
Rapid	NULL
induction	NULL
of	NULL
CD38	NULL
antigen	NULL
on	NULL
myeloid	NULL
leukemia	NULL
cells	NULL
by	NULL
all-trans	NULL
retinoic	NULL
acid	NULL
.	NULL

Biochem	NULL
Biophys	NULL
Res	NULL
Commun	NULL
195:545	NULL
,	NULL
1993	NULL
72	NULL
.	NULL

Hickstein	NULL
D	NULL
,	NULL
Back	NULL
A	NULL
,	NULL
Collins	NULL
S	NULL
:	NULL
Regulation	NULL
of	NULL
expression	NULL
of	NULL
the	NULL
CD11b	NULL
and	NULL
CD18	NULL
subunits	NULL
of	NULL
the	NULL
neutrophil	NULL
adherence	NULL
receptor	NULL
during	NULL
human	NULL
myeloid	NULL
differentiation	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
264:21812	NULL
,	NULL
1988	NULL
73	NULL
.	NULL

Oberg	NULL
F	NULL
,	NULL
Botling	NULL
J	NULL
,	NULL
Nilsson	NULL
K	NULL
:	NULL
Functional	NULL
antagonism	NULL
between	NULL
vitamin	NULL
D3	NULL
and	NULL
retinoic	NULL
acid	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
CD14	NULL
and	NULL
CD23	NULL
expression	NULL
during	NULL
monocytic	NULL
differentiation	NULL
of	NULL
U-937	NULL
cells	NULL
.	NULL

J	NULL
Immunol	NULL
150:3487	NULL
,	NULL
1993	NULL
74	NULL
.	NULL

Agura	NULL
ED	NULL
,	NULL
Howard	NULL
M	NULL
,	NULL
Collins	NULL
SJ	NULL
:	NULL
Identification	NULL
and	NULL
sequence	NULL
analysis	NULL
of	NULL
the	NULL
promoter	NULL
for	NULL
the	NULL
leukocyte	NULL
integrin	NULL
3-subunit	NULL
(	NULL
CD18	NULL
)	NULL
:	NULL
A	NULL
retinoic	NULL
acid-inducible	NULL
gene	NULL
.	NULL

Blood	NULL
79:602	NULL
,	NULL
1992	NULL
75	NULL
.	NULL

Pahl	NULL
HL	NULL
,	NULL
Rosmarin	NULL
AG	NULL
,	NULL
Tenen	NULL
DG	NULL
:	NULL
Characterization	NULL
of	NULL
the	NULL
myeloid-specific	NULL
CD11b	NULL
promoter	NULL
.	NULL

Blood	NULL
79:865	NULL
,	NULL
1992	NULL
76	NULL
.	NULL

Singer	NULL
SJ	NULL
:	NULL
The	NULL
structure	NULL
and	NULL
insertion	NULL
of	NULL
integral	NULL
proteins	NULL
in	NULL
membranes	NULL
.	NULL

Annu	NULL
Rev	NULL
Cell	NULL
Biol	NULL
6:247	NULL
,	NULL
1990	NULL
77	NULL
.	NULL

Manfioletti	NULL
G	NULL
,	NULL
Ruaro	NULL
ME	NULL
,	NULL
Del	NULL
Sal	NULL
G	NULL
,	NULL
Philipson	NULL
L	NULL
,	NULL
Schneider	NULL
C	NULL
:	NULL
A	NULL
growth	NULL
arrest-specific	NULL
(	NULL
gas	NULL
)	NULL
gene	NULL
codes	NULL
for	NULL
a	NULL
membrane	NULL
protein	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
10:2924	NULL
,	NULL
1990	NULL
78	NULL
.	NULL

Hartzell	NULL
S	NULL
,	NULL
Ryder	NULL
K	NULL
,	NULL
Lanahan	NULL
A	NULL
,	NULL
Lau	NULL
LF	NULL
,	NULL
Nathans	NULL
D	NULL
:	NULL
A	NULL
growth	NULL
factor-responsive	NULL
gene	NULL
of	NULL
murine	NULL
BALB/c	NULL
373	NULL
cells	NULL
encodes	NULL
a	NULL
protein	NULL
homologous	NULL
to	NULL
human	NULL
tissue	NULL
factor	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
9:2567	NULL
,	NULL
1989	NULL
79	NULL
.	NULL

Demay	NULL
MB	NULL
,	NULL
Gerardi	NULL
JM	NULL
,	NULL
DeLuca	NULL
HF	NULL
,	NULL
Kronenburg	NULL
HM	NULL
:	NULL
DNA	NULL
sequences	NULL
in	NULL
the	NULL
rat	NULL
osteocalcin	NULL
gene	NULL
that	NULL
bind	NULL
the	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
receptor	NULL
and	NULL
confer	NULL
responsiveness	NULL
to	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
87:369	NULL
,	NULL
1990	NULL
80	NULL
.	NULL

Izum	NULL
S	NULL
,	NULL
Mahdavi	NULL
V	NULL
:	NULL
Thyroid	NULL
hormone	NULL
receptor	NULL
a	NULL
isoforms	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2530	NULL
generated	NULL
by	NULL
alternative	NULL
splicing	NULL
differentially	NULL
activate	NULL
myosin	NULL
heavy	NULL
chain	NULL
gene	NULL
expression	NULL
.	NULL

Nature	NULL
334:539	NULL
,	NULL
1988	NULL
81	NULL
.	NULL

Noda	NULL
M	NULL
,	NULL
Vogel	NULL
RL	NULL
,	NULL
Craig	NULL
AM	NULL
,	NULL
Prahl	NULL
J	NULL
,	NULL
DeLuca	NULL
HF	NULL
,	NULL
Denhardt	NULL
DT	NULL
:	NULL
Identification	NULL
of	NULL
a	NULL
DNA	NULL
sequence	NULL
responsible	NULL
for	NULL
binding	NULL
of	NULL
the	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
,	NULL
receptor	NULL
and	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
,	NULL
enhancement	NULL
of	NULL
mouse	NULL
secreted	NULL
phosphoprotein	NULL
1	NULL
(	NULL
Spp-1	NULL
or	NULL
os-teocalcin	NULL
}	NULL
gene	NULL
expression	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sei	NULL
USA	NULL
§7:9995	NULL
,	NULL
1990	NULL
SCOTT	NULL
,	NULL
MUELLER	NULL
,	NULL
AND	NULL
COLLINS	NULL
82	NULL
.	NULL

Costa-Giomi	NULL
MP	NULL
,	NULL
Gaub	NULL
MP	NULL
,	NULL
Chambon	NULL
P	NULL
,	NULL
Abarzua	NULL
P	NULL
:	NULL
Characterization	NULL
of	NULL
a	NULL
retinoic	NULL
acid	NULL
response	NULL
element	NULL
isolated	NULL
by	NULL
whole	NULL
genome	NULL
PCR	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
20:3223	NULL
,	NULL
1992	NULL
83	NULL
.	NULL

Doucas	NULL
SV	NULL
,	NULL
Brockes	NULL
JP	NULL
,	NULL
Yaniv	NULL
M	NULL
,	NULL
de	NULL
The	NULL
H	NULL
,	NULL
Dejean	NULL
A	NULL
:	NULL
The	NULL
PML-retinoic	NULL
acid	NULL
receptor	NULL
a	NULL
translocation	NULL
converts	NULL
the	NULL
receptor	NULL
from	NULL
an	NULL
inhibitor	NULL
to	NULL
a	NULL
retinoic	NULL
acid-dependent	NULL
activator	NULL
of	NULL
transcription	NULL
factor	NULL
AP-1	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
90:9345	NULL
,	NULL
1993	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

®	NULL
blO	NULL
0d	NULL
1996	NULL
88	NULL
:	NULL
2517-2530	NULL
E3	NULL
,	NULL
a	NULL
hematopoietic-specific	NULL
transcript	NULL
directly	NULL
regulated	NULL
by	NULL
the	NULL
retinoic	NULL
acid	NULL
receptor	NULL
alpha	NULL
LM	NULL
Scott	NULL
,	NULL
L	NULL
Mueller	NULL
and	NULL
SJ	NULL
Collins	NULL
4	NULL
_	NULL
5	NULL
,	NULL
'	NULL
_	NULL
>	NULL
,	NULL
#	NULL
04	NULL
;	NULL
©1004	NULL
@	NULL
207	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/88/7/2517.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

